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SUMMARY 
IV 
Summary 
G protein-coupled receptors (GPCRs) are 7-helical transmembrane receptors 
holding a pivotal position in many cellular signal transduction processes. GPCRs act as 
molecular switches to transfer extracellular signals into the cell by conformational 
rearrangements within the protein, and to eventually evoke a cellular response. 
Deregulation or dysfunction of GPCRs is the cause of many pathophysiological 
conditions. Hence, GPCRs are not only essential to cell survival, but also represent a 
major drug target covering about 40% of all marketed drugs.  
However, GPCR research is as challenging as it is interesting. In vitro studies, 
covering mechanistic studies, structure determination and drug screening approaches, are 
necessary to better characterize GPCR function and regulation, but are severely limited 
due to the difficulties in obtaining high quantities of detergent-solubilized and stable 
protein. Hence, GPCR research is far behind its expectations and significance.  
The low expression levels and detergent-stability of GPCRs are the major 
roadblocks that need to be solved in order to expand and simplify GPCR research. By 
means of a previously developed FACS-based selection system, several GPCRs were 
efficiently evolved for higher expression and detergent-stability by introduction of only a 
few amino acid substitutions. Obviously, the limitations are directly related to their poor 
biophysical properties, i.e. the amino acid sequence.   
Despite its success, the random mutagenesis approaches did not suffice to 
conclude why certain sequences were selected, and how every single amino acid 
contributes to the restraints in expression and stability. This question was the basis for the 
work presented here. 
The first project of this work describes the saturation mutagenesis of every 
receptor position of the neurotensin receptor 1, with subsequent selection for high 
functional expression. The evolved pools of 380 position-specific libraries were analyzed 
by ultra deep sequencing, revealing which residues are preferred, tolerated and not 
accepted for every single position of the receptor. Thirty shift mutants, carrying one 
selected point mutation, were found to increase expression levels of D03. The detailed 
analysis of these shift mutants revealed that many of them also ameliorate detergent 
stability of the receptor.   
In a subsequent project, the identified mutations with advantageous effect on the 
biophysical protein properties were shuffled by in vitro DNA recombination and by DNA 
assembly of a synthetic binary library to generate combinatorial libraries. From these 
libraries, receptor variants with unprecedented expression levels and detergent stability 
could be evolved, showing a strong coevolution of both properties. The best variants 
express more than 25,000 functional receptors per E. coli cell, are highly stable in short-
chain detergents and retain their receptor-typical ligand binding profile and signaling 
ability.  
The final study describes the selection of DARPin binders to the final evolved 
NTR1 variants for later co-crystallization purposes. The GPCR-surface available for 
protein-protein interactions is constrained to the solvent-accessible areas that are mainly 
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composed of helix ends and flexible loops. Despite highest detergent-stability, these 
limitations are obviously critical. 
In summary, this work has provided detailed and exhaustive insight into the 
contribution of every receptor position to expression and detergent-stability, allowing us to 
better understand the concepts and limitations of natural versus directed evolution. The 
results of this study enabled us to evolve combinatorial NTR1-variants with maximal 
effects, which are of high interest for drug discovery, in vitro functional and structural 
studies.  
 
   
ZUSAMMENFASSUNG 
VI 
Zusammenfassung 
G Protein-gekoppelte Rezeptoren (GPCRs) sind Zelloberflächenrezeptoren mit 
einer bedeutenden Funktion in der Signaltransduktion. GPCRs sind gekennzeichnet durch 
sieben Helices, welche die Lipidmembran senkrecht durchspannen. Sie agieren als 
molekulare Schalter, indem sie extrazelluläre Information in Form von Ligandenbindung 
durch eine Konformationsänderung des Proteins in die Zelle übertragen, und so eine 
zelluläre Reaktion auslösen. Funktionsstörungen von GPCRs und Fehlregulation von 
GPCR-basierten zellulären Prozessen sind die Ursache vieler Erkrankungen. Aufgrund 
dieser Relevanz stellen GPCRs ein bedeutendes Zielmolekül für die pharmakologische 
Intervention dar, mit einem Marktanteil von geschätzten 40% an allen verschriebenen 
Medikamenten.  
Die Erforschung von GPCRs ist daher äusserst interessant, jedoch ebenso 
schwierig. Viele Forschungsansätze zum besseren Verständnis der GPCRs, vor allem in 
vitro-basierte Studien wie die funktionelle Charakterisierung von GPCRs sowie die 
Strukturbestimmung als auch innovative drug screening-Methoden werden durch die 
schlechten biophysikalischen Eigenschaften der GPCRs erschwert. Eines der 
Hauptprobleme ist dabei die Herstellung von hohen Mengen an detergens-gelöstem und 
aufgereinigtem Rezeptor.  
Um die Arbeit an GPCRs zu vereinfachen und intensivieren, ist es notwendig, das 
allgemein sehr niedrige Expressionsniveau von GPCRs und ihre begrenzte Stabilität in 
Detergensmicellen zu verstehen und zu optimieren. Die gerichtete Evolution von 
Proteinen stellt eine elegante Methode dar, um Proteine auf einen gewünschten Phänotyp 
hin zu evolvieren, und ist mit der Entwicklung eines FACS-basierten Selektionssystems 
inzwischen auch auf GPCRs anwendbar. Mithilfe dieses Verfahrens konnten bereits 
einige Rezeptoren erfolgreich evolviert werden. In allen Fällen waren nur wenige 
Mutationen notwendig, um hohe Expression und robuste Detergensstabilität zu erreichen. 
Offensichtlich ist der Phänotyp des GPCRs direkt auf die biophysikalischen Eigenschaften 
und demnach auf die Aminosäuresequenz zurückzuführen. 
Der Erfolg der zufälligen Mutagenese und Selektion ist unbestritten, jedoch 
generiert diese Methode nicht genügend Daten, um zu verstehen, warum bestimmte 
Sequenzen selektiert werden und wie jede einzelne Position des GPCRs seine 
Expression und Stabilität beeinflusst.  
Die erste Studie dieser Arbeit beschreibt daher die vollständige Mutagenese des 
Neurotensinrezeptors 1 (rNTR1), in der jede Aminosäure des Rezeptors separat und 
vollständig randomisiert wurde. Die 380 positionsspezifischen Bibliotheken wurden auf 
hohe Expression hin selektiert, und die evolvierten pools wurden mittels ultra-deep 
sequencing analysiert. Diese Analyse machte deutlich, welche Aminosäuren bevorzugt, 
toleriert und inakzeptabel für die jeweilige Rezeptorposition sind. So wurden dreissig Shift-
Mutanten, die je eine Mutation in der Rezeptorsequenz tragen, identifiziert, die das 
Expressionsniveau von D03 erhöhen. Die detaillierte Analyse dieser Mutanten zeigte, 
dass einige dieser Mutationen auch die Detergensstabilität des Rezeptors verbessern.  
In der folgenden Studie wurden kombinatorische Bibliotheken der bereits 
charakterisierten Einzelmutationen hergestellt. Hier wurden einerseits in vitro DNA-
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Rekombination als auch die synthetische Assemblierung einer binären Bibliothek 
angewendet. Aus diesen Bibliotheken konnten Rezeptorvarianten mit beispielloser 
Expression und Detergensstabilität, unter offensichtlicher Korrelation beider Faktoren, 
evolviert werden. Die besten Varianten zeigten mehr als 25,000 funktionelle Rezeptoren 
pro Zelle, sind hochstabil auch in kurzkettigen Detergenzien, erhalten aber auch ihre 
rezeptortypische Ligandenbindung als auch Signalfähigkeit. 
Die finale Studie beschreibt die Selektion von DARPin Bindeproteinen an die 
evolvierten Varianten, um diese für Co-Kristallisationsstudien einzusetzen. Die Oberfläche 
des GPCRs, welche für Protein-Protein-Wechselwirkungen zur Verfügung steht, ist 
beschränkt auf den extra- und intrazellulär orientierten Bereich, der hauptsächlich aus 
loops (unstrukturierter Abschnitt zwischen zwei Helices) und den Helixenden besteht. 
Trotz hoher Detergensstabilität der evolvierten Varianten scheinen diese 
Einschränkungen limitierend für die Selektion zu sein. 
Zusammenfassend lässt sich sagen, dass diese Arbeit einen detaillierten und 
gründlichen Einblick in die Bedeutung jeder Rezeptorposition für Expression und Stabilität 
des Rezeptors erreicht hat. Diese Daten ermöglichen ein besseres Verständnis und 
Vergleich der natürlichen gegenüber der in vitro-Evolution. Das Ergebnis dieser Arbeit 
sind hochexprimierte und stabile Rezeptorvarianten von enormer Relevanz für zukünftige 
Studien im Bereich des drug screenings, sowie für Funktions- und Strukturanalysen.   
 
   
AIM OF THE THESIS 
VIII 
Aim of the thesis 
By means of directed evolution, this study aims to first identify, and subsequently 
to overcome the constraints within the primary sequence of a GPCR that determine its 
poor biophysical properties, and to generate receptor variants with high functional 
expression levels and high detergent-stability that facilitate subsequent in vitro studies, 
such as functional studies, drug screening approaches and crystallization studies. The 
D03-variant of the rat neurotensin receptor 1 (rNTR1) is used as a model receptor. 
 
Chapter 1 provides the theoretical background to this work. Chapter 2 (article in 
press) introduces GPCRs as targets for directed evolution, and explains the methods 
covering library generation and selection that are used throughout the study. The 
experimental results are divided in two parts: The first part (Chapter 3-A, published article) 
focuses on the elucidation of the critical residues in the receptor sequence which 
determine and limit functional expression and detergent stability of GPCRs. One by one, 
every receptor position is turned into an NNN-library that is subsequently selected for the 
variants with highest expression levels and analyzed by ultra deep sequencing. Chapter 
3-B is a separate manuscript highlighting the theoretical background and statistical 
corrections applied to analyze the ultra deep sequencing data. The second part (Chapter 
4, published article) aims to maximize receptor expression and stability by combining the 
advantageous shift mutations identified in part one. Shuffled libraries of shift and D03 
residues are generated by two different approaches, and selected for high functional 
expression. The best variants are characterized in detail with respect to expression, 
detergent stability and signaling activity. The highest evolved receptor variants are used 
as targets for selection of DARPin binders by ribosome display for cocrystallization 
purposes (Chapter 5). Chapter 6 draws general conclusions and shows future 
perspectives for this study. 
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1.1 Membrane proteins 
Integral membrane proteins (IMPs) are found in all organisms from bacteria to 
man. Many fundamental physiological processes rely on the proper functioning of IMPs, 
among which transport mechanisms (ranging from ions to nutrients) and signaling 
processes are essential for cell survival. In signaling processes, IMPs transfer information 
across the lipid bilayer and evoke a cellular response to adapt to environmental changes. 
Gram-negative bacteria are surrounded by two membranes, differing in their 
composition and function. The inner membrane is a symmetric lipid bilayer composed of 
phospholipids, functioning as a major permeability barrier, whereas the outer membrane is 
asymmetric with phospholipids on the inside and lipopolysaccharides on the outside. Both 
membranes are populated by integral membrane proteins that optionally contain soluble 
domain(s) located within the cell or outside, but that differ substantially in their 
transmembrane architecture: In contrast to soluble proteins, IMPs populate only two 
protein folds, namely -helices and -barrels (Minetti and Remeta, 2006). The -helical 
fold comprises proteins with single-spanning transmembrane helices to proteins 
composed of helix bundles of 2 to up to 12 individual helices. The -helical fold is highly 
abundant, and is found from inner membranes of bacteria to plasma membranes of 
mammalian cells. In contrast to that, -barrels, composed of 8 to 22 -sheets building a 
closed barrel, are exclusively found in the outer membrane of gram-negative bacteria, 
mitochondria and chloroplasts (Tamm et al., 2004). The -helical and -barrel membrane 
proteins differ in their hydrophobicity, which is larger for -helical membrane proteins and 
smaller for -barrels which, to the inside, form a rather hydrophilic pore for the selective 
transport of cargo across the outer membrane.  
Biosynthesis of IMP requires correct targeting to and folding and insertion into the 
membrane. Not surprisingly, -helical and -barrel membrane proteins are characterized 
by individual protein targeting, folding and insertion pathways. All IMPs are targeted from 
the translating ribosome to the translocon pore (SecYEG in bacteria, Sec61 in eukaryotes) 
located in the inner bacterial membrane (plasma membrane in eukaroytes). The -helical 
proteins designated for the inner membrane (or plasma membrane) attain secondary 
structure during this process, and the -helices are subsequently and laterally released 
from the translocon pore into the lipid bilayer (Rapoport, 2007; Shan and Walter, 2005). 
The fact that backbone hydrogen bonding is satisfied within the entity of a single helix 
sufficiently compensates for the cost of helix insertion into the hydrophobic lipid bilayer, 
hence facilitating simultaneous folding and insertion, with tertiary interactions formed 
between individual helices in a later stage within the membrane. Fully denatured -helical 
IMPs do not spontaneously refold in vitro, further highlighting the complex nature of the in 
vivo folding and insertion process. 
In contrast to that, proteins with a signal sequence for the outer membrane are 
translocated into the periplasmatic space in an unfolded state, where these polypeptides 
are bound by specific chaperones that prevent aggregation and assist folding of -barrels. 
A unique feature of -barrels is that they fold form a fully unfolded polypeptide sequence, 
GENERAL INTRODUCTION 
 
- 3 - 
both in vivo in the bacterial periplasm as well as in vitro (Huysmans et al., 2010; Tamm et 
al., 2001). The intramolecular hydrogen bonding pattern of -folds and -barrels in 
particular is established on the tertiary structure level, requiring at least a partially formed 
barrel before insertion into the hydrophobic outer membrane can occur (tilted folding-
insertion mechanism). This, in turn, also explains the relative high hydrophility of -barrel 
proteins in order to facilitate folding in the periplasm. Insertion of the -barrel into the outer 
membrane is believed to be a spontaneous process (Tamm et al., 2001).    
Positioning and anchoring of -helical IMP within the lipid bilayer is enhanced by 
the presence of an “aromatic belt”, in which aromatic amino acids anchor the protein in the 
lipid bilayer (Kelkar and Chattopadhyay, 2006), and basic residues at the intracellular helix 
ends interact with the phospho-moiety of the lipid head groups (Heijne, 1986). The 
hydrophobic shell of IMPs is both imperative in vivo and disadvantageous in vitro (see 
Section 1.4). The -helical membrane proteins are compactly folded, and relay signals 
into the cell rather than cargo, as achieved by pumps. 
1.2 G protein-coupled receptors  
Eukaryotic signaling processes are primarily mediated by G protein-coupled 
receptors (GPCRs), the largest group of IMPs that is characterized by seven membrane-
spanning helices (TMs) with differences in the (optional) soluble N-terminal domain, 
located on the extracellular side (Figure 1-1).  
 
The human genome comprises approximately 1000 GPCRs, grouped according to 
sequence homology, function and nature of the ligand (groups A-F, (Lefkowitz, 2004; 
Pierce et al., 2002)). Class A comprises the large group of rhodopsin-like receptors, 
Figure 1-1. GPCR architecture in the lipid bilayer (dopamine receptor D3, PDB ID 3PBL).
The 7 transmembrane helices (I-VII) are connected by three extracellular (ECL1-ECL3) and
three intracellular loops (ICL1-ICL3). Ligand binding occurs at the extracellular surface
(EC), and coupling with G proteins on the intracellular surface (IC). Adapted from Katritch
et al., 2012.  
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including the diverse set of olfactory receptors (~400) as well as receptors activated by 
endogenous ligands. Class A receptors are distinguished from the other classes by their 
short and flexible N-terminus, and their endogenous ligands which bind in a groove 
between the C-terminal helices and loops (depending on the nature and size of the 
ligand). Recently, an alternative classification system has been proposed, following the 
results of a new and strict phylogenetic analysis (GRAFS-system, “R” stands for the 
rhodopsin family which is roughly equivalent to class A (Bjarnadottir et al., 2006)). GPCRs 
share common and unique sequence motifs in every helix (Table 1-1), exhibiting a 
functional or structural role (Mirzadegan et al., 2003). Consensus motifs are conserved for 
functional or structural reasons. The Ballesteros-Weinstein nomenclature refers to the 
most conserved position of a helix as x.50, with x denoting the helix in sequential order, 
and the second number counting downwards to the N-terminus and upwards to the C-
terminus (Ballesteros and Weinstein, 1995). The E/DRY motif in TM3 is a highly 
conserved motif in GPCRs, and involved in receptor activation (Rovati et al., 2007). 
 Table 1-1. GPCR consensus motifs.  
 Consensus Position rNTR1 
TM 1 GNxxV 811.49-851.53 GNSVT 
TM 2 LxxxD 1092.46-1132.50 LALSD 
TM 3 DRY 1663.49-1683.51 ERY, D03: ELY 
TM 4 W 1944.50 W 
TM 5 FxxP 2465.47-2495.50 FLFP 
TM 6 CWxP 3206.47-3236.50 CWLP 
TM 7 NPxxY 3657.49-3697.53 NPILY 
 
 
GPCRs show enormous diversity with respect to the nature and the size of the 
ligand molecule, ranging for example from photons (rhodopsin) to odorants (olfactory 
receptors) and peptide hormones (e.g. angiotensin) to nucleotides (e. g. ATP) and ions 
(e.g. Ca2+) (e.g. (Kobilka, 2007)). Despite their broad ligand diversity, all GPCRs share a 
common activation and signaling mechanism upon ligand binding: Binding of an 
extracellular receptor agonist induces conformational rearrangement of the helices, 
bringing the receptor into the activated state R*, in which the receptor can bind and 
activate the downstream heterotrimeric G proteins (Deupi and Kobilka, 2007). While the 
detailed mechanism of receptor activation is not fully elucidated yet, there is structural 
evidence that agonist binding induces “collapsing” of the TM helices, resulting in a more 
constrained agonist binding site. The necessary conformational rearrangements are 
enabled by movement of the helices, and it is assumed that movement of TM5 and TM6 
reveal the G-protein interaction surface on the intracellular side of the membrane (Ye et 
al., 2010). 
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Binding of the G protein to the activated GPCR induces exchange of GDP for GTP 
at the G subunit, and signal transduction is continued by the dissociation of the G-
subunit from the G-subunits after nucleotide hydrolysis (Figure 1-2). At this step, signal 
transduction to downstream effectors includes strong signal amplification, thus ensuring 
fast and efficient signal propagation (Figure 1-3), eventually resulting in a cellular 
response and adaptation to environmental changes. The downstream signaling pathways 
are highly diverse and not necessarily dependent on G proteins (Lefkowitz, 2004; Pierce 
et al., 2002). Phosphorylation of the GPCR by G protein-coupled receptor kinases (GRKs) 
and subsequent binding of -arrestins was assumed for a long time to mainly drive 
receptor desensitization, recycling and degradation (Ferguson, 2001). Recently, it 
emerged that -arrestins are multifunctional, with an additional role in signal transduction 
(Lefkowitz and Shenoy, 2005).  
Figure 1-2. Illustration of the GPCR-G-protein interaction. Agonist binding to the GPCR
induces GDP for GTP exchange at the G subunit, resulting in dissociation of G from G
and further downstream signaling. Picture adapted from www.rcsb.org, molecule of the
month October, 2004.  
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1.3 G protein-coupled receptors as drug targets 
  GPCRs act as bridges between extracellular information and intracellular 
reaction, and this key switch position in signal transduction makes them essential for cell 
survival. GPCR deregulation and dysfunction causes many pathophysiological conditions, 
including diseases such as cardiovascular conditions (1-adrenergic receptor (Drake et al., 
2006)) and asthma (2-adrenergic receptor (Kawakami et al., 2004)); while some diseases 
are the consequence of alterations at the genetic level, ranging from retinitis pigmentosa 
(RP) to female infertility (follicle-stimulating hormone receptor (Insel et al., 2007; 
Schöneberg et al., 2004)) or cancer (Lappano and Maggiolini, 2011). Furthermore, 
perception and treatment of pain is conveyed via GPCRs (Stone and Molliver, 2009), a 
major target of pharmaceutical intervention. As a direct consequence, GPCRs represent 
highly prevalent drug targets, covering about 40% of all currently marketed drugs 
(Overington et al., 2006).  
GPCR drug discovery has long been based on screening large compound libraries 
in cellular ligand-displacement studies. Such studies rely on the availability of a high-
affinity radiolabelled ligand, and are hence not applicable to “orphan” receptors, for which 
no ligand has been identified. Additionally, they also produce considerable waste disposal 
Figure 1-3. Overview of GPCR downstream signaling. The GPCR is activated by its ligand,
inducing recruitment of the heterotrimeric G protein and exchange of GDP for GTP at the G
subunit, followed by nucleotide hydrolysis and dissociation of the G from the G
subunits.  Both G and G can activate downstream effectors, depending on the G protein
isoform. Picture adapted from Lappano and Maggiolini, 2011.
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costs (Eglen and Reisine, 2009) and do not allow agonists, antagonists or partial 
agonists/antagonists to be distinguished (Eglen et al., 2007). Consequently, the last 
decade observed a shift in drug discovery towards more cell-based functional assays, 
allowing the study of orphan receptors as well as directly differentiation between agonistic 
or antagonistic compounds (Salon et al., 2011). Such assays monitor, for example, the 
ability of a compound to recruit G proteins, measured as GTPS binding to G, or the 
increase in second messengers such as Ca2+ or inositolphoshate. However, such indirect 
assays are highly susceptible to assay conditions, cell viability issues and interference 
with other cellular signaling processes resulting in difficult-to-interprete data (Salon et al., 
2011). Hence, none of these methods has achieved the hit rate of ligand-based methods 
(Eglen et al., 2007; Macarron, 2006). 
Recently, fragment-screening approaches (Congreve et al., 2011) and in vitro 
screening approaches became more prevalent in drug discovery. In vitro biochemical and 
biophysical assays circumvent the described limitations of cell-based assays, allowing 
direct and unequivocal measurement of G protein recruitment to purified receptor and 
specific targeting of receptor transition states or interaction surfaces, a promising 
approach in drug development (Alkhalfioui et al., 2009). An interesting method in this 
respect is the use of surface plasmon resonance (SPR) employing detergent-solubilized 
and purified GPCRs. These bimolecular assays are advantageous as they are label-free 
and allow simultaneous acquisition of kinetic binding data (Navratilova et al., 2005). 
Similar to in vitro studies using conventional small-molecule compound libraries, 
recent advances in drug development making use of binding proteins such as antibodies 
(e.g. (Chan and Carter, 2010) and others) or alternative scaffolds such as DARPins (for 
recent review, see Tamaskovic et al., 2012) as therapeutics can only become applicable 
to GPCRs if suitably solubilized and purified GPCR targets are available (Hutchings et al., 
2010). (Tamaskovic et al., 2012) 
In addition to these innovative screening approaches opening new ways for 
development of GPCR-targeting drugs, a detailed understanding of the molecular 
mechanisms driving GPCR activation is fundamental to decipher the basis of GPCR-
derived pathophysiological conditions. Recently, Kobilka and coworkers have shown that 
receptor activation and G-protein interaction can be monitored in vitro by attaching 
fluorescence probes to the 2-adrenergic receptor (Swaminath et al., 2005; Yao et al., 
2006), providing insights into conformational receptor rearrangements upon ligand 
binding. Eventually, these results will help to advance treatments by tailored drug design.  
1.4 Caveats in G protein-coupled receptor research 
Seen its pivotal role for pharmacology, GPCR research is far behind what is 
needed, despite enormous efforts. In vitro-based studies of GPCR function have great 
potential for pharmacology and for gaining mechanistic insight into GPCR activation. 
However, GPCRs have evolved to function efficiently in vivo in a lipid bilayer, and their 
adapted characteristic features are often contrary to what is desirable for in vitro studies. 
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When isolated from the membrane, GPCRs necessarily require the presence of a 
detergent micelle to substitute for the lipid bilayer and to shield the hydrophobic outer 
surface. The availability of a suitable detergent for membrane protein extraction and 
retention of protein activity may constitute the main bottlenecks and challenges in GPCR 
research. While membrane proteins in general can be remarkably stable in the lipid 
bilayer (Haltia and Freire, 1995), they are inevitably more prone to protein denaturation 
over time when solubilized in detergent, since no detergent can fully compensate for the 
stabilizing effect of the lipid bilayer (Figure 1-4 for illustration). Moreover, conformational 
flexibility is inherent to GPCR function, allowing both antagonists and agonists to be 
accommodated, and to respond to this binding with individual receptor conformations 
representing different and intermediate activity states. In a detergent micelle, the sampling 
of conformational states is detrimental to protein stability.  
 
 
 
 
In particular, GPCR research is further plagued by low expression levels. The 
exception is rhodopsin, which can be directly isolated from its natural source due to its 
high abundance (isolation from bovine eye tissue (Palczewski et al., 2000)). In vivo, low 
expression levels account for low basal signaling activity, compensated by fast and strong 
signal amplification in the case of receptor activation, and both expression and stability 
have evolved to facilitate appropriate signal termination by receptor recycling and 
degradation. Recombinant expression of GPCRs requires laborious and often costly 
large-scale setups to obtain milligram amounts of purified protein. Many GPCRs are 
difficult to express in Escherichia coli, further impeding the process of obtaining 
recombinant and purified GPCR protein. More complex expression hosts such as yeast, 
mammalian cells or Spodoptera frugiperda (Sf9)-insect cells might prove successful for 
the expression of a specific target GPCR, but are not only slower and more expensive, but 
importantly cannot overcome the limitations imposed by the protein sequence itself, e.g. 
low detergent-stability.  
These major roadblocks to produce large amounts of detergent-solubilized, 
purified and detergent-stable GPCR dramatically restrict drug development, functional 
studies and structural biology of GPCRs.  
Figure 1-4. Scematic illustration of the lipid bilayer and detergent micelle environment. 
GPCR, homology model of rNTR1 (homology model by A. Honegger).  
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1.5 Structural studies on GPCRs 
Structural biology of GPCRs suffers from the above described caveats, and is 
further aggravated by limited options for crystal contact formation, since most of the 
receptor is shielded by the detergent micelle, and only the extra- and intracellular receptor 
surfaces composed of flexible loops are solvent-accessible. Detergents with a small 
micelle size (short-chain detergents) are preferred for crystallization, but are strongly 
protein-denaturating (le Maire et al., 2000; Ostermeier and Michel, 1997). Addition of 
cholesteryl hemisuccinate (CHS) has been shown to aid in GPCR crystallization (Lebon et 
al., 2011), pointing to the modulation of GPCR stability by lipid-like molecules. Recent 
advances in GPCR crystallization have been facilitated by the development of new 
methodologies: Replacement of the large and flexible intracellular loop 3 (IL3), connecting 
transmembrane helices (TM) 5 and 6,  by the soluble and rigid protein T4 lysozyme (T4L) 
has proven successful for crystallization of various GPCRs. In addition to replacing 
unstructured regions, this approach increases the protein surface available for crystal 
contact formation (see (Katritch et al., 2012) for review). The inherent conformational 
flexibility of GPCRs is reduced by ligand binding to the receptor, and indeed, all currently 
solved GPCR structures except for opsin have been solved as ligand-receptor complexes. 
Antagonist binding is preferred, since the inactive state R of the receptor is inherently 
more stable than the activated state R* (Gether et al., 1997). From the first structure of a 
non-rhodopsin GPCR in 2007, it took another four years for the first agonist-bound 
receptor structure to be solved (Rasmussen et al., 2011a). Combined with the lipidic-cubic 
phase-methodology for crystallization of membrane proteins (LCP, for review 
see(Cherezov, 2011), it seems that a main bottleneck of GPCR crystallography has been 
solved. However, the T4 lysozyme strategy comes with a major drawback: Replacement 
of IL3 by T4L masks the G-protein interaction surface, thus precluding any conclusions on 
downstream signaling mechanisms. Recently, the structure of the 2-adrenergic receptor 
in complex with Gs provided some information (Rasmussen et al., 2011b), but it 
represents only one snapshot of the myriad of possible GPCR-G protein interactions 
(Figure 1-5). 
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While at the beginning of this thesis work no structure of a GPCR other than 
rhodopsin had been solved, more than 15 GPCR structures are now solved, and hence 
commonalities and differences between individual receptors start to emerge. Obviously, 
the receptor part oriented towards the extracellular space accounts for ligand binding, with 
a high diversity between individual receptors, but only small conformational changes (see 
Figure 1-1 for illustration). The more intracellular half of the receptor interacts with 
downstream effector proteins, and is thus more conserved to maintain functional coupling, 
but includes larger conformational changes that can be distinguished between signaling-
inactive and signaling-active states of the receptor (for review, see(Katritch et al., 2012).  
Rather unclear from a structural point of view is the prevalence and role of the 
“ionic lock” between the arginine (position 3.50) of the E/DRY motif in TM3 and the 
glutamate in TM6 (position 6.30) for the inactive receptor state, which was observed to be 
in the locked conformation in the first structure of rhodopsin (Palczewski et al., 2000), but 
could not be confirmed in many of the subsequent structures of GPCRs (e.g.(Cherezov et 
al., 2007), hence questioning a functional role for this motif. Subsequent studies revealed 
that the ionic lock exists in solution, and is compromised in the crystal as a consequence 
of the presence of T4 lysozyme and crystal lattice restraints (Dror et al., 2009; Romo et 
al., 2010). The structure of the dopamine receptor D3 fused with T4L displays the ionic 
lock (Chien et al., 2010), showing that formation of the ionic lock is not generally 
precluded in the presence of T4L, but is rather dependent on the receptor conformational 
Figure 1-5. Crystal structure of the 2-adrenergic receptor in complex with Gs (PDB ID
3SN6). The GPCR is depicted in rainbow colours, Gs in grey, G in green and G in yellow.
The C-terminus of Gs is responsible for interaction with the GPCR, and protrudes into the
GPCR helix bundle upon binding. Picture generated with PyMOL (http://www.pymol.org/).  
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state that is populated in the T4L-fusion protein. Despite its unchallenged relevance, these 
studies show that current GPCR structural biology, especially the use of protein fusions, 
nonetheless has its limitations. 
1.6 Requirement of new GPCR engineering approaches 
Structure determination alone will not suffice to fully understand GPCR function, 
drug binding and activity. Such data need to be complemented with functional data for the 
soluble protein. During the last few years, the model of GPCRs exhibiting a simple on/off-
mode of action has been expanded tremendously, revealing that GPCRs rather populate 
several intermediate receptor states during the activation process (Deupi and Standfuss, 
2011). While this observation opens new intervention possibilities for drug development 
(see Section 1.3), it also highlights that any single structure can not tell the entire story. 
Additionally, despite the broad applicability of the T4 lysozyme strategy, structure 
determination is still restricted to GPCRs which can be recombinantly expressed, 
solubilized and purified and which retain their integrity in detergent micelles. Many GPCRs 
that exhibit poor recombinant expression and detergent stability, among them receptors of 
utmost pharmacological relevance, fail already during earlier steps of the protein 
production pipeline.  
The necessity for functional characterization and in vitro drug screening methods 
demand innovative approaches to broaden the spectrum of GPCRs that become 
accessible to in vitro studies. Process engineering aims at maximizing protein yield by 
optimization of external parameters such as expression conditions, expression host, 
detergent used for solubilization and the purification process itself. However, such 
parameters have to be individually tested and optimized for each target protein, making it 
a cumbersome undertaking. Also, process engineering alone cannot overcome the 
limitations imposed by the primary protein sequence itself, hence restricting its 
implications.   
1.7 Directed evolution of proteins 
Natural evolution has shaped protein function over millions of years. According to 
Darwin, natural selection drives evolution, and “survival of the fittest” leads to continuous 
adaptation of the species to the environment, thus shaping the gene pool. A very 
important principle in adaptive evolution is the occurrence of neutral mutations, that 
remain silent with respect to protein function as they occur but have potential effects when 
combined with other mutations. Furthermore, natural evolution is shaped by the 
preference for single base exchanges and the conserved nature of the genetic code. As a 
consequence, only 7 of 19 possible amino acid substitutions are typically assessed and 
these usually have similar biophysical properties (Miyazaki and Arnold, 1999). The 
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consequences of this limitation on natural evolution are difficult to assess, but certainly 
contribute to making natural evolution a slow process.  
Directed evolution of proteins is a very elegant and efficient approach to engineer 
a given target protein for a desired phenotype. Basically, the process of natural evolution 
is mimicked in vitro in a condensed form, allowing a target protein to be evolved for a 
desired phenotype in a short time, typically weeks to months. Genetic diversity is most 
commonly introduced by random mutagenesis of the target DNA sequence, providing 
control over mutagenic load and bias. Very similar to natural evolution, however, random 
mutagenesis is biased towards substitutions encoded by single base changes. Different 
from natural evolution, in vitro evolution allows the product of evolution to be directed by 
adjustment of selection pressure, while iterative randomization and selection rounds allow 
enrichment of protein variants with a new phenotype within a short time. By means of 
random mutagenesis and selection, protein properties such as enzyme selectivity (Chen 
and Arnold, 1993) or thermal stability (Liao et al., 1986) have been efficiently evolved. 
Natural evolution of membrane proteins, and GPCRs in particular, is a comparably 
slow process. However, the high conservation of GPCRs over time is not neccessarily a 
result of low mutagenic tolerance, but represent strong conservation of GPCR function in 
a finely-tuned network, keeping in vivo-expression and stability at an acceptable level. 
Indeed, it has been shown by Bowie and coworkers that stabilizing mutations are 
not rare in membrane proteins (Bowie, 2001), which are rather unused in natural evolution 
due to contrary or absent selection pressure. Likewise, it can be assumed that mutations 
can be found that improve expression level and detergent stability, thereby facilitating in 
vitro studies. Until recently, such methods could not be applied to GPCRs, mainly 
because of the lack of an appropriate selection system. This deficit could recently be 
overcome with the development of a FACS (fluorescence activated cell sorting)-based 
screening and selection method that enables application of directed evolution to GPCRs 
(Sarkar et al., 2008) (Figure 1-6). Briefly, the target GPCR sequence is diversified by 
random mutagenesis, allowing isolation — under the applied selection pressure — near-
target like receptor variants with improved phenotype, specifically increased expression 
and detergent stability. Most importantly, receptor functionality is retained as a 
consequence of employing a fluorescence-labeled agonist for selection. This methodology 
has proven successful to render the tachykinin receptor NK1 accessible to downstream 
studies (Dodevski and Plückthun, 2011). In its wild-type state, NK1 expresses at very low 
levels, but more critically, cannot be functionally solubilized from the membrane, thus 
precluding any functional or structural studies. In other words, most GPCR studies so far 
have concentrated on receptors with reasonable expression and stability that are 
amenable to the above described methodologies. Obviously, the biophysical properties of 
receptors such as NK1 are different and, for that reason, highly interesting for 
characterization, since especially the comparison of differences in GPCR function and 
architecture can broaden our understanding of this protein class.  
Several receptors could be efficiently evolved for high expression, accompanied by 
increased detergent stability. The apparent coevolution suggests that there are at least 
partially overlapping forces driving expression and detergent stability, since detergent 
stability is never under direct selection pressure. A possible explanation for this 
GENERAL INTRODUCTION 
 
- 13 - 
coevolution could be improved protein folding and packing, resulting in more efficient 
targeting to and protein folding within the membrane, and simultaneously resulting in 
higher detergent resistance due to more compact protein folding and decreased 
conformational flexibility. 
 
While it is not entirely clear yet how the observed amelioration of the biophysical 
protein properties is achieved at the molecular level, FACS-based selection is obviously 
successful for quick and efficient evolution of receptors for expression and stability, 
rendering GPCRs amenable to in vitro study which had not been previously possible. As 
suggested by Bowie in 2001, we found that stabilizing mutations were frequent and easy 
to identify by random mutagenesis, and as few as 4-10 mutations were needed to 
substantially increase expression and detergent stability (Dodevski and Plückthun, 2011; 
Sarkar et al., 2008). With an average length of 300-400 amino acids for a GPCR, these 
mutants retain very high sequence homology, usually greater than 95%, giving these 
evolved variants high relevance for functional and structural investigations.  
 Expression and selection in E. coli is preferred over other systems for its technical 
ease and its efficiency to produce high amounts of recombinant protein in a time- and 
cost-saving manner. At the same time, removal of the target receptor from its native 
environment might be valuable and even mission-critical. Although the evolved receptor 
variants also exhibit higher expression in eukaryotic expression systems, selection in the 
Figure 1-6. FACS-based selection for high functional expression. The randomized GPCR
library is expressed in E. coli (4), and subsequently incubated with a fluorescence-ligand to
label the cells relative to their expression level (5). The highest expressing cells are then
selected by fluorescence-activated cell sorting (6). The selected receptor variants are
analyzed (7) or alternatively, iterative expression and selection rounds are performed to
further enrich the best receptor variants (8). 
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context of natural signaling networks could constrain the product of directed evolution and 
could limit expression and stability in order to avoid deregulation of GPCR-related cellular 
processes. Overexpression of certain GPCRs can itself be the cause of a 
pathophysiological condition, as observed for the 2-adrenergic receptor when 
overexpressed in mouse heart (Liggett et al., 2000). With the absence of any GPCR 
signaling networks in E. coli, selection for high functional expression is only restricted by 
the limitations imposed by the protein itself. 
D03, the product of directed evolution of the neurotensin receptor 1 (rNTR1), 
revealed that a 10-fold increase in functional expression is achieved by only nine amino 
acid substitutions (Sarkar et al., 2008). Interestingly, the directed evolution of further 
GPCRs plateaued at a similar expression level per cell, raising the question whether an 
upper limit intrinsic to GPCRs or intrinsic to the expression host E. coli had been reached, 
or whether this rather represents a hurdle that has to and can be cleared to proceed to 
new grounds. Despite its potential, random mutagenesis using error prone PCR is limited 
in its depth (mutational spectrum) and breadth (sequence coverage). The bias towards 
amino acid exchanges encoded by single nucleotide exchanges (Wong et al., 2006) 
constrains especially the fraction of non-similar mutations, for example hydrophobic to 
charged residues. Furthermore, random mutagenesis stochastically samples the receptor 
sequence, but is far from exhaustive regarding sequence coverage.  
To assess the existence and contribution of internal (GPCR) and external (random 
mutagenesis) limitations for GPCR expression and stability, a systematic mutagenic 
analysis is required. Alanine-scanning mutagenesis is commonly used to screen a target 
protein for phenotype-critical residues (Clackson and Wells, 1995; Wells, 1991). Every 
position is replaced one-by-one by alanine, and the effect on protein function is assayed. 
Alanine is characterized by a small and inert side chain with helical propensities, making it 
a good candidate to identify positions with side chains involved in protein activity. With 
respect to GPCRs, alanine is a likely tolerated substitution, and might even be favorable 
for helix folding and packing. Alanine-scanning mutagenesis has been applied to three 
GPCRs, the 1-adrenergic receptor (Serrano-Vega et al., 2008), the adenosine A2A 
receptor (Magnani et al., 2008) and the neurotensin receptor (Shibata et al., 2009). 
However, this analysis is incomplete, missing all advantageous mutations other than 
alanine. Full randomization of every position can overcome these constraints, and such 
approaches recently became feasible with the availability of a suitable selection for 
GPCRs.  
The analysis of such a saturating mutagenesis and the evolved receptor variants 
can help to shed light on protein activity, to elucidate activation mechanisms and to 
decipher the constraints of protein stability.  
1.8 The rat neurotensin receptor as target GPCR 
The neurotensin receptor is a typical class A GPCR, liganded by the 13-amino acid 
peptide neurotensin (ELYENKPRRPYIL; active fragment RRPYIL). Neurotensin receptors 
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are predominantly found in the brain, where they regulate neurotransmitting processes 
such as analgesia, hypothermia and hormone secretion, and to a lesser degree in the gut, 
regulating colon motility, respectively (Vincent et al., 1999). More interesting from a 
directed evolution-point of view is that the wild-type rat neurotensin receptor 1 (rNTR1) 
shows low, but detectable expression in E. coli with approximately 500 receptors per cell 
when expressed as a fusion protein with N-terminal MBP and C-terminal thioredoxin 
(Grisshammer et al., 1993; Tucker and Grisshammer, 1996). While the periplasmatic MBP 
efficiently directs the GPCR to the inner membrane, the C-terminal thioredoxin is assumed 
to function as a “folding chaperone” to increase the fraction of functional receptor (Kern et 
al., 2003). Its expression profile in E. coli makes rNTR1 an optimal candidate for directed 
evolution. By means of directed evolution using random mutagenesis and FACS-based 
selection, rNTR1-D03 was evolved from the wild type, displaying a 10-fold increase in 
expression and higher detergent stability, and the effects are conveyed by nine amino 
acid substitutions (Sarkar et al., 2008). The expression levels of D03 is the basis for the 
full saturation mutagenesis performed here, since only the robust expression of D03 
allows reliable detection of small changes. 
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Abstract 
G protein-coupled receptors (GPCRs) are cell-surface receptors exhibiting a key 
role in cellular signal transduction processes, thus making them pharmacologically highly 
relevant target proteins. However, the molecular mechanisms driving receptor activation 
by ligand binding and signal transduction are poorly understood, since as integral 
membrane proteins, most GPCRs are very challenging for functional and structural 
studies. The biophysical properties of natural GPCRs, usually required by the cell in only 
low amounts, support their functionality in the lipid bilayer, but are insufficient for high-
level recombinant overexpression and stability in detergent-solution. Current structural 
information about GPCRs is thus limited to a subset of GPCRs with either intrinsically 
favorable or properly improved biophysical behavior. Recently, directed protein evolution 
techniques for functional expression and detergent stability have been developed to 
increase the accessibility of GPCRs for functional and structural studies. Directed 
evolution does not rely on any preconceived notion of what might be limiting biophysical 
properties. By random mutagenesis combined with a high-throughput screening and 
selection system, directed protein evolution has the power to efficiently isolate rare 
phenotypes and thus contribute to the elucidation of the stability-determining factors, in 
addition to solving the practical problem of creating stable GPCRs. In the current chapter, 
protocols for generation of genetic diversity within GPCRs and selection are provided and 
discussed. 
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1. Introduction 
1.1  G protein coupled receptors 
Natural evolution has designed G protein-coupled receptors (GPCRs) for 
functionality in a cellular context: As integral membrane proteins they are adapted to the 
lipid bilayer, and most of them are needed only in very small amounts by the cell. Their 
mode of action requires a considerable conformational change, transmitting the 
information of a ligand binding on the extracellular side to the inside of the cell, where a 
heterotrimeric G protein binds to the activated receptor (Rosenbaum et al., 2009). After 
activation, the GPCR is often phosphorylated, internalized and degraded to avoid 
continuous signaling (Ferguson, 2001). The biophysical protein properties of GPCRs are 
thus evolved to fulfill their key role in signal transduction processes, allowing for efficient 
and sensitive activation of signaling pathways upon changes in the extracellular 
environment. Nature has evolved GPCRs to fulfill these requirements in vivo, which are 
almost antithetic to what is desired for in vitro characterization purposes. 
About 1% of open reading frames in vertebrates code for GPCRs (Bjarnadottir et 
al., 2006) and the number of class A GPCRs is estimated to cover about 800 different 
receptors in humans, of which 50% are olfactory receptors (Bjarnadottir et al., 2006; Foord 
et al., 2005). The remaining 400 GPCRs play key roles in many signal transduction 
processes making non-olfactory GPCRs important pharmaceutical targets, and it is 
estimated that about 30% of all currently marketed drugs target GPCRs (Lagerström and 
Schiöth, 2008; Overington et al., 2006). Almost certainly, among the 400 GPCRs of 
potential interest, there are many valid targets that have not even been explored. 
Although GPCRs are physiologically expressed at low levels, high ligand affinities 
and strong amplification of downstream signals guarantee specific and efficient signal 
transduction. Moreover, the low expression levels further account for minimal background 
signaling activity. Similar to expression levels, the biophysical protein properties have 
evolved for functionality, and the limited stability of GPCRs might even be a desired 
feature in the cellular context to facilitate fast turnover and degradation.  
In vitro, however, the protein properties of GPCRs desired and evolved in vivo turn 
out to be a biochemist's nightmare. Many GPCRs cannot be expressed in E. coli, 
representing the easiest, fastest and cheapest system to produce high quantities of 
recombinant protein. Some of them are poorly expressed even in mammalian cells. 
Receptor solubilization from membranes to obtain functional and stable receptor in 
detergent solution is a further crucial challenge along the purification process. Moreover, 
the intrinsic conformational flexibility of GPCRs, enabling activation of the receptor by 
conformational changes upon ligand binding, hinders structure determination.  
Consequently, our understanding of GPCR architecture and mechanism has 
remained limited, and the design features of agonists and antagonists for the diverse set 
of receptors have remained mostly enigmatic. The evident discrepancy between the high 
pharmacological relevance and the poor status of GPCR characterization accounts for the 
enormous scientific effort in GPCR research. The effort of decades started to pay off only 
recently with the crystal structure determination of a handful of GPCR receptors.  
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1.2 GPCR structures 
The first crystal structure of a GPCR, bovine rhodopsin, was solved in the year 
2000 (Palczewski et al., 2000), and remained unchallenged for several years until 2007. 
The pioneer position of rhodopsin in GPCR structural research is a result of its 
extraordinary and unique features, namely its high natural abundance and high 
conformational stability and homogeneity as a result of its covalently bound ligand 11 cis-
retinal, acting as a potent antagonist. However, its uniqueness limits implications for other 
GPCRs.  
Recent GPCR structures, including the inactive states of the human adenosine 
receptor A2A (Jaakola et al., 2008), human 2-adrenergic receptor (Cherezov et al., 2007; 
Rosenbaum et al., 2007), turkey 1-adrenergic receptor (Warne et al., 2008), CXCR4 and 
the human dopamine D3 receptor (Chien et al., 2010), pointed out differences between 
rhodopsin and the remaining class A GPCRs, which, different from rhodopsin, are 
liganded by diffusible molecules (reviewed for example in (Katritch et al., 2012)). The 
recent determination of the 2-adrenergic receptor structure in complex with a 
heterotrimeric G-protein (Katritch et al., 2012; Rasmussen et al., 2011b) depicts a 
landmark in the understanding of the signaling process itself.  
Except for rhodopsin, most GPCR structure determination required changes within 
the protein sequence, including loop deletions, engineered domain insertions and/or trial-
and-error optimization of the protein sequence.  
Domain insertions (for example T4-lysozyme (Rosenbaum et al., 2007)) or 
deletions of flexible loops (for example (Cherezov et al., 2007)) and the use of binding 
proteins such as a specific camelid VHH antibody domain (Rasmussen et al., 2011a) or a 
conventional antibody Fab fragment (Rasmussen et al., 2007) were used to successfully 
facilitate crystal contact formation for the above described receptors. The binding proteins, 
however, cannot overcome intrinsic limitations in biophysical properties, and the domain 
insertions and loop deletions mask functional information about receptor activation 
mechanisms in the resulting structures. Trial an error stabilization in detergents using 
alanine scanning has been used as well (Serrano-Vega et al., 2008; Warne et al., 2008). 
Despite these efforts, the limited number of receptor structures and the 
redundancy of the datasets do not reflect the functional diversity of GPCRs, and thus 
general conclusions about their activation mechanism remain limited as well. Most 
importantly, fundamental rules for agonist and antagonist design have not yet emerged. 
So far, structure determination is limited to a subset of GPCRs that can be well-expressed 
and purified and requires already detergent-stable GPCRs. Most GPCRs are not 
amenable to functional and structural studies, as the bottleneck lies in earlier steps, 
namely expression and purification, which involves detergent stability as well.  
To increase the spectrum of GPCRs accessible for functional and structural 
analysis and to gain detailed understanding of the GPCR activation and inactivation 
mechanisms, two main parameters have to be optimized, the recombinant functional 
expression of a target GPCR and its biophysical protein properties. Improved biophysical 
CHAPTER 2 
- 24 - 
properties, mainly stability in detergents, increase the chances of crystal formation, 
particularly when conformational homogeneity is achieved.  
1.3 Engineering of GPCRs 
Process engineering 
 
Two different and orthogonal engineering strategies can be distinguished: First and 
conventionally, alterations are made to the “external” conditions of GPCR expression and 
purification. Here, we focus on heterologous expression of GPCRs in E. coli. This can be 
subsumed under process engineering, as opposed to protein engineering. 
Empiric optimization of expression host, temperature and medium of expression 
and plasmid copy number can substantially influence functional expression levels (for 
example (Tucker and Grisshammer, 1996)). For example, GPCRs are typically expressed 
from low copy plasmids to reduce toxicity of GPCR expression in E. coli. We showed in 
several of our studies that low copy numbers are essential for non-optimized receptors 
(Sarkar et al., 2008), while GPCRs with improved biophysical properties can be expressed 
from higher copy number plasmids without toxic effects (Sarkar et al., 2008; Schlinkmann 
et al., 2012a).  
GPCR overexpression in yeast cells, mammalian cells or the baculovirus 
expression system using Spodoptera frugiperda (Sf9) cells is an alternative. We observed, 
in the analysis of numerous mutants, a strong correlation between the relative expression 
levels in all these hosts (Sarkar et al., 2008; Schlinkmann et al., 2012a). Thus, changes in 
the protein sequence that have been found to improve expression in E. coli have also 
been found to improve expression levels in eukaryotic hosts, including mammalian cells 
where the receptors came from. 
As a production host, these alternative systems are more time-consuming, 
laborious and expensive, but need to be used of course when the posttranslational 
modifications are studied. Yet, for most GPCRs, posttranslational modifications, mainly 
glycosylation, are not imperative, and the respective site can be mutated or the flexible N-
terminus can be deleted for expression in E. coli, even though a small subset of GPCRs 
might potentially remain non-expressible.  
Optimization of GPCR overexpression in eukaryotic hosts is further hampered by 
the fact that high GPCR levels can lead to increased basal signaling activity, which often 
interferes with cellular signaling pathways, also leading to high toxicity after 
overexpression. 
Similar to the expression conditions, detergent solubilization from membranes has 
to be optimized for a given target protein. Many detergents are available, differing in 
solubilization efficiency and capability to retain the membrane protein in a functional state 
(see for example (Duquesne and Sturgis, 2010; le Maire et al., 2000; Seddon et al., 
2004)). 
While probably every GPCR will require some kind of process optimization, it 
currently appears that most members of the family cannot be studied with process 
optimization alone. Furthermore, most processes are not transferable, as the above 
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laborious empiric optimization process has to be specifically optimized for each given 
target receptor. Moreover, in many cases, no feasible conditions at all will be found. Thus, 
with this conventional approach alone, most GPCRs would remain inaccessible, since the 
biophysical protein properties itself are limiting. 
 
 
Protein engineering 
 
The second strategy thus focuses on identifying a related protein sequence with 
improved biophysical properties. A commonly used strategy is to screen the “homology 
space” for target homologs with similar function, but better protein behavior with respect to 
expression and biophysical properties. It is commonly found that homologous proteins of 
bacterial origin, notably from thermophilic bacteria, have more favorable properties than 
proteins from eukaryotes, and this has been observed for membrane proteins as well 
(Granseth et al., 2007). 
Unfortunately, the above strategy cannot be applied to GPCRs, as it appears that 
prokaryotes do not contain such proteins. Despite the fact that this strategy is popular in 
current structural biology, the homologs used often share only very low sequence identity, 
thus potentially limiting the relevance of homolog characterization. 
In this situation, protein engineering techniques provide a valuable alternative to 
the classical (but limited) homology search to identify near-target like GPCR variants with 
a desired phenotype, which are first of all functional, stable and show high expression. 
Many protein engineering strategies are routinely applied to soluble proteins, but cannot 
easily be transferred to integral membrane proteins. Rational design of a protein 
sequence relies on sufficient structural and functional information about the target protein 
in order to design a favorable phenotype — the very reason of writing this chapter is that 
this information is not available yet. For GPCRs, rational design is thus not an alternative, 
at least not yet, since the limited structural information and the difficulties of protein 
expression and purification constitute major roadblocks in the application of this strategy. 
Furthermore, using classical trial and error approaches, many variants would have to be 
individually designed and tested for a given target protein. 
Directed evolution and selection for the desired phenotype provides a more 
attractive methodology, and the availability of a screening and selection technique would 
render sampling of highly diverse libraries possible in order to identify a rare mutant with 
the envisaged phenotype. A main focus in GPCR research is to improve receptor 
expression levels and stability, in order to increase the diversity of receptors that are 
accessible to functional and structural studies. It has been shown by Bowie and coworkers 
(Bowie, 2001) that stabilizing mutations are not rare in membrane proteins, emphasizing 
the great potential of membrane proteins as a target for directed protein evolution.  
In our laboratory, we had previously developed an E. coli-based selection system 
to evolve and engineer GPCRs for high functional expression and stability in detergent 
(Dodevski and Plückthun, 2011; Sarkar et al., 2008; Schlinkmann et al., 2012a; 
Schlinkmann et al., 2012b). The lack of GPCR-homologs in E. coli turns out as an 
advantage here, as these receptors cannot interfere with any cellular signaling pathway, 
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as opposed to when using eukaryotic expression systems. By multiple and iterative 
rounds of gene randomization followed by selection for high functional expression using a 
FACS-based approach, functional and highly expressed receptor variants can be 
efficiently identified within less than a month time.  
The main prerequisite for this approach is the availability of a functional ligand: The 
FACS-selection is based on positive selection using a fluorescence-labeled ligand, 
thereby ensuring functionality of the receptor. No further functional or structural 
information other than the primary protein sequence is needed, since unfavorable variants 
are efficiently selected against. Furthermore, library sizes of >107 can be easily 
transformed in E. coli and efficiently be screened by the FACS-based selection system 
(screening of approximately 107 single cells per hour in yield mode). High-efficiency 
transformation of yeast cells or mammalian cells is not as straightforward and thus less 
suitable for highly diverse libraries.  
The robustness of our method allows application of stringent selection conditions 
on receptor libraries with high diversity, as only the coverage of a large mutational space 
increases the chances to identify rare receptor variants with the desired phenotype. We 
have successfully applied this methodology to substantially improve the expression levels 
of several GPCRs from hardly detectable (<500 receptors per cell) to well expressed 
(6,000 - 25,000 receptors per cell) receptors (Dodevski and Plückthun, 2011; Sarkar et al., 
2008; Schlinkmann et al., 2012a; Schlinkmann et al., 2012b).  
In the above studies we further observed an inherent coevolution of detergent 
stability with functional expression levels, the latter one never being under direct selection 
pressure. During selection, pressure is applied on functional receptor expression, which is 
a result of the efficiency of correct protein folding, insertion into the lipid bilayer and 
stability within the lipid bilayer (Jungnickel et al., 1994). It is thus an indirect selection for 
biophysical properties, emphasized by the fact that mutants selected in E. coli also 
express better in eukaryotic cells (Dodevski and Plückthun, 2011; Schlinkmann et al., 
2012a). Nonetheless, functional expression and detergent stability are not directly linked 
as we find residue substitutions influencing one property but not the other (Dodevski and 
Plückthun, 2011; Sarkar et al., 2008; Schlinkmann et al., 2012a; Schlinkmann et al., 
2012b). Different from our selection technique, in vitro alanine-scanning solely for 
detergent stability leads to uncoupling of receptor expression and stability, and 
coevolution is thus unlikely to be detected (Shibata et al., 2009).  
The selected receptor variants display very high sequence identity to their original 
target (usually above 95%). Only a few amino acid changes are necessary to significantly 
improve the expression and biophysical behavior of the target protein, clearly illustrating 
that GPCRs maintain a delicate balance between stability in the membrane, flexibility 
required for signaling and the subsequent steps of receptor inactivation and degradation 
or recycling (Deupi and Kobilka, 2007). These constraints limit stability and at least partly 
explain the paucity of structural information from this large family, despite herculean 
efforts.  
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2. Methods 
2.1  Generation of genetic diversity 
The described diversification methodologies are applicable to all GPCRs for which 
the coding sequence is known and which can be successfully cloned into an E. coli -
expression vector. If the below described FACS-based selection method is applied, a 
respective receptor ligand has to be available (see above). 
 
 
Error-prone PCR to randomize GPCR sequences 
 
By default, random mutagenesis is a stochastic process, without any external 
influence on the distribution of the introduced mutations. This assumption-free process is 
an easy and fast method to create genetically diverse receptor libraries on DNA level. 
Random alterations are introduced to the receptor coding sequence by error-prone PCR, 
and the mutational load per receptor sequence can be controlled by adaptation of the 
reaction conditions. Error-prone PCR amplification should be limited to the receptor 
coding sequence to keep the fusion protein tags intact and functional. Evidently, 
diversification can be further restricted to a specific receptor region, if desired. 
The obtained mutational load is a product of the number of base misincorporations 
per amplification round and the number of amplification rounds. Both factors need to be 
adjusted to ensure optimal results since the optimal mutational load highly depends on the 
target protein and the desired phenotype. From our experience, in the case of GPCRs 
under functional selection of ligand binding a low mutational load of 1-5 amino acid 
substitutions per randomization round is suitable. The argument for choosing a low error 
rate and rather more selection cycles are as follows: The 7 transmembrane helices of the 
GPCR are long stretches where the introduction of even one charged residue would 
render protein non-functional. Such a substitution would therefore mask the beneficial 
effect of other mutations, and the clone would be lost. Thus, we have to treat carefully and 
add the mutations slowly, "purifying" the population by selection rounds after 
mutagenesis. Error-prone PCR mainly introduces single-base changes, and a subset of 
substitutions will hence remain silent on the amino acid level, but they can become non-
silent with further diversifications rounds. Even some mutations on the amino acid level 
will only show their beneficial effect in the presence of existing mutations. These beneficial 
"neutral drift" phenomena are an inherent property of the evolutionary process.  
Different alternatives exist for gene diversification: First, a low fidelity DNA 
polymerase such as Taq DNA polymerase can be employed. To support base 
misincorporations, Mg2+-concentrations, Mn2+ or the amount of polymerase are elevated to 
increase the likelihood of continuous strand synthesis after mismatches, and unbalanced 
nucleotide mixtures or nucleotide analogues can be used to favor mismatches (Cadwell 
and Joyce, 1994; Spee et al., 1993). However, the obtained diversification is highly 
nonrandom, since Taq DNA polymerase favors AT to GC substitutions over others 
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(Wilson and Keefe, 2001). A different mutational bias (GC to AT) can be obtained by using 
Mutazyme® DNA polymerase (Stratagene GeneMorph Kit). The need for random 
diversification led to the development of a new and optimized enzyme blend, Mutazyme 
II® (Stratagene GeneMorph Kit II), a DNA polymerase with reduced mutational bias by 
combination of the Mutazyme® with a novel Taq DNA polymerase (for example 
(Vanhercke et al., 2005)). A routinely used method in our laboratory employs the 
Mutazyme II® DNA polymerase.  
The GPCR coding sequence of interest is used for error prone PCR, and 10 ng of 
template DNA are used as input. Flanking PCR primers should include suitable restriction 
sites for subcloning into the expression vector. Low template DNA input decreases the 
final fraction of wild-type sequence in the diversified sequence pool, and increases the 
likelihood that amplification and diversification in further GPCR rounds starts from a 
previously diversified template. Thirty cycles of PCR amplification are routinely used for 
error-prone PCR, and the diversified PCR product is treated with DpnI to digest template 
sequences, as it is specific for methylated DNA as produced in E. coli in the form of the 
starting plasmid. A subsequent PCR amplification with a high fidelity polymerase, for 
example Phusion® Polymerase (Finnzyme), is used to obtain sufficient quantities for the 
subsequent cloning steps. The diversified PCR product is then purified, if necessary from 
a preparative agarose gel to avoid carryover of PCR side products, and is subsequently 
digested with the flanking restriction enzymes. A further purification step is used to obtain 
the final PCR product for subcloning, typically, 2-3 μg of DNA.   
Despite optimization of error-prone PCR conditions to minimize mutagenic bias, it 
has to be considered that error-prone PCR will still favor certain amino acid substitutions 
over others, as some substitutions would require two consecutive base changes, which 
are statistically unlikely to happen. 
Random mutagenesis using error-prone PCR was successfully applied to create 
genetic diversity within the rNTR1 (Sarkar et al., 2008), the adrenergic receptors 1a and 
1b and the tachykinin receptor NK1 (Dodevski and Plückthun, 2011) for selection for high 
functional expression and stability. Notably, the tachykinin receptor NK1 did not only 
evolve to higher expression levels, but could also be evolved for functional extraction from 
the lipid bilayer by detergent treatment, which is not possible for the wild type (Dodevski 
and Plückthun, 2011). For all receptors, increase in expression levels was associated with 
improvement of biophysical protein properties. 
 
Single amino acid scanning-mutagenesis approaches 
 
Alanine-scanning mutagenesis is a common approach to identify positions of a 
target protein that are crucial for a desired phenotype (Clackson and Wells, 1995; Wells, 
1991). Every amino acid position of a given target protein is sequentially and separately 
replaced by alanine and every mutant is analyzed for the desired phenotype.  
With respect to GPCRs, the high helical propensities, the small side chain size and 
the relative inertness of alanine make it a most likely tolerated substitution in most 
receptor positions, and might in principle improve the biophysical properties of the 
receptor by improving helix propensities and packing. Yet in a comprehensive all-versus-
all screen (Schlinkmann et al., 2012b), almost no alanines were the most preferred amino 
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acid type. By alanine scanning alone, mutational space is only minimally covered, and the 
relevance of a specific position for detergent-stability may not be identified if the favorable 
effect would not be conveyed by Ala, but only by a different amino acid substitution. 
Nonetheless, alanine-scanning mutagenesis has been successfully applied to two 
GPCRs, rNTR1 (Shibata et al., 2009) and the human 1-adrenergic receptor (Serrano-
Vega et al., 2008). Recently, leucine-scanning mutagenesis of the human 1-adrenergic 
receptor was performed and revealed further beneficial substitutions (Miller and Tate, 
2011).  
 
 
Technical aspects of mutant construction 
 
The production of a collection of single mutants is a straightforward point 
mutagenesis, albeit becoming laborious with the number of mutants to be generated. For 
each mutant to be constructed, a mutagenic and complementary primer pair covering the 
codon of interest and introducing the mutation is required. Two cloning strategies can be 
applied: First, the mutagenic primer pair can be used for PCR amplification of the entire 
expression vector, for which only the mutagenic primer pair is needed. The PCR reaction 
is performed for 15-18 cycles using a high fidelity DNA polymerase such as Pfu DNA 
polymerase (Promega). For elongation, 2-2.5 min per 1000 base pairs (bp) are 
recommended for optimal performance of the reaction. Digestion of the input template 
DNA is achieved by DpnI treatment, followed by transformation of the amplified 
expression vector into E. coli. With complete digestion of the input DNA, only mutant 
clones should be obtained. Plasmid DNA from a single colony is then isolated, the 
sequence is recloned into a fresh vector (to eliminate any spurious introduction of 
backbone mutations in the vector which could mask the true phenotype), and the 
sequence of the final construct is verified by sequencing.  
Second, a two-step assembly PCR strategy (Fig.1A) can be alternatively used. In a 
first PCR amplification round, the two following PCR fragments are generated: A flanking 
forward primer, introducing the 5’ restriction site, and the reverse mutagenic primer are 
used to obtain a PCR fragment covering the 5’-half of the receptor sequence, including 
the desired mutation. Similarly, the 3’- half fragment including the desired mutation is 
obtained from a PCR reaction using the forward mutagenic primer and the reverse 
flanking primer, introducing the 3’- restriction site. The quality of the two PCR products is 
analyzed on an analytical agarose gel, and PCR products are purified from a preparative 
agarose gel in case of additional side products. If large numbers of mutants have to be 
generated, it is worth to optimize PCR conditions such that a pure and single PCR product 
of correct length is obtained every time. In this case, the output of the first PCR 
amplification round can be directly used as input for the second PCR assembly step. 20-
100 ng of each purified PCR fragment or 1-2 μl of each unpurified PCR reaction are used 
for extension of the two fragments and assembly of the full-length mutagenized receptor 
sequence. Both PCR products overlap in the mutagenized region, and the mutagenic 
primer pair should be designed such that the overlap is 25-30 base pairs. The flanking 
PCR primers are used for PCR amplification of the full-length mutagenic sequence.  
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For fragments of similar length, a standard amplification PCR protocol is working 
well. However, particularly for fragments with larger differences in length, the extension of 
the two fragments from the overlap region before assembling them is beneficial for 
obtaining the specific PCR product. For this purpose, 5-10 PCR cycles are performed in 
the absence of the flanking primers, and 25-30 amplification rounds are subsequently 
performed after addition of the flanking primers. If the position to be mutagenized is close 
to one end of the receptor sequence, the corresponding flanking primer can be elongated 
to include the target position and introduce the desired mutation. In this case, only one 
PCR amplification step is necessary. Primers of approximately 100 nucleotides have been 
successfully used by the authors to introduce mutations. 
The assembly strategy can be easily employed for fast generation of multiple 
defined mutants by generation of multiple mutagenic and overlapping fragments that are 
assembled to the full-length construct in the second PCR step. A triple mutant can be 
successfully obtained within one round of assembly (Fig. 1B). For this purpose, mutagenic 
primer pairs covering the target positions, denoted X, Y and Z here in sequential order, 
are designed to introduce the desired mutations. In the first PCR amplification, four 
fragments are generated: The first fragment covers the region from the 5’ end to the most 
upstream mutation X (obtained with the 5’- flanking primer and the reverse mutagenic 
primer X), the second fragment reaches from mutation X to mutation Y, and 
corresponding fragments are amplified for Y to Z and Z to the 3’ end. Individual fragment 
lengths should be 200 bp at minimum for optimal results. All fragments are then combined 
in a second PCR step for assembly of the full-length sequence by amplification with the 
flanking primers as described above. If the assembly of four fragments is inefficient or 
results in PCR side products, it is recommend to assemble two overlapping fragments in 
two separate reactions and to assemble the full-length sequence from these intermediate 
fragments. 
The full-length mutagenic fragment is then purified, if necessary from a preparative 
agarose gel, and the flanking restriction sites are digested by the respective restriction 
enzymes. The purified mutagenic fragment is then ligated into the expression vector and 
transformed into E. coli. The DNA of a single colony is isolated and sequence-verified. 
The second strategy seems to be more work-intensive at first sight. However, it 
contains only one cloning step, as every sequence is cloned directly into a fresh 
expression vector. In contrast, amplification of the entire expression vector by PCR can 
easily accumulate mutations in the vector backbone, affecting origin of replication or the 
promotor, for example. In order to avoid any spurious mutation, the mutagenized receptor 
sequence has to be cut and ligated into a fresh vector backbone by restriction digest, 
hence making this strategy actually more time-consuming than the second strategy.  
 
 
Comprehensive mutagenesis 
 
A more integrative method is to explore the entire mutational space by full 
randomization of a specific receptor position with selection for the amino acid variant 
conveying the desired phenotype. With our FACS-based selection system, a powerful and 
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efficient selection method exists to select for high functional expression and stability 
(Sarkar et al., 2008).  
Because of the incomplete coverage of mutational space as well as target 
sequence space by random mutagenesis, we recently performed a saturating and 
exhaustive mutagenesis on rNTR1-D03 to determine for every position the residue types 
that are not permitted, permitted and preferred (Schlinkmann et al., 2012b). Importantly, 
the already improved mutant rNTR1-D03 was used as framework, since rNTR1-wt 
expression levels were too low for these experiments.  
A full coverage of mutational space should ideally include the full codon diversity, 
to ensure phenotype selection and exclude any bias from variable tRNA levels, mRNA 
secondary structure or other undesired influences. The occurrence of several or all 
codons of a preferred amino acid after selection internally verifies the selection outcome.  
Generally, the strategy to fully randomize a specific amino acid position, that is to 
create a position-specific library, is based on the generation of a single point mutagenesis 
(Fig. 1A).  The mutagenic primers contain an NNN sequence at the target codon, where N 
denotes an equimolar mixture of all four nucleotides. An NNN mixture also includes stop 
codons, and depending on the screening and selection technique that is employed, the 
primer design may have to be adapted to exclude stop codons. However, with FACS-
based selection for functional expression using fluorescent ligands, stop-codon mutants 
are counter-selected, as most of these mutants do not contain a functional ligand binding 
site (unless the stop codon occurs after TM7). Thus, the counter-selection of stop codons 
is a useful internal quality control of the selection success.   
Primers should be designed such that the hybridization temperature with the 
template is between 55 to 65°C so that differences in specific primer sequences are 
negligible. Two overlapping half fragments of the target sequence are then generated 
similar to the approach described above, extended and amplified. Very importantly, 
throughout all steps of library generation, care must be taken to preserve library diversity. 
Thus, DNA amounts equivalent to 10-20 fold of the library diversity should be used as 
input in every PCR step. The expression vector for subcloning of the position specific 
library should not contain a wild-type receptor sequence in order to avoid wild-type 
overrepresentation due to incomplete vector digest (for details, see (Schlinkmann et al., 
2012a)). 
 
 
In vitro DNA shuffling of GPCR sequences to generate highly diverse 
chimeric receptor libraries 
 
In vitro DNA shuffling is used to generate chimeras from two receptor sequences. 
We have recently adapted and optimized the staggered extension process (StEP) (Fig. 
2A) for generation of chimeric libraries starting from the rNTR1-D03 and a mutagenized 
artificial receptor sequence, rNTR1-M30 or rNTR1-M303 (Schlinkmann et al., 2012a). 
StEP is a PCR-based approach (Aguinaldo and Arnold, 2002; Zhao and Zha, 2006), in 
which two or more different sequences are used as input templates. By using a very short 
combined annealing and extension step at a suboptimal DNA polymerase elongation 
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temperature, the amplification primers are only extended by a few nucleotides per StEP 
PCR cycle. After the subsequent denaturation step, the primers are further extended, until 
eventually a full-length receptor sequence is obtained. Most importantly, by using two or 
more different input templates, the growing primer fragment can switch templates between 
two PCR cycles, and thus accumulates mutations from two different templates in one 
chimeric receptor sequence.  
For shuffling of two GPCR variants of approximately 1200 base pairs (bp), 10 ng of 
each plasmid template DNA is mixed per 50 μl PCR reaction using 2 units VentR® DNA 
Polymerase (NEB) and 30 pmol each of the two flanking primers, introducing a restriction 
site. The choice of DNA polymerase greatly affects shuffling efficiency, and the following 
aspects should be considered: High fidelity is desired to avoid undesired mutations as a 
result of high number of StEP PCR cycles. To yield short recombination distances, a 
slower DNA polymerase is preferred, for example VentR® (NEB, approx. 1000 bp per 
minute) over Phusion® DNA polymerase (Finnzymes, 1000 bp per 15 seconds).  
The amplification yield in a StEP reaction is comparably low, and further PCR 
amplification of a single StEP reaction should be avoided, as it does not increase 
diversity. With a theoretical diversity of about 107, twelve reactions are set up in parallel to 
increase the product amount while simultaneously generating high diversity. StEP 
shuffling is performed for 125 PCR cycles on a Biometra T3 thermocycler (heating rate of 
2°C/s) with 30 seconds denaturation at 94°C and 6 seconds annealing/ elongation at 50°C 
per cycle and 2 minutes of initial denaturation. A final and extended elongation step 
should be omitted, as it could lead to amplification of the template sequences without 
shuffling.  
StEP is a delicate PCR-based process, reacting strongly to small changes in 
reaction conditions. The most important parameters for optimization and troubleshooting 
are as follows: Duration and temperature of annealing and elongation are key 
determinants of shuffling efficiency. Under these conditions, recombination events within 
30 bp distance are obtained. Importantly, the differences in heating and cooling rates 
between thermocyclers strongly influence the recombination efficiency and yield of the 
StEP process, and should be controlled and adjusted together with the elongation 
conditions. With slow heating and cooling rates (2°C/s), the actual window of DNA 
polymerase activity is longer than defined by the annealing and elongation cycle (here 6 
seconds per cycle),compared to thermocyclers with fast heating rates (up to 6°C/s). Under 
these conditions, elongation times might have to be extended to allow sufficient product 
formation. 
VentR® and Phusion DNA polymerases both exhibit 3’ to 5’- proofreading 
exonuclease activity, which, for the case that an incorporated mutation locates at the 3’-
end of the growing fragment, could lead to correction by the polymerase proofreading 
activity after template switching. Here, a DNA polymerase lacking 3’ to 5’- proofreading 
exonuclease activity, for example Deep VentR™ (exo -) (NEB), might be compared with 
respect to recombination efficiency, but resulted in high amounts of PCR side products in 
our experiments and was thus not used.  
Further, despite the presence of 2 mM MgSO4 in the PCR reaction buffer, we 
observed that the use of additional 2 mM MgSO4 positively affected the reaction yield, 
probably by stabilizing DNA-polymerase complexes after mismatches. 
DIRECTED EVOLUTION OF G PROTEIN-COUPLED RECEPTORS FOR HIGH FUNCTIONAL 
EXPRESSION AND STABILITY 
- 33 - 
The shuffled StEP product is digested with DpnI to minimize the carryover of input 
templates. The StEP product should be purified from a preparative agarose gel, as PCR 
side products are common to StEP reactions. The purified product is digested with the 
corresponding restriction enzymes and purified. At least 3 μg of final StEP-product should 
be obtained for subcloning of a product with a theoretical diversity of 107. 
Shuffling by StEP is an easy and fast technique to generate a chimeric library from 
two or more target sequences. However, mutations close in sequence (3 to 30 bp) are 
inefficiently separated by StEP, and sequences with coupled mutations are 
overrepresented, compared to the recombined sequences. If more than two templates are 
shuffled, the apparent recombination efficiency can suffer from a “dilution effect” (Fig. 2B): 
If 10 individual point mutants of a given receptor are used as input templates for StEP 
shuffling, one sequence will contain a particular mutation, while 9 templates contain the 
wild-type codon in the respective position. Statistically, 8 of 9 recombination events will 
shuffle wild type against wild type and the accumulation of mutations in one shuffled 
sequence is consequently low. 
Alternatively, an artificial receptor sequence combining all mutations of interest can 
be synthesized and shuffled against the wild-type sequence for an mutant to wild type 
ratio of 1:1 (for example (Schlinkmann et al., 2012a)). Evidently, the above effect can be 
easily exploited to direct and influence recombination by adjustment of template ratios and 
template design. 
The selection output from a diverse StEP-library can be easily subjected to a 
further StEP-shuffling by plasmid DNA isolation from the selected cell pool.  
 
 
Cloning and transformation of GPCR libraries with high diversity 
 
Cloning and transformation of single point mutants, i.e. single plasmids, is 
straightforward and explained elsewhere (Sambrook and Russel, 2001). 
Library cloning and transformation is technically more demanding, and care must 
be taken to ensure full library diversity throughout all cloning steps. In case of random 
mutagenesis, library diversity can be estimated by multiplying the number of substitutions 
per sequence with the number of molecules in the reaction. For a StEP shuffling of two 
sequences, the theoretical diversity can be calculated from the mutational load of the input 
templates. In a StEP reaction from two templates, which differ in 30 amino acid positions, 
the theoretical diversity is given as 230 (~ 109). 
For a theoretical diversity of 107 and a 1200 bp StEP product to be subcloned, 3 µg 
of purified product DNA is ligated into the expression vector with a 3-fold molar excess of 
insert DNA over vector DNA and 10 units of T4 DNA ligase per µg of DNA in the ligation 
mix in a total volume of 500 µl. Ligation is performed for 12-16 h at 16°C. Ligation 
products are then purified using, for example, Qiagen MinElute columns. Column 
purifications are quick, the final concentration of the ligated product can be controlled by 
the elution volume and the product is quantitatively recovered. Other methods such as 
DNA precipitation or purification from agarose gels can be alternatively used, but are more 
time consuming and less quantitative. 
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Usually, the limiting step in keeping library diversity is transformation of E. coli. 
Electrocompetent E. coli cells are superior to chemocompetent cells with regard to 
transformation rates and should be routinely used for library transformations (for 
protocols, see for example (Chuang et al., 1995; Dower et al., 1988)). The amount of DNA 
per electroporation reaction has to be optimized with respect to the cell density of 
electrocompetent cells. Routinely, a maximum of 1 µg ligation product in a 5 µl volume, 
preferably water or a 5 mM Tris-buffered solution, is transformed per 100 µl of 
electrocompetent cells. DNA and cells are premixed on ice, and transferred to a prechilled 
electroporation cuvette (2 mm, for example Eurogentec electroporation cuvettes). A Gene 
Pulser® II electroporator (Biorad) is used to electroporate the DNA-cell mixture at 2500 V 
with a capacitance of 25 µF and 200  resistance. Time constants should be above 4 ms, 
ideally 4.5 to 5 ms to ensure high efficiency of transformation. The given protocol is found 
to give optimal electroporation efficiency, which is particularly affected by changes in the 
electroporation volume, and larger volumes per electroporation cuvette will dramatically 
decrease electroporation efficiency.  
Electroporated cells are directly recovered in 1 ml SOC medium for 1 h at 37°C in 
a shaking incubator. Directly after the 1 hour recovery of the transformed cells, dilution 
series are plated on agar dishes to determine electroporation efficiency (10 µl, 101 to 107-
fold dilutions). Typically, 5·107 to 3·108 colonies can be obtained using the described 
procedure. The recovered cells are subsequently diluted into in 500 ml 2YT medium, 
supplemented with 1% glucose and antibiotic selection marker and grown for 12-16 h at 
28°C in a shaking incubator. Growth temperature should be low to minimize possible 
growth differences between mutants. The final cell density should be approximately 109 
per ml of culture volume (OD600 of 1). For long-term storage, aliquots of > 109 cells are 
supplemented with 20% glycerol, snap-frozen in liquid N2 and stored at -80°C until further 
use.  
Optimally, single colonies of the naïve library should be analyzed by sequencing of 
the receptor sequence to ensure library quality and analyze randomization or shuffling 
efficiency. In case of high genetic diversity, 48-96 colonies should by assayed at 
minimum.  
2.2  Expression and selection 
Design of expression vector and GPCR fusion construct 
 
As discussed above, the expression vector and the receptor construct have to be 
empirically optimized for a given target receptor, for which the following general 
considerations apply: 
First, depending on the expression host, GPCRs are often expressed as fusion 
proteins to allow efficient targeting of the receptor to the lipid bilayer. For expression of the 
wild-type rat neurotensin receptor in E. coli, expression levels were highest when 
expressed with an N-terminal maltose binding protein (MBP) and a C-terminal thioredoxin 
fusion (Tucker and Grisshammer, 1996).  
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For receptors that do not contain any N-terminal domain that is directly involved in 
ligand binding and that does not contain critical modifications, the flexible N-terminus can 
often been truncated. For some receptors, however, the N-terminal domain is large, and 
involved in ligand binding and GPCR activation (see for example (Pin et al., 2004)).The 
rNTR1 receptor for example is expressed with deletion of the first 42 N-terminal amino 
acids (Grisshammer et al., 1993). All solved non-rhodopsin GPCR structures have 
truncated or modified N- and C-termini (Katritch et al., 2012).  
MBP is connected to the GPCR target by a flexible linker including a protease 
cleavage site, for example tobacco etch virus (TEV) protease. MBP is efficiently targeted 
to the periplasmatic space by its signal sequence, thereby directing the GPCR to the inner 
membrane. Even though the GPCR can be incorporated into the membrane without this 
fusion and without a native signal sequence, the use of this MBP fusion system may 
better guide the receptor to the Sec translocon in E. coli.  
C-terminally, thioredoxin is fused to the GPCR, again via a flexible linker and 
protease cleavage site, and is followed by a His10-tag for purification purposes. Whether 
thioredoxin, a small well-folding and soluble protein, really serves as a "folding chaperone" 
(Tucker and Grisshammer, 1996) will require further investigations, and it might suffice 
that it provides a defined soluble folded domain that helps correct positioning of the C-
terminal end on the cytoplasmic side. In any event, thioredoxin considerably affects the 
functional expression level of a GPCR in E. coli  
Different fusion protein tags and purification tags might be tested for optimal 
expression of a specific target GPCR. We have replaced the C-terminal His10-tag by an 
AviTag sequence (GLNDIFEAQKIEWHE, biotinylation on K) for enzymatic in vivo 
biotinylation of the receptor fusion construct (Dodevski and Plückthun, 2011) by the E. coli 
biotin protein ligase (BirA). In vivo biotinylation using an AviTag sequence is simple, 
stoichiometric, specific and quantitative, and hence superior to chemical biotinylation of 
the purified receptor. While quantitative biotinylation of a highly expressed recombinant 
protein requires coexpression of BirA ligase and addition of free biotin, these measures 
are not necessary for in vivo biotinylation of GPCRs expressed at only about 500 – 6000 
receptors per E. coli cell.  
Second, promotor strength and plasmid copy number are critical determinants of 
GPCR expression, as has already been mentioned above, and have to be adapted to 
avoid toxicity of GPCR expression in E. coli. A low copy plasmid should be used for 
difficult-to-express target receptors, combined with a tunable and tight promotor. For 
expression of wild type rNTR1, a pBR322-derived origin of replication and the lac-
promotor is used (Tucker and Grisshammer, 1996).  As discussed above, with 
improvement of the biophysical receptor properties (rNTR1-D03, see (Sarkar et al., 
2008)), higher plasmid copy numbers are tolerated, and plasmid copy number can even 
limit expression levels of superior receptor variants (Schlinkmann et al., 2012a). 
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Expression of highly diverse GPCR libraries in E. coli  
 
GPCRs are generally expressed at low temperatures in E. coli, leading to 
decreased protein synthesis rates, probably positively affecting targeting efficiency to and 
insertion efficiency into the lipid bilayer. The rNTR1 is expressed in the E. coli strain 
DH5. A given volume of 2YT medium, supplemented with 0.2% glucose and selection 
marker, is inoculated to a cell density of OD600= 0.05, and grown at 37°C in a shaking 
incubator to OD600= 0.5. Expression is then induced by addition of 250 μM IPTG 
(isopropyl--D-thiogalactopyranoside), and expression is continued for 18-24 hours at 
20°C. Receptor variants with improved biophysical properties tolerate higher expression 
temperatures up to 30°C (Schlinkmann et al., 2012a).  
For high-diversity libraries, inoculation density has to be controlled to sustain 
library diversity at this step. Expression temperatures should be kept low, i. e. 20°C, for 
the naïve library and optionally for the first rounds of selection to minimize possible 
differences in growth behavior of individual receptor variants. 
If the cell density of the glycerol stock is known, the cell number needed for an 
inoculation density of OD600= 0.05 can be calculated on the assumption that 109 cells per 
ml in a cuvette with 1 cm pathlength equal 1 OD600.The cell number used for inoculation 
should again cover 10-20 fold the library diversity. It is recommended to increase 
expression culture volumes, and not inoculation density, if the above recommendation 
does not hold for a given expression volume. A library with a diversity of 107-108 variants 
is expressed in 60 ml culture volume in a 300 ml Erlenmeyer flask. To reach an 
inoculation density of OD600= 0.05 in a volume of 60 ml, 3 OD units of cells, equaling 3·109 
cells, are needed, thus oversampling library diversity 30-300 fold.  
 
 
Fluorescence-labeling of GPCR-expressing E. coli cells 
 
FACS-selection is applicable to any receptor for which a known ligand with 
reasonable affinity exists that can be fluorescence-labeled. Peptide ligands and many 
small molecules are known to work well, whereas ligands that are too hydrophobic tend to 
bind nonspecifically to the cells, thus making their use more difficult with respect to 
receptors with low basal expression levels, as the ratio specific : nonspecific signal is low. 
The size of the labeled ligand affects permeability and labeling efficiency, and small 
ligands of approximately 1 kilodalton (kDa) diffuse well through the permeabilized outer 
membrane, while also larger ligands of up to 10 kDa in size were shown to penetrate the 
outer membrane (Chen et al., 2001) after suitable permeabilization. However, for selection 
by FACS sorting, cell viability after recovery from FACS selection is a relevant parameter 
that might suffer from harsh permeabilization conditions and should be tested for a 
specific buffer. 
The fluorescence label has to be compatible with excitation wavelengths and 
emission filter wavelengths on the respective FACS machine, which are most commonly 
equipped with a 488 nm laser and a 633 nm laser (for example BD FACS Aria Series). 
Depending on the machine configuration, a 355 nm or 405 nm UV laser, or a 561 nm laser 
might be available for excitation.  
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For selection of well-expressed receptor variants by FACS, cells are labeled 
relative to their expression levels by use of a fluorescence-labeled receptor ligand. In case 
of rNTR1, a BOPIPY-labeled neurotensin peptide is used (BODIPY-neurotensin(8-12), 
BP-NT) (Sarkar et al., 2008). The outer membrane of E. coli is gently permeabilized to 
allow diffusion of the BP-NT to the inner membrane, where the receptor is located. A Tris-
salt buffer (50 mM Tris·HCl pH 7.4, 150 mM KCl, abbreviated TKCl buffer) is found 
optimal for permeabilization of E. coli DH5cells expressing rNTR1 (Sarkar et al., 2008), 
but might differ for a specific target receptor and receptor ligand (Dodevski and Plückthun, 
2011). Sodium salts should be avoided when working with rNTR1, since the receptor is 
sodium-sensitive (Martin et al., 1999). Depending on the library diversity, an aliquot of 
cells covering 10-fold library diversity should be used for selection. The volume for 
permeabilization and labeling should be adjusted accordingly to ensure efficient labeling, 
and can be concentrated during later washing steps if necessary. Cell densities of 5·107 to 
2·108 are suitable under these conditions. Cells are collected by centrifugation for 3 
minutes at 6000 g, washed once in TKCl buffer and resuspended in the appropriate 
volume of TKCl buffer. 20 nM BP-NT is added, and permeabilization and labeling is 
performed for 1-2 hours on ice in the dark. The optimal ligand concentration should be at 
least 10-fold above KD, to ensure quantitative binding to receptors. The apparent KD 
needs to be tested in a saturation binding experiment before selections, since the ligand 
diffusion across the permeabilized outer membrane might cause the system not be at full 
equilibrium. Furthermore, if receptor expression levels per cell are expected to be high, 
the ligand concentration might have to be increased to prevent ligand depletion. 
Nonspecific binding is assayed in the presence of 10 μM unlabeled neurotensin peptide 
(AnaSpec). Cells are then washed twice in 1 ml TKCl buffer, and resuspended in 1-2 ml 
TKCl buffer and directly subjected to FACS sorting.  
 
 
Selection for high functional GPCR expression using FACS  
 
The labeled and washed receptor-expressing cells are subjected to selection by 
FACS (Fig. 3). We routinely work with a BD FACS Aria I. Unlabeled cells are used to gate 
for the viable cell population. For selection for high functional expression, the fluorescence 
signal of the viable cells is used to gate for highest cell fluorescence, hence functional 
expression. If applicable, multiple fluorescence parameters can be analyzed and gated in 
parallel or consecutively. The 1% highest fluorescent cells are gated and selected. 
Selection stringency can be adjusted by the gate size and the selection mode. Gate sizes 
of 0.5-2% are recommended, with higher stringency in subsequent rounds of selection. 
The purity of selection is adjusted by the sorting mode, where yield mode should be used 
for naïve libraries to recover any positive cell within the gate, while purity mode is routinely 
used for subsequent rounds to avoid carry-over of non-gated cells (refer to the 
manufacturer's FACS manual for further detail). On a BD FACS Aria I, flow rates of 5,000-
20,000 cells are working well. The most fluorescent cells, usually 106 cells for the naïve 
library and 105 cells for subsequent rounds, are then directly sorted into 2 ml recovery 
medium, 2YT medium supplemented with 1-2% glucose and selection marker. If cell 
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viability is low, the selection marker should be decreased in the recovery medium or even 
omitted.  
To screen and select very large libraries, a “fluorescence-threshold selection” can 
be performed. For that purpose, the labeled cells are highly concentrated to allow flow 
rates of about 500,000 cells per second. Note that not every FACS machine technically 
supports this application. 
Next, a threshold is set to the fluorescence signal, until only the most highest 
fluorescent cells are recorded by the machine and the apparent flow rate is reduced to 
20,000-30,000 cells per second. Finally, the most fluorescent cells of this population are 
gated and selected. By this approach, very high cell numbers can be screened, but the 
sort is of low purity, since the true flow rate, i.e. cell density, is much higher. Under these 
conditions, many non-relevant cells, which are close to a cell falling within the sorting 
gate, are co-sorted, because they fall below the fluorescence and are not detected by the 
FACS machine, so that the sorting mask (purity or yield) does not apply. The output can 
be directly resorted, if a sufficient number of cells are isolated, or subjected to purity 
selection in the subsequent round. 
Cells are recovered for 1 hour at 28-37°C, then diluted into 5-20 ml of 2YT medium 
supplemented with 1-2% glucose and selection marker and grown at 25-28°C to 
OD600 < 1. Aliquots of > 109 cells are supplemented with 20% glycerol, snap frozen and 
stored at -80°C until further use. Expression for subsequent selection rounds can directly 
be inoculated from a glycerol stock.  
2.3  Characterization of selected GPCR variants 
Sequence analysis of selected GPCR variants 
 
First of all, the sequence diversity, mutational load and sequence distribution of 
mutations in the selected cell pool is analyzed by sequencing. Either the plasmid DNA of 
single colonies is isolated and the receptor sequence is sequenced, or the receptor 
sequence is directly amplified from a single colony by colony PCR for subsequent 
sequencing of the PCR product. Colony PCR (cPCR) is much faster than plasmid DNA 
isolation and suitable to analyze large numbers of different variants, since it can be easily 
adapted to a 96-well format. For this purpose, a 20 µl PCR reaction is set up containing 
0.1 μM of each flanking primer, 0.8 mM dNTP mix in PCR buffer with 2 mM MgCl2 and 1-
2 units of DNA polymerase. Taq DNA polymerase is sufficient for sequences up to 1000 
bp, while a DNA polymerase with higher fidelity should be used to amplify longer 
sequences, for example VentR™ (NEB) or Phusion® (Finnzymes) DNA polymerase. A 
10 µl-pipette tip is used to gently pick a single colony from an agar plate and transfer it in 
into one well of a 96-well PCR plate. During transfer of cells, any carryover of agar should 
be avoided, since it inhibits the cPCR reaction. For very large colonies, a small sample 
from the colony boundary should be used.  Cells are resuspended by repeated pipetting, 
and the pipette tip is then transferred to the corresponding well on a 96 deep-well plate 
containing 1 ml 2YT medium supplemented with 1% glucose (to suppress expression) and 
selection marker. The mini-cultures are then grown at 37°C for 6-12 hours in a shaking 
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incubator and either stored at 4°C for a few days, or as glycerol stocks at -80°C. Receptor 
variants of interest can thus be easily regrown from a stock culture for further analysis or 
storage. 
The cPCR reaction includes a 10 min initial denaturation step which ensures cell 
disruption, while PCR amplification conditions have to be adjusted to primer sequence, 
product length and DNA polymerase.  
The PCR products are then purified, using for example MultiScreen PCR96 Filter 
Plate (Millipore) and subsequently sequenced.  
 
 
Expression levels of individual selected GPCR variants 
 
The final selected pool of cells is plated on agar plates to obtain single colonies, 
which can then be individually analyzed. Single colonies are grown and expressed in 24-
well plates in 3-5 ml of 2YT medium with 0.2% glucose and selection marker each, sealed 
with gas-permeable seals, and expression is performed as for the library expression. 
Analytical flow cytometry can then be used to analyze the relative expression level, 
using the fluorescence-labeled receptor ligand. The assay is performed as described for 
the FACS sorting, except that smaller expression volumes and number of cells for 
analysis can be used (106-107 cells for flow cytometry analysis).  
For quantification of functional receptor expression, a radioligand-binding assay 
(RLBA) can be used, with the assumption that 1 OD600 in a cuvette of 1 cm pathlength 
equals 109 cells per ml. RLBAs are high-throughout compatible and hence suitable for the 
screening of large variant numbers. For rNTR1, a [3H]-labeled neurotensin peptide is used 
(PerkinElmer). All steps are performed in 96-well plates. For one measurement, 2·107 cells 
are collected by centrifugation, washed once in ligand binding buffer (LBB, 50 mM 
Tris·HCl pH 7.4, 1 mM EDTA, 0.1% BSA and 40 μg/ ml bacitracin) and resuspended in 
100 μl LBB buffer. 100 μl of LBB containing 20 nM [3H]-neurotensin are added to a final 
concentration of 10 nM and incubated for 2-3 h at 4°C to allow for ligand saturation. 
Nonspecific binding is determined in the presence of 5 µM unlabeled neurotensin peptide 
(Anaspec). Unbound and free [3H]-neurotensin is separated from the cell-bound ligand by 
vacuum filtration using 96-well glass fiber filter plates (Millipore MultiScreen-FB plates 
MAFBN0B50, pretreated with 100 µl of 0.01% polyethylenimine (PEI)), on a 96-well 
vacuum filtration device (for example Millipore MultiScreen Vacuum Manifold). The 
sample volume is applied to a well of the filter plate, and filtrated by application of vacuum, 
and the filters are washed 4-5 times with 200 μl of LBB buffer. Filters are dried for 30-60 
minutes at 60°C, and the filter- and cell-bound radioactivity is then quantified by liquid 
scintillation. For this, filters are transferred to scintillation plates (IsoPlate 96, PerkinElmer) 
containing 200 µl of OptiPhase SuperMix scintillation cocktail (Perkin Elmer). Filters are 
allowed to dissolve for 3-12 hours and quantified for 2 minutes in a Wallac 1450 Microbeta 
plus liquid scintillation counter. 
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Detergent stability of selected variants in the presence and absence of 
receptor ligand 
 
To assess the detergent stability of the selected variants, we have previously 
reported a fast and efficient method to screen large numbers of variants, which is 
explained in detail elsewhere (Dodevski and Plückthun, 2011). Briefly, receptor variants 
are in vivo biotinylated using the AviTag sequence, detergent-solubilized and immobilized 
on magnetic, streptavidin-coated beads (MyOne Streptavidin T1 beads, Invitrogen). 
Detergents can be efficiently exchanged after immobilization by repetitive washing in the 
detergent of choice (Fig. 4). According to our experiments, stability measurements in a 
particular detergent are not affected by the choice of detergent used for solubilization or 
the rebuffering process (Fig. 4). 
The solubilized and immobilized receptor is then thermally challenged, and the 
remaining receptor activity is quantified by RLBA. In this experimental setup, the apparent 
detergent-stability in the absence of ligand is determined. The assay is easily adapted to 
study apparent detergent-stability in the presence of ligand: For this purpose, the 
immobilized receptor is first saturated with [3H]-neurotensin for 2 hours, free ligand is 
washed away, and the receptor is then thermally challenged. Depending on the sample 
volume, the concentration of [3H]-neurotensin has to be adjusted to allow ligand saturation 
under these conditions. LBB buffer containing 3-5 nM [3H]-neurotensin is then added and 
incubated for 1 hour before remaining receptor activity is quantified by liquid scintillation 
counting. 
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Figure legends 
Figure 1. Generation of position-specific randomized GPCR libraries (A) and 
multiple GPCR mutants (B). (A) Fully randomized position-specific libraries are 
generated by a 2-step PCR assembly strategy. First, two separate PCR reactions are 
performed with the GPCR coding sequence (1) as template: With primers p1fw and pNre 
(2a), the 5'-end of the library N is generated. Primer pNre and pNfw are NNN-randomized 
in the codon of library position N, thus introducing the desired randomization. For a 
specific point mutation, primer pNfw and pNre have a defined sequence at the target 
position. Primer p1fw and p2re introduce restriction sites for subcloning into the 
expression vector (blue ends). With primers pNfw and p2re (2b), the 3'-end of library N is 
generated. The resulting PCR products (3a, 3b) are isolated and purified, and used as 
template for the subsequent assembly PCR (4). Primers p1fw and p2re are used to 
generate and amplify the full-length library PCR product from the two fragments. The full-
length library is purified and subsequently cloned into the expression vector. (B) A triple 
mutant is assembled from four separate fragment PCRs similar to the position-specific 
library in (A). 
 
Figure 2. Generation of shuffled GPCR libraries using StEP-PCR. (A) Two (or 
more) different GPCR templates are used for in vitro DNA shuffling, denoted as seq.1 and 
seq 2 here (1). By using high numbers of very short StEP-PCR cycles, the flanking 
primers are only extended by a few nucleotides (3a- 3c) until eventually, a full-length and 
chimeric GPCR sequence is generated (3d). By template switches between the StEP-
PCR cylces, mutations from two templates are combined in one StEP-PCR product (3c). 
The StEP-PCR product is then purified from an agarose gel (4) and the flanking restriction 
sites are digested (5) for ligation into the expression vector (6). (B) Recombination 
efficiency of a StEP-reaction on 10 individual point mutants will suffer from «dilution» of a 
given mutation with wildtype (wt) from other mutant sequences, and the observed 
recombination efficiency is much lower than the actual efficiency, since many 
recombination events will not result in sequence changes. 
 
Figure 3. Selection for high functional expression. Here, a GPCR library is 
generated from two GPCR templates, denoted as seq. 1 and seq. 2 here, (1) using StEP 
shuffling (2). The resulting library (3) is electroporated and expressed in E. coli DH5 cells 
(4).The fluorescence-labeled agonist BP-NT (BODIPY-neurotensin(8-13)) is used to label 
the cells relative to their functional expression levels (5). Highly expressing cells are 
identified and isolated by fluorescence-activated cell sorting (FACS) (6). Individual 
selected clones are either grown for single clone analysis (7), or the selected cell pool is 
subjected to iterative selection rounds with optional reshuffling by StEP (8). 
 
Figure 4. Influence of detergent exchange on thermostability measurements. 
GPCR variants are solubilized from E. coli membranes by DDM (n-dodecyl--D-
maltopyranoside, black) or DM (n-decyl--D-maltopyranoside, grey) and immobilized on 
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streptavidin-coated magnetic beads. Detergents are exchange by repeated washing and 
pull-down of the beads in the final detergent buffer. Final detergents are DDM (open 
circles), UM (n-undecyl--D-maltopyranoside, diamonds) or DM (squares). Aliquots of 
solubilized and rebuffered GPCR are thermally challenged and the remaining ligand 
binding affinity is analyzed by radioligand binding assay.  
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 3-A.3  Further Experiments 
3.2.1 Shift mutants A86L, I253A and F358V: Further characterization 
of detergent stability  
Detergent stability of the single shift mutants in comparison to D03 was assessed 
in the detergent n-dodecyl--D-maltopyranoside (DDM) in the absence of agonist, a 
condition under which D03 displays a Tm of 30°C (see Chapter 3.1-A, published article 
and Table 1 therein). The three dominant single shift mutants with strongly increased 
detergent stability compared to D03 (A86L1.54, I253A5.54 and F358V7.42) were further 
analyzed in the shorter and harsher detergent n-decyl--D-maltopyranoside (DM), a 
condition under which D03 is barely stable, and additionally in the presence of agonist.  
In the absence of agonist, the detergent stability of the shift mutants A86L1.54 and 
I253A5.54 in DM is strongly increased compared to D03, which is only marginally stable 
under these conditions (see Table 3-1).  
 
 
Table 3-1. Detergent stability in DM in the absence of agonist. 
  
rmsd 
454 
Tm  (°C)* 
(n = 2)    
Tm,D03 
(°C) 
S83G 10.2 15.8 0.1 
A86L 4.9 23.5 7.8 
I253A 5.2 32.0 16.3 
I260A 7.1 14.8 -0.9 
I260S 7.1 15.7 0.0 
F358V 4.8 17.1 1.5 
D03 ctrl**   15.7   
* average error 2°C; ** n=3  
 
 
The shift mutants A86L1.54, I253A5.54 and F358V7.42 do also lead to stabilization of 
the agonist-bound state, showing that the effect is independent of the receptor state (see 
Table 3-2).  
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Table 3-2. Detergent stabilities in the presence of agonist.  
            
Tm  (°C)* 
  rmsd DDM DM NM OG 
A86L 4.9 53 47 39 29 
I253A 5.2 55 51 46 35 
F358V 4.8 51 47 41 27 
D03 47 42 42 16 
* n=2; ** n=4 
 
 
The stabilizing effect of the three shift mutants is most prominent in the harsh 
short-chain detergent n-octyl--D-glucopyranoside (OG), where increases of more than 
11°C in Tm are observed (see Table 3-2). It can be concluded that the stabilizing effects 
are independent of the assay condition, and that positions with crucial role for detergent 
stability were identified. 
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Abstract 
Directed evolution techniques provide powerful tools to engineer proteins for an 
envisaged phenotype, and its applications range from the optimization of industrial 
enzymes to the generation of new biopharmaceutical drugs.  
While generation of genetic diversity and selection procedures are high-throughput 
compatible, the subsequent analysis of the selection by Sanger sequencing is limited in its 
sampling capacity since it requires the individual handling of individual, selected variants. 
The fairly recent development of high-throughput and cost-effective deep sequencing 
technologies has hence great application potential in directed evolution.  
Here, we have used deep sequencing to evaluate the directed evolution of a G 
protein-coupled receptor (GPCR). GPCRs act as molecular switches in most signal 
transduction processes, making them key targets in pharmacology. GPCRs have naturally 
evolved for protein functionality in a membrane environment, requiring low expression 
levels and fast turnover to sustain efficient signal activation and regulation. However, 
these poor biophysical properties constitute major roadblocks for in vitro characterization 
and structure determination of GPCRs, as well as for the utilization of purified proteins in 
high-throughput drug screening. To overcome this problem, directed evolution provides 
powerful techniques to engineer proteins variants with improved biophysical properties 
that are able to signal and have ligand binding properties very similar to the wild type. Our 
recent development of a FACS-based screening and selection technique to efficiently 
display and isolate GPCRs with high functional expression rendered GPCRs accessible to 
directed evolution. We have developed technologies to comprehensively randomize a 
GPCR to understand the critical information content of the GPCR sequence and structure 
with respect to protein biosynthesis, stability in the lipid bilayer and, after solubilization, in 
detergent micelles. Every residue of the receptor was separately and fully randomized into 
all 64 codons, and each library was subsequently selected for high functional expression 
using the previously established selection method. The combined sequencing of more 
than 350 independently selected pools required overcoming profound sample preparation 
challenges and customized data analysis, which will be described in detail in the following 
chapter. The analysis of the selected pools by deep sequencing revealed the amino acid 
preference in every position of the receptor. This unique data set allowed us, for the very 
first time, to compare in vitro with natural selection and to identify several positions that 
restrict functional expression and detergent stability.  
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1. Introduction 
1.1  Application of deep sequencing in directed evolution projects 
The recent developments and improvements of deep sequencing approaches 
have revolutionized many scientific projects that were not accomplishable before by 
standard sequencing. While de novo genome assemblies or SNP detection became 
feasible and even routine projects by means of the high throughput and oversampling 
capacities of deep sequencing approaches (reviewed for example in (Pareek et al., 
2011)), these technologies do also have a tremendous application potential in 
mutagenesis and directed evolution projects, where robust analysis of a mutagenic load 
and correlation or sensitive detection of rare sequence variants and correlation between 
sequence variants is desired.  
Directed evolution projects can be grouped into two types. In the first, a rather 
diverse collection of sequences is selected, typically for binding affinity. These sequences 
differ in many positions, as exemplified in the CDRs of antibodies or in the many 
randomized positions of a synthetic scaffold. In vitro directed evolution methods such as 
ribosome display can easily accommodate libraries with a diversity of 1012, but in vivo 
techniques such as phage display are limited by transformation efficiencies and typically 
reach diversities of 107-108. Iterative rounds of screening and selection lead to enrichment 
of a subpopulation displaying an envisaged phenotype, e.g. a tight binding to a target 
molecule. Since in general the binding properties (phenotype) of individual selected 
clones need to be connected to their sequences, and since toward the end of the 
selection the number of molecules of interest becomes small, deep sequencing has not 
found widespread use. Standard Sanger sequencing appears to be more suitable in this 
situation, since individual clones can be accessed. 
In contrast, deep sequencing offers unparalleled powers when it comes to using 
the directed evolution process for generating statistical information on sequence 
preferences. Such a scenario would arise, e.g., in affinity maturation where it can be of 
interest which amino acid types are enriched during this process, and where one might 
want to combine the amino acids found afterwards. In other words, unlike in the case of a 
naïve diverse library, these libraries are closely related point mutants of a defined starting 
molecule, and thus much more tightly connected to each other than, e.g., a synthetic 
antibody library. By these means, statistically robust sequence information about an 
enriched subpopulation can be obtained, and it is easily feasible to monitor selection 
processes over several rounds. In contrast, the number of analyzed clones in standard 
Sanger sequencing is not only limited by the availability and capacity of high throughput 
screening (HTS), but also by the significant costs for standard Sanger sequencing of 
individual clones.  
Here, we have employed deep sequencing using the 454 technology to evaluate 
the directed evolution of a GPCR for high functional expression and detergent stability, 
using a comprehensive randomization study of a GPCR. This is conceptually closer to the 
second scenario, but it required new technologies for the selection itself, as well as for 
sequence analysis, because the length of the protein far exceeds the read length of 
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available deep sequencing technologies. Finally, no commercial software was available 
for the required data analysis, again requiring own developments. 
1.2 Principles of directed evolution 
Different from rational design approaches, directed evolution does not require any 
prior structural information about the target protein or any prejudice concerning the 
stabilizing mechanisms, but is based on the generation of genetic variability, coupled to 
subsequent selection of the desired phenotype from a diverse library. This process mimics 
natural evolution in vitro, with the advantage that the genetic diversity is artificially 
introduced and can be controlled in its mutational load, i.e. number of changes and mutant 
spectrum of allowed amino acids and their percentage by adjustment of the reaction 
conditions. The key requirement for the directed evolution of any target protein of interest 
is the availability of a suitable selection system to isolate a rare phenotype from a large 
and highly diverse library.  
A relevant target protein class for directed evolution are G protein-coupled 
receptors (GPCRs): GPCRs play a key role in most eukaryotic signal transduction 
processes, and are thus indispensable to nearly all physiological processes. Activation of 
these receptors by an extracellular stimulus induces a conformational change within the 
protein, resulting in signal transduction across the cell membrane. GPCRs are embedded 
in a fine-tuned network of receptor activation, signal transduction to and signal 
amplification by heterotrimeric G proteins, and regulation of signaling by receptor 
desensitization and degradation (Deupi and Kobilka, 2007). Their pivotal role in cell 
signaling and survival is reflected in the fact that many non-olfactory receptors are the 
target of some the most frequently prescribed drugs, such as the treatment of 
pathophysiological heart conditions by -blockers acting on -adrenergic receptors 
(Frishman, 2008), or the control of pain by targeting opioid receptors (Stein et al., 2003). 
Currently, it is estimated that 30% of all prescribed drugs target GPCRs (Lagerström and 
Schiöth, 2008; Overington et al., 2006). 
The pharmacological relevance of GPCRs is fundamental to the huge scientific 
efforts to functionally and structurally characterize GPCRs. However, the biophysical 
properties of GPCRs have naturally evolved for activity in a cellular context, and their 
notoriously poor biophysical properties constitute a major bottleneck for in vitro 
characterization studies. Low expression levels, poor solubilization efficiency and low 
stability in detergent micelles restrict the spectrum of GPCRs that is accessible to in vitro 
characterization studies, let alone in vitro drug screening approaches.  
Directed evolution provides promising and powerful method to approach the 
current limitations in GPCR research, and such studies became accomplishable with the 
recent development of a FACS-based, high-throughput selection method to isolate well-
expressed and functional GPCRs from large receptor libraries (Sarkar et al., 2008). This 
strategy directly targets the intrinsic bottleneck of the given GPCR, i.e. the primary amino 
acid sequence, and allows to identify receptor variants with binding and signaling 
properties close to wild type but with improved expression levels and biophysical 
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behavior, with the great potential to render non-accessible GPCRs amenable to functional 
in vitro studies. 
Randomization by mutagenic PCR is a suitable and well-established method to 
generate highly diverse libraries (Cadwell and Joyce, 1994), starting from the target 
sequence, and has been successfully applied to evolve several GCPRs for higher 
expression levels and detergent stability, using iterative rounds of random mutagenesis 
and selection (Dodevski and Plückthun, 2011; Sarkar et al., 2008). 
However, random mutagenesis techniques are limited with respect to coverage of 
the target sequence (target space), and with respect to the coverage of the mutant space, 
the latter being a result of the degeneracy of the genetic code in combination with 
preferred single-base changes in mutagenic GPCRs. Consequently, it is not possible to 
fully cover the target sequence and mutant space by random mutagenesis approaches. 
Alanine-scanning approaches specifically target every residue and have also been 
recently applied to GPCRs to generate variants with improved protein properties 
(Rosenbaum et al., 2007; Shibata et al., 2009), but fail to identify beneficial mutations 
other than alanine. In both cases, critical residues for protein function and stability might 
remain unidentified.  
Thus, the most crucial step is to explore the entire mutant space by full 
randomization of every receptor position with selection for the amino acid variant 
conveying the desired phenotype.  
 
1.3 Directed evolution of the GPCR rNTR1-D03 using comprehensive 
randomization 
The rNTR-D03 (D03) variant was chosen as a typical GPCR to perform a 
saturating and exhaustive randomization with subsequent selection for high and functional 
expression using the previously established FACS-based selection system (Sarkar et al., 
2008). Synthetic libraries with an NNN-diversified codon were generated for receptor 
positions 43 to 418 (Schlinkmann et al., 2012). The full sampling of the degenerate 
genetic code is highly valuable for two reasons: First, any codon bias introduced prior to 
translation, e.g. variable tRNA levels, mRNA secondary structure, codon usage 
preferences can be excluded or identified. Second, the full codon diversity functions as an 
internal quality control to ensure phenotype selection. While the full NNN-randomization 
approach allows to verify the absence – or presence  –  of any codon bias effects, it also 
adds a technical bias to the selection that requires bioinformatics correction during data 
evaluation, which will be explained in detail later. Furthermore, a high enough 
oversampling of sequencing after selection allows discrimination between real positive 
selection and tolerance of certain amino acid properties. Theoretically, the presence of 
stop codons could be reduced by using an NNK triplet at the target residue. However, the 
presence of stop codons in the naïve library is uncritical when selecting for protein 
functionality, and their absence after selection provides an important measure of quality 
control.  
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For the first time, this study provided knowledge about the preferred residue for 
every position, including positions where the wild-type residue is preserved. Even more 
importantly, this study allowed to identify positions where a residue other than wild-type is 
preferred. The comparison of in vitro selection with natural evolution of GPCRs further 
elucidated the different constraints of protein biosynthesis, integration and folding in the 
lipid bilayer and formation of a functional ligand binding site as observed during in vitro 
evolution (D03 libraries) in E. coli, versus maintenance of a finely tuned signaling network 
in natural GPCR evolution (Schlinkmann et al., 2012). These results provide a unique data 
set that will greatly help in future GPCR engineering. 
2. Experimental Details 
2.1  Generation of synthetic libraries 
The specific and separate targeting of every target protein residue, here a GPCR, 
in combination with full randomization into an NNN-library, assures that every possible 
permutation is generated and available for selection. Throughout library generation and 
handling, continuous representation of the entire library diversity is most crucial, since 
subsequent analysis of the selection outcome is based on the assumption of a fully NNN-
randomized position following a theoretical distribution. Naïve library members have to be 
sequenced to guarantee that the naïve library corresponds to its design, namely that it 
varies in exactly one codon from the starting sequence and that the NNN-randomization 
represents all codons at equal frequencies.  
Apart from sustaining library diversity throughout all steps by an oversampling 
threshold of at least 30-fold, the generation of a single library is rather straightforward, 
albeit laborious, considering the number of libraries that have to be produced. Most 
importantly, any overrepresentation of the wild-type codon in the resulting library has to be 
avoided. Main sources for wild-type contamination are the amount of wild-type DNA 
template during the primary PCR step, and usage of an acceptor plasmid containing the 
wild-type coding sequence. Consequently, the template amount during the PCR step 
should be kept at an absolute minimum, and the acceptor plasmid should not contain any 
receptor coding sequence, but a stuffer sequence or negative selection marker.  
To construct the 376 libraries used in this study, the codons encoding the D03 
residues 43 to 418 were randomized by replacing them, one at a time, with the diversified 
trinucleotide NNN, where N stands for an equimolar mixture of A, G, C, and T. Depending 
on the position of the diversified codon relative to the 5’ and 3’ ends of the gene, one of 
two PCR-based methods was employed: For codons close to one of the gene ends, an 
oligonucleotide covering both the target codon site and the restriction recognition site was 
designed with an NNN trinucleotide annealing to the target codon site. The full-length 
library fragment was then PCR-amplified using a second amplification oligonucleotide 
hybridizing to the opposite end of the gene, also containing a suitable restriction 
recognition site. To randomize codons distant from the two ends, a two-step PCR 
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assembly strategy was employed. Two complementary oligonucleotides were designed to 
cover the target codon with a diversified NNN sequence, and each of these 
oligonucleotides was paired with the appropriate amplification oligonucleotide at either 
end of the gene, so that by PCR amplification, two half-gene fragments overlapping at the 
target codon site were generated. The PCR products were then combined and extended 
in a second PCR reaction to obtain the full-length product containing exactly one 
diversified codon (for details, see (Schlinkmann and Plückthun, 2012)). The final PCR 
products were purified, the flanking restriction sites were digested and the library PCR 
fragment was ligated into the acceptor plasmid pRG-del. pRG-del is a derivative of 
pRGD03 (Sarkar et al., 2008; Schlinkmann et al., 2012), where, for the reasons explained 
above, the GPCR-coding sequence was replaced by a stuffer sequence containing 
multiple restriction recognition sites. The ligation product was then purified and 
transformed into E. coli DH5 cells by electroporation. 
Sanger sequencing of a representative subset of library variants verified that 
library diversity conformed to its design. Sequences of a total of 2170 clones from naïve 
(unselected) libraries were shown to contain an equal distribution of the four bases in all 
codon positions (Table 4-1), consistent with full randomization. No overrepresentation of 
any codon, especially the wild-type codon, was detected. Importantly, since Sanger 
sequencing can cover the full length of the GPCR, it can be ascertained that the genes do 
not have any spurious mutations in addition to the randomized position. Thus, one can be 
assured that the phenotype is indeed caused by the randomized amino acid. 
2.2  Library expression and FACS selection 
Libraries were transformed into and expressed in E. coli DH5 cells. A sufficient 
oversampling of library diversity was ensured by controlling the transformation efficiency, 
with a threshold of minimally 2500 colonies after transformation, corresponding to a 30-
fold overrepresentation of library diversity.  
Briefly, cells were grown to early log-phase (OD600 = 0.5) and each GPCR library 
was expressed for 20 hours at 20°C (Schlinkmann et al., 2012). Low expression 
temperatures are recommended during library selections, to reduce the toxic effects of 
GPCR overexpression in E. coli and minimize growth rate differences between individual 
library members, at least before enough stabilizing mutations have accumulated and as 
long as the phenotype is still wild-type like and poor..  
 An aliquot of cells was washed in TKCl buffer (50 mM Tris pH 7.4, 150 mM KCl), 
rendering the outer membrane permeable, and fluorescence-labeled by binding of 
fluorophor-conjugated agonist, BODIPY-neurotensin,  essentially as described in (Sarkar 
et al., 2008). Hence, cells were fluorescence-labeled according to their level of functional 
GPCR expression. 2500 cells with expression levels corresponding to the top 1% of 
functional expression were collected for each library. Note that the parental sequence 
D03, even though itself already the product of a directed evolution, serves here as "wild 
type", as all mutants are derived from it. Generally, the selection window has to be 
adjusted in a proof-of-concept experiment to ensure meaningful selection. Here, the 
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library of position 347, in the wild-type a tyrosine residue known to be involved in ligand 
binding (Barroso et al., 2000), was used to optimize and validate the method. With one 
round of selection, tyrosine was exclusively recovered from the selection, with equal 
representation of the two synonymous codons (Schlinkmann et al., 2012). Selected cells 
were recovered and stored as glycerol stocks for later analyses.  
2.3  Design and setup of the 454 sequencing reaction 
In a first analysis step, 5-20 single clones from each selected pool were analyzed 
by standard Sanger sequencing. This primary data set allowed to deduce trends for every 
receptor position, and confirmed, also for conserved positions, phenotype selection by 
representation of the synonymous codons for a given amino acid. Most importantly, 
Sanger sequencing of the full-length, selected GPCR sequence assured that no spurious 
undesired mutations at sites other than the randomized codon influenced the selected 
phenotype.  
Nevertheless, a robust statistical analysis of preferred, tolerated and avoided 
amino acids at each receptor position required a larger dataset. For this purpose, each 
selected library pool was further analyzed by 454 sequencing. The D03 gene is about 
1200 base pairs long, and thus too long to be covered by the read length of deep 
sequencing by the 454 technology (at least at the time of the experiment). At the time of 
the experiment, the 454 read length typically reached 250 bases. By design, each library 
contains only one diversified codon, allowing us to sequence only a small region of the 
gene, since the Sanger sequencing of the whole gene had already confirmed the absence 
of other mutations outside of the designed ones. Ideally, one would have kept each 
library, in which one amino acid was randomized, separate. However, this would have 
been an overkill, given that with even a few thousand sequences excellent statistics can 
be obtained, and the achievable million sequences would offer no additional benefit. More 
importantly, the independent handling of 376 deep sequencing projects for one single 
gene is way beyond economic feasibility. Conversely, the multiplexing of samples by 
pooling of all libraries into one big mixture, with particular primer pairs containing 
multiplex-identifier-sequences (MIDs) to untangle where a mutation came from, would be 
hard to achieve in practice and would be so expensive in primer pairs that it would again 
be not feasible. Multiplexing of samples without the use if MIDs is practically 
accomplishable and cost-effective, but comes with a drawback affecting later data 
assignment: In such a setup, conserved sequences are identical to the parental reference 
sequence D03, and hence the information which position was conserved would be 
completely lost, as explained in more detail below. 
The challenge was therefore to devise a strategy which is a compromise between 
these two extremes. Seven amplicons were thus designed as 250 bp overlapping 
fragments to fully cover the receptor sequence (Fig. 4-1A, for primer sequences see 
(Schlinkmann et al., 2012)), with an sample preparation and analysis strategy explained in 
the following.  
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The DNA of each selected pool was isolated, and the DNA fragment covering the 
diversified codon was amplified by choosing the flanking amplicon primer pair. For this 
study, 376 amplicon PCR products, each representing the corresponding diversified 
library codon, were generated (Fig. 4-1A and 4-1B). The PCR products were purified, and 
the DNA amount corresponding to 2·1011 molecules was used as input material for the 
454 sequencing reaction (performed at Functional Genomics Center Zurich, FGCZ). 
While the generation of 376 individual PCR products is rather a matter of diligence 
than finesse, the actual experiment required a sophisticated sample setup: In principle, 
the DNA of several libraries could be mixed in one reaction. By default, every sequence 
contains only one diversified codon, thus allowing identification of its origin by alignment to 
the reference sequence D03 (serving as starting sequence, or new "wild type"). This 
strategy is both cost- as well as work-effective, as it avoids tagging each library by the 
above mentioned MIDs. The usage of MIDs to identify the sample origin is clearly valuable 
when a few samples are mixed in one reaction, a reference sequence is not available and 
accurate sequence assignment is crucial. In this case, the usage of 376 individual, MID-
tagged amplicon primer pairs would have not only dramatically increased and complicated 
the workflow of sample preparation, but the cost of 376 individual primer pairs would have 
even exceeded the cost of a large scale 454 sequencing run, and was thus considered 
inappropriate. 
However, as mentioned above, our strategy to mix multiple library samples in one 
454 sequencing reaction has one drawback: While sequence reads different from the 
parental reference sequence D03 can be unambiguously assigned, sequences that 
perfectly match the reference sequence remain unassigned, since it is not clear from 
which (maintained) position they originate. These sequences were not processed further, 
and a bioinformatics correction was applied during data evaluation to account for this 
shortcoming. 
We decided to not sequence all randomized positions falling within one amplicon 
(typically 50) in the same pool, but rather distribute them over 8 individual 454 sequencing 
reactions, such that each reaction is pooled from only 6-8 randomized positions falling 
within one amplicon (Fig. 4-1C), for the following reason: In a mixed sample of 50 different 
PCR products coming from the 50 different randomized positions within one amplicon, 
about 2% of the obtained sequence reads would be assignable to its library origin as 
mutations within this codon. However, for each position, the remaining 98% of sequence 
reads would be wild type in a given position and thus align perfectly to the D03 reference 
sequence in that specific codon, since their diversified codon is at a different position. This 
would make the accurate determination of mutant frequencies rather difficult. From a pilot 
experiment, we learned that the noise of our 454-sequencing reaction was ~ 0.1%, 
meaning that 0.1% of sequence reads contain one or more mismatches in the non-
randomized gene regions. The observed error frequency here is a sum of base pair 
mismatches introduced during amplicon PCRs as well as sequencing errors during the 
454 sequencing reaction. The 454 sequencing reaction accuracy is mostly limited by 
shortcomings in the identification of homopolymer length by pyro-sequencing (Chan, 
2009; Ronaghi et al., 1998), and the noise of 0.1% here is mainly observed in 
homopolymeric sequence stretches. Here, all sequences showing miscalled bases in 
addition to the randomized codon were excluded from analysis. In the given example, an 
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assignment of 2% of sequences per library and 0.1% noise would have resulted in a 
signal-to-noise ratio of only 20.  
In order to obtain a higher ratio of assignment % over noise % (i. e. signal-over-
noise), we have prepared the samples as follows (Fig. 4-1C): 376 different libraries were 
grouped into 8 individual 454 sequencing reactions, run separately on 1/8 of a 454-
picotiterplate. Every reaction contains 45-52 individual PCR products in total, of which 6-8 
fall within each of the amplicons 1-7. Alignments of 454 sequence reads to the D03 
reference sequence (i.e. assignment of 454 sequence reads to a specific library origin) 
were later run independently for each 454 sequencing reaction and amplicon. One 
alignment of 454 sequence reads to the D03 reference sequence thus contains sequence 
reads of 6-8 individual amplicon PCR products, meaning that sequences from this pool 
are randomized in one of these 6-8 positions. Thus, 12.5 – 16% of sequences are 
assigned per library (i.e. for a given codon that was randomized in this set, this is the 
percentage of sequences actually carrying an altered codon in this position), resulting in 
an improved signal-to-noise ratio of at least 125 (12.5% over 0.1%) (Fig. 4-2). 
2.4 Computational analysis of 454 sequencing data 
The fast expansion of deep sequencing technologies is facilitated by major 
technical advances during the last years. The outsourcing of the actual sequencing 
process to a specialized institution and the comparably low prices per sequence makes 
deep sequencing essentially accessible to most researchers. However, data evaluation is 
by far not as easy as sending out a DNA sample: The obtained raw data sets are huge, 
and the evaluation requires both computational power and suitable processing software. 
While more and more software packages are available for analysis of deep sequencing 
data, we have found none of these to fit to our needs for data analysis, let alone statistical 
corrections that are necessary regarding our sample setup.  
Basically, our data evaluation is restricted to one codon per sequence read, and is 
based on trinucleotide analysis, i.e. codon level and amino acid level. Further, the unique 
setup of our 454 sequencing reactions required separate analysis of individual amplicons, 
for which the sequences had to be assigned and separated into individual clusters. We 
have thus developed customized EXCEL-based visual basic macro functions to serve our 
needs for sequencing data analysis. 
 
Sequences acquisition and assignment 
 
The raw sequences were transferred from the 454 system as large FASTA-format 
text files, imported into EXCEL and processed using a set of custom Visual Basic macros.  
First, the amplicon and the reading frame had to be identified.  We searched for 
the first 12 base exact match between each sequence and the D03 reference sequence 
(forwards and reverse), representing a unique sequence string, and cut off all nucleotides 
before the start of the first in-frame codon match.   
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The sequence was aligned without gaps and cut into in-frame nucleotide triplets. 
For our experiment, it was crucial to keep the background of sequencing errors as low as 
possible. Therefore, we stringently eliminated unreliable parts of the sequence. 454 
sequences tend to acquire insertions and deletions in runs of the same nucleotide 
(homopolymers; see (Chan, 2009)), and indeed most sequences eventually went out of 
frame. Since we did not expect any frameshifts from a selection for functional receptors, 
we took the occurrence of frame shifts in the sequence as a sign that the sequence quality 
had deteriorated and truncated the shifted part of the sequence. Mismatched codons were 
trimmed back from the end of the sequence until a 4 codon (12 bases) exact match was 
found. The truncated sequences were compared to the D03 reference sequence. Only 
those sequences that differed by exactly one codon from the D03 reference sequence 
were used for further analysis. For the pilot experiment, these were 86,734 out of 206,405 
sequences (42%), covering 48 randomized positions. For each randomized position, an 
average of 1,800 sequences differed from the consensus; for non-randomized positions, 
only 7.6 sequences (noise < 0.5%). In the actual experiment, 476,322 sequences (69.6%) 
showed exactly one deviation from the D03 reference sequence, covering 331 positions 
with 1,400 sequences per randomized position, against a background of 4.4 mutations in 
nonrandomized positions. The process of sequence acquisition and assignment is 
illustrated in Figure 4-2. 
 
Analysis of codon and amino acid distribution 
For each amplicon, comprising 3 to 8 randomized positions, the frequency 
distribution of the 64 codons was determined for each position in the sequence. As 
explained above, the frequency of the wild-type codon in the randomized positions could 
not be determined directly, as it could not be distinguished from the wild-type codon 
originating from sequences randomized in a different position. For amino acids encoded 
by several synonymous codons, the frequency of the wild-type codon was estimated as 
the average of the frequencies of synonymous codons. This correction could not be 
applied for the two amino acids encoded by a unique codon, Met (ATG) and Trp (TGG). 
The codon frequency distribution was normalized to give a sum over all 64 codons of 
100%.  
The amino acid frequency distribution was derived as the sum of the frequencies 
of synonymous codons. For further analysis, we evaluated the effects of selection on the 
width of the frequency distribution (sequence variability) and the peak of the distribution 
(sequence consensus). The amino acid distributions demonstrated a high tolerance of the 
D03 towards randomization: The average positional variability in the transmembrane 
regions of the sequences recovered from the top 1% neurotensin-binding E. coli clones 
isolated by FACS was comparable to that derived from the corresponding regions in an 
alignment of all Class A (rhodopsin-like) GPCR sequences.    
NNN randomization at equal and theoretically expected frequencies, combined 
with the degeneracy of the genetic code, introduces a technical bias in the amino acid 
distribution. Ser, Arg and Leu, encoded by 6 codons each, are six-fold overrepresented 
over Trp and Met, encoded by a single codon; other amino acids lie between the two 
extremes. For most positions, the selection pressure was not strong enough to overcome 
this technical bias: amongst amino acids with similar properties, the amino acid sequence 
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consensus frequently went to the one encoded by the highest number of codons, e.g. to 
Leu in membrane-embedded positions that tolerated Leu, Val, Ile and Met, or to Arg in 
positions that required a positively charged amino acid. Usual metrics of sequence 
variability (e.g. Shannon sequence entropy (Shannon, 1963; Strait and Dewey, 1996) or 
Kabat sequence variability (Kabat et al., 1977)) and of sequence consensus did not 
perform well in this context, as they assume all amino acids to be equally probable and 
therefore affects the results in favor of the amino acids over-represented in the original 
library, due to the degeneracy of the genetic code. The classical amino acid consensus 
sequence therefore differed significantly from the translation of the codon consensus (Fig. 
4-3), and amino acids encoded by a larger number of codons on average appeared more 
conserved than amino acids encoded by fewer codons.  
The root-mean-squares deviation (rmsd) of the observed amino acid distribution 
from the input amino acid distribution generated by equal NNN codon randomization was 
chosen as a measure of the selective pressure shaping the amino acid distribution in a 
given position. The rmsd for a given position is calculated according to formula (1): 
 
ݎ݉ݏ݀ ൌ ට∑ ሺ௙೗೔ି௙ೞ೔ሻమమబ೔సభ ଶ଴
మ
        (1) 
 
where f୪୧ is the frequency of amino acid i in the library before selection and fୱ୧ is 
the frequency after selection. The frequency of amino acid i before selection is deduced 
from the theoretical distribution of a NNN library. Sanger sequencing of the naïve libraries 
confirmed the codon distribution according to a theoretical distribution before selection 
(Table 4-1), and the high oversampling of the library diversity throughout all experimental 
steps kept the statistical noise low.  
A low rmsd denotes a permissive position, where the selection process had little or 
no effect on the observed amino acid frequency distribution, while a high rmsd is a sign of 
a restrictive position with a clear amino acid preference. Intermediate rmsds frequently 
denote positions where the general character of the amino acid is preserved (e.g. 
aliphatic), but not the exact type (e.g. valine).  
This distinction between permissive (low rmsd) and restrictive positions (high 
rmsd) does not depend on whether the wild-type sequence is conserved or not – a 
position can be restrictive, but shift away from the wild-type sequence to a new focus, or 
be permissive and still include and partially preserve the wild-type sequence (e.g. by only 
selecting for the aliphatic character of the amino acid).  
2.5 Data interpretation 
The assessment of sequence conservation and sequence shifts was based on the 
comparison of the wild-type sequence to the selected consensus, generated from a 
normalized table of the observed amino acid frequencies divided by the number of 
synonymous codons for each amino acid. This normalized consensus better reflects the 
influence of the applied selection pressure on the amino acid distribution than the classical 
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amino acid consensus (Fig. 4-3). We will now discuss the reasons for choosing this 
strategy. 
To correctly analyze and interpret the obtained in vitro evolution data, it is 
necessary to consider the differences between natural evolution and in vitro evolution of 
GPCRs. The classical consensus is derived from natural sequences and both well 
established and suitable for the analysis of natural evolution over short evolutionary 
distances.  
Natural evolution is primarily driven by the random appearance of single nucleotide 
exchanges, modifying an ancestral sequence and increasing the width of the amino acid 
sequence distribution. Over relatively short evolutionary distances, the consensus of 
natural sequence variants (e.g. different naturally occurring peptide-binding GPCRs, 
including those from different species) is governed by the ancestral sequence. Few 
mutations occur, neutral or selected, and the mutational tolerance has not yet been fully 
tested. 
As the evolutionary distance covered by a sequence alignment increases, the 
different probabilities of introducing different mutations affect the observed amino acid 
distribution.  Only over evolutionary distances large enough to equilibrate the sequence 
pool (meaning, all nucleotides have been tried) the influence of any codon bias would 
become observable in natural sequences (e.g. in an alignment of all human Class A 
GPCRs).  
In contrast, in our synthetic library approach we start from a known and theoretical 
codon distribution (meaning that all of the 64 NNN codons is present at the same 
frequency) that gets narrowed down by successive selection rounds, until it converges to 
a single sequence. With a single selection round, the observed amino acid distribution is 
influenced by the technical codon bias (i.e. that a particular amino acid is being introduced 
more likely simply because it can be encoded by more synonymous codons) and the 
importance of a particular sequence position to the “fitness” of the entire molecule.   
Classical consensus analysis, not accounting for the number of synonymous 
codons by which different amino acids are represented, is most suitable to the analysis of 
natural sequences that have not diverged very far from the ancestral sequence, and to in 
vitro evolved sequences that have undergone a sufficient number of selection round to 
show clear sequence convergence. In contrast, a consensus corrected for technical codon 
bias (i.e. number of synonymous codons for amino acid types) yields better information 
with highly diverged natural sequences and for in vitro evolved sequences that have 
undergone relatively mild selection. 
We compared the rmsds obtained from the sequences of the selected members of 
the D03-based libraries to those derived from more than 20,000 aligned class A GPCR 
sequences obtained from the GPCRDB (http://www.gpcr.org/7tm/). The ratio of the D03 
rmsds to the GPCR class A rmsds indicates in which of the two systems a given position 
is more highly conserved (Figure 4-4). As expected, positions involved in ligand binding 
were strongly focused in the D03 libraries, but divergent in Class A GPCRs (which bind to 
diverse ligands), while residues involved in G-protein interaction were strongly focused in 
Class A GPCRs but divergent in the D03 libraries (which were selected for ligand binding, 
not for signal transduction). These positions serve as positive controls, showing the 
sensitivity of the rmsd as a measure of the selective pressure shaping the amino acid 
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distribution in given residue position. Residues that appear to be highly focused for less 
obvious reasons are prime candidates for further analysis, especially if the observed 
amino acid distribution in those positions reveals a shift towards an amino acid different 
from the original D03 sequence or Class A GPCR consensus.  
2.6 Conclusions and Discussion 
The comprehensive randomization in combination with deep sequencing resulted 
in a unique data set providing unprecedented insight into the constraints of GPCR 
evolution (Figure 4-4), and the analysis by deep sequencing robustly identified the 
presence of so called shift positions after selection, which are key mutations for 
engineering of the protein. The library design allowed us to constrain the deep sequencing 
to the target region covering the randomized position, and to assign the sequence reads 
by reference alignment. Even though the actual sequence information was contained in 
one trinucleotide, the read length performance of the 454 sequencing technology of 250 
bases facilitated coverage of the full sequence, i. e. all libraries, by only seven amplicons, 
which would not have been possible by other deep sequencing technologies available at 
that time (deep sequencing technologies such as illumina® sequencing or ABI SOLiD 
systems allowed for maximal read length of only 100 bases). In this specific setup, the 
obtained data set had to be corrected for the loss of wild-type codon information by 
statistical methods. With the analyzed data at hand, we can conclude that the approach of 
sample preparation and sequencing setup taken here proved to be appropriate, providing 
an enormous gain in information while keeping sample preparation work and -costs at a 
feasible level.  
Unlike our position-specific libraries, most directed evolution studies are based on 
random mutagenesis of the whole protein sequence (for example random mutagenesis of 
NTR1 (Sarkar et al., 2008)) or the designed randomization of certain positions within the 
sequence (for example DARPin libraries (Binz et al., 2003)). The recent advances of the 
454 technology led to an average read length of 600-800 bases, representing the most 
promising technology for deep sequencing of libraries of small proteins. However, for 
libraries such as the randomized NTR1 sequence with a length of ~1200 base pairs, 
individual mutations can be separated by hundreds of base pairs while coevolving for 
functional or structural reasons. While deep sequencing can easily generate statistically 
robust data about mutational load and distribution under these conditions, it fails to allow 
correlated analysis of individual mutations, since it is not (yet) processive enough to cover 
one sequence in one read.  
Fairly recently, so-called third generation sequencing technologies (single 
molecule sequencing) have become available (Pareek et al., 2011; Schadt et al., 2010), 
among which the SMRTTM sequencing technology (Pacific Biosciences) is most 
advanced regarding the read length, with expected read lengths of 1-10 kilobases. This 
will greatly simplify the analysis of libraries as those of GPCRs described here and 
facilitate further analyses. 
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Figure legends 
Figure 4-1. 454 sequencing setup. (A) Seven amplicon PCR products 
(amplicons) of ~250 bp are designed to cover the GPCR gene. (B) For each selected 
library pool, an amplicon PCR containing the diversified codon is generated (1a-1d). (C) 
One 454 sequencing reaction contains 6-8 members of each amplicon. 8 individual 454 
sequencing reactions are performed to analyze all 380 amplicon PCR products (2), kept 
separately on a subdivided picotiter plate. 
 
Figure 4-2. 454 sequencing read assignment. After amplification of the gene 
region containing the diversified codon (1-3), various amplicon PCR products are 
analyzed in one 454 sequencing reaction (4). The resulting 454 sequencing reads (5) are 
assigned by alignment to the starting sequence D03 (6). The diversified codon 
unambiguously identifies the library origin (6; library positions n, m, x and y). However, 
454 sequence reads with perfect alignment to the starting sequence D03 cannot be 
assigned to a particular randomized codon and statistical correction is applied for 
compensation. 
 
Figure 4-3. Alignment of Sanger and 454 consensus sequences with rNTR1, 
rNTR1-D03 and class A GPCR consensus.  
Sanger NNN consensus/ 454 NNN consensus: The NNN consensus shows the 
amino acid sequence derived from the most frequently observed codon in each position. 
Sanger AA consensus/ 454 AA consensus: For the AA consensus, the 
observed frequencies of synonymous codons were summed up before deriving a 
consensus. 
454 corr. AA consensus: Since in the 454 experiment, the frequency of the wild-
type codon cannot be quantitated, its frequency has been deduced as the average of the 
frequencies of synonymous codons. 
454 AAFreq corr./No. of codons: AA consensus derived from a frequency table 
that has been corrected for the technical bias in the initial amino acid library introduced by 
the degeneracy of the genetic code.  
Consensus Class A GPCR: The classical AA consensus derived from an 
alignment of all Class A GPCR sequences downloaded from the GPCRDB 
(http://www.gpcr.org/7tm/), omitting the variable loop regions. At this level of sequence 
divergence, the amino acid frequency distributions show similar influence of codon bias as 
the 454 results. 
 
Figure 4-4. Correlation between sequence constraints in natural GPCRs and 
in the rNTR1-D03 454 sequencing experiment.  Colors indicate whether the amino acid 
distribution in a given position is equally constrained in both systems (purple), more 
constrained in natural class A GPCR sequences (blue) or in the deep sequencing from 
rNTR1-D03 (red). The size of the circles indicates the constraints imposed by the 
respective system, where large circles indicate positions with high constraints. 
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Table  4-1. Diversity of randomized codons. 
 
  codon position  average  
  1 2 3 
A 530 500 526 519 
T 567 597 565 576 
C 452 523 513 496 
G 534 494 526 518 
N 88 56 40 61 
n = 2170 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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4.3 Further Experiments 
4.3.1 Generation and selection of the StEP30x library 
With optimal reaction conditions, we could successfully shuffle mutations within a 
30 bp-distance by means of the staggered extension process (StEP). Such recombination 
frequencies were achievable by shuffling of the D03 sequence with the synthetic M30 or 
M303 sequence, respectively. M30 and M303 combine 30 or 33 shift mutations in one 
synthetic DNA sequence, providing an equimolar representation of all wild-type and shift 
residues in the StEP reaction. Iterative shuffling and selection of D03 with M30 and M303 
lead to the identification of C7E02, a well-expressed and detergent-stable variant of D03 
(see published article, pages 102 ff). 
To begin with, we had first of all shuffled the thirty individual shift mutants with 
each other. Under these conditions, the frequency of each shift mutant codon in the 
template mix is only 3.4%, while 96.6% are wild type (originating from the other shift 
mutants that have a wild-type codon in the respective codon position; see Figure 4-1 for 
illustration). In other words, the mixing of 30 individual shift mutants results in a dilution 
effect that reduces the apparent shuffling efficiency, since most recombination events 
shuffle a wild-type codon against a wild-type codon and are hence ineffective.  
 
 
The resulting library, termed StEP30x, was subjected to three rounds of StEP 
shuffling (termed A to C), each followed by three rounds of FACS-based selection for high 
functional expression (in pRGD03 (ID 3428), selections as described in the published 
Figure 4-1. Illustration of the dilution effect in StEP shuffling of individual shift mutants. In
this illustration, the DNA of ten shift mutants is mixed. For every shift mutant that is added
to the reaction, the remaining nine template sequences carry a wild-type codon in the
respective position. Hence, the apparent shuffling efficiency is low, since many
recombination events shuffle wild type versus wild type.  
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article, page 114). Figure 4-2 shows the increase in expression levels after round A 
(StEP30x_A111) and B (StEP30x_B111), respectively. Both pools show a step-wise shift 
towards higher expression levels, which is however much smaller than the shifts observed 
for the StEPM30 and StEPM303 libraries (published article, page 105), and far below the 
expression levels of the Sloning libraries (published article, page 104).  
 
Figure 4-2. Expression levels of the evolved StEP30x pools. The final selected pools of 
StEP-shuffling round A (StEP30x_A111, blue line) and round B (StEP30x_B111, red line) 
were analyzed by flow cytometry, showing a successive increase in expression levels 
compared to D03 (grey).  
 
The shuffling and selection was continued for a third round (round C), and was 
subsequently analyzed by sequencing of 24 individual clones from selection rounds A, B 
and C. By shuffling of 30 individual gene sequences, a maximum of three shift mutations 
was combined into a new chimeric sequence (Table 4-1, C332V6.59 highlighted by a red 
box). C332V6.59 is enriched during iterative shuffling and selection rounds, and strongly 
dominates the final evolved pool. Only a few sequences carry further mutations, of which 
I253A5.54 shows the highest frequency. The selection result of the StEP30x library 
emphasizes the relevance of the C332V6.59 for high functional expression of the evolved 
variants.  
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Table 4-1. Sequences of the evolved StEP30x pools after round A (A), B (B) and C (C). 
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4.3.2 Design and analysis of a minimal C7E02-like receptor variant 
As explained in the published article (Sections 4.1 and 4.2), TM86V was rationally 
designed for detergent stability. More precisely, TM86V was originally identified as the 
strongest mutant from a screening and comparison of individual and rational combinations 
of shift mutations. In detail, four individual triple mutant combinations were generated: 
TM86V (A86L1.54, I253A5.54 and F358V7.42), TM86A (A86L1.54, I253A5.54 and F358A7.42), 
TM83V (S83G1.51, I253A5.54 and F358V7.42) and TM83A (S83G1.51, I253A5.54 and 
F358A7.42). TM86V combines the three shift mutations showing the highest increase in 
detergent stability when studied individually. Mutant TM86A, in comparison to TM86V, 
allows to judge whether the observed effect is specific for the F358V7.42 mutation, which 
we had identified previously after full randomization of the receptor position (see Chapter 
3). F358A7.42, on the other hand, was reported to affect detergent stability of the wild-type 
receptor according to alanine-scanning mutagenesis (Shibata et al., 2009). The effect of 
A86L1.54 and S83G1.51 was compared side-by-side with the mutants TM83V and TM86V. 
From the homology model we assume that A86L1.54 leads to improved helix packing and 
compact folding, which reduces detergent-accessibility (homology modeling described in 
Schlinkmann et al., 2012, Chapter 3-A, page 59). S83G1.51 might achieve a similar effect 
by introduction of a glycine residue. While glycines display unfavorable helix propensities 
in soluble proteins and are grouped as “helix breakers” together with proline, they are 
found rather frequently in transmembrane helices, where they exhibit a structural role and 
are often found in helix-helix interaction motifs (Javadpour et al., 1999). In this context, 
S83G1.51 could independently address the same helix packing issue as A86L1.54 by 
allowing helix bending. All four triple mutants were assessed for their detergent stability in 
DDM and DM in the absence of agonist (Figure 4-3).  
 
 
Measurements of detergent stability in the absence of agonist were chosen since 
C7E02 is most stable under these conditions, and the core motif of C7E02 was under 
Figure 4-3. Detergent stability of the triple mutants TM86V, TM86A, TM83V and TM83A in 
DDM (A) and DM (B) in the absence of ligand. Experiments were performed as described 
before (published article, Sections 4.1 and 4.2). 
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investigation here. TM86V displayed highest detergent stability in both detergents, while 
the ranking of the remaining triple mutants is different between the two detergents (Figure 
4-3). In the harsher detergent DM, we see that the presence of A86L1.54 is of key 
importance to achieve high detergent stability, since the mutant TM83V is far less stable 
(Figure 4-3B). Further experiments revealed that TM86V is a true core mutant of C7E02 
and ranked among the top three receptor variants regarding detergent stability (see 
published article, Sections 4.1 and 4.2). 
4.3.3 Combination and analysis of the most-detergent stable shift  
mutations to double mutants 
TM86V shows similar expression levels and even higher detergent stability than 
C7E02 (see published article, Sections 4.1 and 4.2). The detergent stability of TM86V in 
the presence of agonist is similar to L5X, the most stable variant identified (see published 
article, page 85). To further elucidate the contribution of the three shift mutations, all three 
possible double mutants of the three shifts A86L1.54 (Figure 4-4), I253A5.54 and F358V7.42 
were generated. The detergent stability of the double mutants DM-A (A86L5.54 and 
I253A5.54), DM-B (I253A5.54 and F358V7.42) and DM-C (A86L1.54 and F358V7.42) was 
assayed in the presence of agonist and compared to TM86V (Figure 4-5). Experiments 
were performed in the presence of agonist, since the single shift mutants are not very 
stable in the absence of ligand.  
Mutant DM-A, combining the two shift mutations A86L1.54 and I253A5.54, is the 
strongest double mutant with respect to detergent stability. DM-A is very similar to TM86V 
in all detergents tested. As discussed in the published article (Sections 4.1 and 4.2), 
A86L1.54 potentially optimizes helix packing (Figure 4-4), while I253A5.54 restricts 
conformational flexibility.  
 
 
The combination of these two mutations might thus lead to increased detergent 
stability. The comparably low detergent stability of DM-B (I253A5.54 and F358V7.42) further 
Figure 4-4. Homology model of rNTR1 with position A861.54 highlighted in black. 
Surrounding  side chains are highlighted with dots. (A) A861.54 and (B) mutation A86L1.54. 
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emphasizes the important role of A86L1.54 for detergent stabilization (Figure 4-5). 
Additionally, it marks the difference between TM86V and C7E02 compared to L5X, which 
does not contain A86L1.54. 
 
 
4.3.4 Expression and detergent stability of the chimeric TM86V: L5X 
constructs MT1-3 and ML1-5 
L5X combines 15 shift mutations that result in maximal functional expression per 
cell and highest detergent stability. Despite the fact that L5X originates from the fully 
binary Sloning Library (published article, Sections 4.1 and 4.2), not every of the 15 shift 
mutations is necessarily essential for the L5X phenotype: A subset of shift mutations 
might exhibit a neutral phenotype, and might thus have been co-selected in the presence 
of other, beneficial mutations while being dispensable for the observed phenotype. 
Furthermore, certain shift mutations might be essential to achieve high detergent stability, 
and others might be required for increased expression level or for both. In this context, it is 
interesting to note that TM86V behaves similar to L5X with respect to detergent stability, 
Figure 4-5. Agonist-bound detergent stability of the double mutants DM-A, DM-B and DM-C
compared to TM86V. Measurements were performed as described in the published article,
page 114. 
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but displays much lower expression levels under all conditions tested (published article, 
Sections 4.1 and 4.2).    
To elucidate better the contribution of certain shift mutations to the phenotype of 
L5X, two sets of mutants were generated: First, certain shift mutations that are present in 
L5X were added onto TM86V (mutants of TM86V, termed MT), and second, the same 
shift mutations were removed from L5X (mutants of L5X, termed ML). Subsequently, the 
mutants MT1-MT3 and ML1-ML5 (Table 4-2 for sequences) were studied for their 
expression levels in both pRGD03 (plasmid ID 2438) and eLIC47D03 (plasmid ID 3254) 
and for their detergent stability. 
 
 
 
 
 
 
The expression levels of mutant MT1, adding D113S2.50 and C332V6.59 onto 
TM86V, are increased compared to TM86V and show a L5X-like phenotype in the high 
Figure 4-6. Expression levels of the mutants MT1-3 and ML1-5. Expression levels were
analyzed after 20 h expression at 20°C or 30°C in the plasmids pRGD03 (ID 2438) and
eLIC47D03 (ID 3254). D03, L5X and TM86V (red box) are simultaneously expressed for
comparison. Expression of MT1 is performed in duplicates (MT1-a and MT1-b).  
Table 4-2. Sequences of the mutants MT1-MT3 and ML1-ML5 compared to their parental 
sequences TM86V and L5X. 
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copy plasmid eLIC47D03 (Figure 4-6), pointing towards a key role for D113S2.50 and 
C332V6.59 for high functional expression.  
The role of D113S2.50 and C332V6.59 in high functional expression is further 
emphasized by the phenotype of mutant ML1: ML1 is derived from L5X, with D113S2.50 
and C332V6.59 reverted to aspartate and cysteine, respectively. Restoration of the D03 
phenotype in these positions significantly decreases expression to a level similar to 
TM86V (Figure 4-6). 
 
 
The detergent stability of TM86V and L5X is rather similar, and the intermediate 
variant MT1 is slightly increased compared to TM86V and identical to L5X in both DM 
(Figure 4-7A) and OG (Figure 4-7C). ML1, on the other side, also retains detergent 
stability. It thus looks that D113S2.50 and C332V6.59 do only minimally affect detergent 
stability. The mutants ML2, ML3, ML4 and ML5 do have no dramatic effect on detergent 
stability of L5X (Figure 4-7B and D). 
It can be summarized that MT1 is a minimal mutant of L5X that exhibits high 
expression, and the phenotype of high expression can be directly attributed to the shift 
mutations D113S2.50 and C332V6.59. Different from that, high detergent stability can 
Figure 4-7. Detergent stability of MT1-3 and ML1-5 in the presence of agonist in the 
detergent DM (A, B) and OG (C, D). Comparison of MT1 and ML1 with TM86V and L5X is 
separately illustrated in (A) and (C).  
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apparently be achieved by individual solutions: TM86V carries only the three most 
stabilizing shift mutations A86L1.54, I253A5.54 and F358V7.42, while L5X carries only 
I253A5.54 and F358V7.42 among its 15 shift mutations. Detergent stability of L5X is hence 
conveyed by a more complex mechanism and synergistic effects between individual shift 
mutations.  
4.3.5 Design and selection of additional Sloning library constructs for 
high functional expression and detergent stability 
The fully binary Sloning library provided an excellent system to assess the 
influence of various expression conditions on the directed evolution of this library. The 
improved expression levels of the previously identified receptor variants, among them 
C7E02, indicated a reduced toxicity of overexpression. To exclude that expression is 
artificially limited by external parameters, the Sloning library was expressed in the 
standard plasmid pRGD03 (Sloning library L1, ID 3493) and furthermore in the high copy 
plasmid eLIC47D03 (Sloning library L5, ID 3501). It turned out that, indeed, high 
expression of evolved variant L5X was dependent on expression from the high-copy 
plasmid eLIC47D03 (published article, Sections 4.1 and 4.2). 
 
 
Additional to the successfully evolved libraries L1 and L5, we have tried to evolve 
the Sloning library under further conditions (Table 4-3 and Appendix 1.3 for construct 
design): Library L6 was expressed from the plasmid eLIC47patD03, a derivative of 
eLIC47D03 carrying additional mutations in the origin of replication that increase plasmid 
copy number (termed “patent mutations”, mutant 9 from Bayer et al., 2007). Libraries L2 to 
L4 were expressed from the plasmid pRGD03, and are characterized by truncation of the 
GPCR sequence after helix 8 (truncation after amino acid C389). In library L2 (ID 3495), 
C389 was followed by the asparagine linker, TEV cleavage site and thioredoxin, similar to 
the standard fusion construct. In libraries L3 (ID 3497) and L4 (ID 3499), the Sloning 
library was expressed without a C-terminal fusion protein but terminated directly after 
C389 with two stop codons (L3) or a His10-tag followed by two stop codons (L4). The 
rational behind these constructs is that in previous selections, enrichment of stop codons 
in the flexible receptor C-terminus was observed, indicating that expression without a C-
terminal fusion protein (trx) might be advantageous. Also the ultra-deep sequencing data 
of the C-terminal positions show a higher tolerance towards stop codons, which is in 
agreement with the previous data (published article, Chapter 3).  
Table 4-3. Overview of Sloning library constructs. 
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Figure 4-9. Expression levels of the evolved libraries L2s6 (A), L3s4 (B) and L6s5 (C) 
analyzed by flow cytometry. (A) and (B) Final selection after expression at 30°C, (C) final 
selection after expression at 20°C. L6s5 expressed poorly at 30°C. Expression and 
fluorescence-labeling were performed as described in the published article, page 114. 
Expression levels of the evolved pools L1s6 and L5s5 are described in the published article, 
page 107. 
Figure 4-8. Expression of the naïve libraries L1-L6 measured by flow cytometry. Libraries 
were expressed for 20 h at 20°C, and specific ligand binding was measured in the presence 
of 20 nM BODIPY-neurotensin.   
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Expression of the naïve libraries L1 to L6 was characterized two subpopulations, a 
dominant population of ca. 85-95% that did not bind the agonist (fluorescence-labeled 
neurotensin), and a small population that expressed functional receptor variants and 
specifically bound the agonist, hence showing a shift towards high fluorescence (Figure 4-
8). Expression of L2, L3 and L4 was hardly detectable, while L1, L5 and L6 showed small, 
but clear expression peaks (Figure 4-8, see zoom-in on right side). L1, L5 and L6 express 
the Sloning library in the identical fusion protein construct (MBP - Sloning library - 
thioredoxin) from plasmids with different copy numbers (Table 4-3), and these differences 
apparently affect expression levels of the naïve libraries, and the degree of expression 
positively correlates with plasmid copy number.  
Interestingly, L5 could be successfully evolved and was highly superior to L1 with 
respect to expression levels (published article, page 107). L6 however could not be 
evolved further, but showed a plateau at much lower expression levels (Figure 4-9C). This 
observation is intriguing with respect to the fact that the high copy library L6 showed the 
highest degree of expression for the naïve library (Figure 4-8). It thus looks that the NTR1-
variants represented within the Sloning library are still too toxic to be expressed from high 
copy plasmids in E. coli. L2 could be successfully evolved (Figure 4-9A), but the final 
expression niveau was only slightly higher compared to D03. Selection of L3 could not be 
evolved to even reach expression of D03, and L4 could not be enriched for high 
expression.  
Hence, from these results, it can be deduced that for maximal expression, the C-
terminally fused thioredoxin is required.  
4.3.6 Expression levels and detergent stability of the cysteine-free 
variants of rNTR1-wt, D03 and C7E02 
C332V6.59 is a shift mutation with highest relevance for expression. C332V6.59 was 
retrieved as the dominant mutation from the StEP-recombination of the 30 individual shift 
mutations (StEP30x), and it is essential for the high-expression phenotype of L5X and 
MT1. We assume that expression is positively affected by the absence of a free cysteine 
in the periplasmic space, since this could facilitate fast and correct disulfide formation 
between C1423.25 and C225 (EL2). We might observe this as a result of expression in 
E. coli, for which oxidizing conditions and disulfide formation and shuffling are different 
from mammalian cells. Furthermore, long-term experiments under oxidizing buffer 
conditions might result in uncontrolled and undesired oxidation, which could hamper for 
example crystallization. We have thus designed synthetic sequences of rNTR1-wt, D03 
and C7E02 in which all non-essential cysteines, apart from those involved in disulfide 
formation, are replaced by the most tolerated amino acid according to the 454 results from 
the saturating mutagenesis study (Table 4-4 and published article, Chapter 3). The 
resulting variants wt-cf (cysteine-free), D03-cf and C7E02-cf were studied for their 
expression and detergent stability in comparison to their parental sequence.  
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Table 4-4. Cysteine substitutions of the cysteine-free mutants D03-cf, C7E02-cf and wt-cf. 
amino acid position
variant    142 152 172 226 278 320 332 386 388 417 
D03_cf C L R C S L V S S S 
D03    C C C C C C C C C C 
yellow – hydrophobic aa, green – polar aa, blue – charged aa 
 
 
Replacement of all non-essential cysteines did not significantly affect expression 
levels (Figure 4-10A), but lead to decreased detergent stability (Figure 4-10B) for all the 
receptor variants. rNTR1-cf could not be analyzed due to the decrease in detergent 
stability. 
In agreement with previous results, it appears that certain substitutions have 
different effects on expression and detergent stability.  We have observed for the thirty 
individual shift mutations that while all do individually increase expression levels, only a 
subset of these shift mutants show also increased detergent stability. While any cysteine 
was replaced by the most suitable amino acid according the selection and sequencing 
results, it might well be that the combination of these mutations is not compatible with 
respect to detergent stability. 
4.3.7 Detergent stability of the signaling-active evolved variants 
C7E02-BM, TM86V-BM and L5X-BM 
D03, the basis of all shift mutants and evolved variants with multiple shift 
mutations, carries nine mutations compared to rNTR1-wt. Among these, we find 
R167L3.50, a mutation that is located in the highly conserved E/DRY motif of TM3. The 
Figure 4-10. Analysis of expression levels (A) and detergent stability (B) of the cysteine-free 
variants of rNTR1-wt (wt), D03 and C7E02. (A) All variants were expressed from the plasmid 
pRGD03 for 20 h at 20°C. (B) Detergent stability was assessed in the absence of agonist in 
the detergent DDM (as described in the published article, page 114). 
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E/DRY motif is involved in the formation of the so-called ionic lock that keeps the receptor 
in the inactive state (Deupi and Kobilka, 2007), and is released during receptor activation 
to facilitate downstream signaling. Mutation of the E/DRY motif leads to decreased 
signaling competence, as observed for D03 in comparison to rNTR1-wt (Sarkar et al., 
2008). Reconstitution of the E/DRY motif for D03 (D03-L167R3.50) recovers signaling 
competence (Sarkar et al., 2008).  
Consequently, we also recovered the E/DRY motif for the evolved variants C7E02, 
TM86V and L5X to assess their signaling competence (published article, page 110). To 
confirm that the “backmutation” L167R3.50 (“BM”) did not affect detergent stability, the 
respective variants C7E02-BM, TM86V-BM and L5X-BM were studied for their agonist-
bound detergent stability. 
 
Restauration of the E/DRY-motif leads only to small and negligible changes in the 
detergent stability of the respective variant. Studies aiming at the cocrystallization of 
GPCR and heterotrimeric G protein complex might thus rely on the BM-receptor versions 
with restored E/DRY-motif, while the original variant might be preferred for crystallization 
of the receptor alone.  
4.4 Summary and Discussion 
For the shuffled StEP- and Sloning libraries, coevolution of expression and 
detergent stability was observed (see published article, page 102 ff.). This coevolution is 
loose, meaning that the while both expression and detergent stability are increased for 
any selected receptor variant compared to the parental D03, they are affected to a 
different degree for individual receptor variants. Obviously, expression- and stability-
increasing shift mutations are efficiently selected for, and shift mutations that, when 
combined, are incompatible which each other, are efficiently selected against. Besides the 
required shift mutations that define the phenotype of an evolved receptor variant, these 
receptor variants may contain additional shift mutations with a neutral phenotype. Such 
Figure 4-11. Detergent stability of the evolved variants C7E02, TM86V, L5X and their 
backmutants (BM) with reconstituted E/DRY motif in DM (A) and OG (B).  
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shift mutations are, other than beneficial or detrimental shift mutations, not detected by the 
selection system, and thus co-selected with beneficial shift mutations.   
The fully binary library proved to be superior the StEP-shuffled libraries, and this is 
likely a consequence of the fact that only a fully binary library allows efficient separation of 
required from incompatible shift mutations that are close in sequence and not separated 
by StEP shuffling. The efficient but incomplete shuffling by StEP is reflected by the mutant 
C7E02 and its core mutant TM86V, which displays even higher detergent stability than the 
parental C7E02.  
L5X is derived from the fully binary Sloning library, but nevertheless includes also 
shift mutations with a neutral phenotype with respect to expression and detergent stability. 
The additional experiments presented here provide further insight into the combinatorial 
effects of the evolved receptor variants, and identify the required and neutral shift 
mutations of L5X with respect to functional expression. In particular, the chimeric 
constructs MT1 (Figure 4-12) and ML1 allowed us to identify the shifts D113S2.50 and 
C332V6.59 to be crucial for the high-expression phenotype of L5X. 
 
 
 
According to the homology model (Figure 4-12), the 5 shift mutations of MT1 are 
not in a distance where they could interact, which is different for L5X. MT1 retains L5X-like 
detergent-stability, indicating that this phenotype is rather the sum of individual effects, 
than of synergistic effects.  
C332V6.59 likely affects expression by avoiding alternative oxidation pathways 
during formation of the crucial disulfide bridge between C1423.25 and C225 (EL2), since 
removal of C3326.59 leaves only these two cysteines accessible to disulfide formation in 
the periplasmatic space. D1132.50 confers sodium sensitivity to the receptor (Martin et al., 
Figure 4-12. Location of the MT1-defining shift mutations in the homology model of rNTR1 
(homology model by A. Honegger). Positions of MT1-mutations are highlighted in black. The 
highlighted positions illustrate the rNTR1-side chain. 
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1999), and is thus functionally relevant in vivo. From the homology model of rNTR1, we 
assume that D1132.50 is close to N821.50, which itself is also identified as a shift position. 
Potential sterical constraints could affect protein folding, which might be relieved by either 
of the two shifts D113S2.50 or N82H1.50. 
On the other hand, these shift mutations are not essential for detergent stability, 
indicating the different forces that drive high expression compared to high detergent 
stability.  
While the phenotype of MT1 and ML1 clearly identify the determinants of high 
functional expression, we did not identify a “killer mutation” or a “winner mutation” for the 
high detergent stability of L5X. L5X does not contain the highly stabilizing shift mutation 
A86L1.54, and its high detergent stability is thus rather the sum of many small effects, using 
an alternative route to detergent-stability compared to TM86V and C7E02, that makes 
only partial use of the “stability motif” A86L1.54, I253A5.54 and F358V7.42. Further 
experiments, especially structure determination, could elucidate the underlying principles 
of improved detergent stability.  
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5.1   Introduction 
D03 was successfully evolved for high functional expression and detergent 
stability, leading to the identification of C7E02, TM86V and L5X. These three receptor 
variants were identified under different selection and screening conditions (Schlinkmann 
et al., 2012), Chapter 4 of this work). C7E02, selected from the StEP303 library, displays 
the highest detergent stability in the absence of ligand. Thirteen individual shift mutations 
are the basis for the C7E02 phenotype. Selection of the fully binary Sloning library 
resulted in the highly evolved variant L5X, with the highest obtained expression level of up 
to 25,000 receptors per E. coli cell. Interestingly, the high expression level of L5X is 
dependent on expression from a high copy plasmid (eLIC47D03, (Schlinkmann et al., 
2012), Chapter 4 of this work), meaning that the toxicity of overexpression is strongly 
reduced for L5X such that the high copy number is tolerated and leads to more functional 
protein. L5X is strongly stabilized in the agonist-bound state as a direct consequence of 
screening for detergent-stability in the presence of agonist. In contrast to C7E02, signaling 
competence and antagonist binding of L5X is decreased. In a parallel rational design 
approach, TM86V was generated by combination of the three most stabilizing shift 
mutations. TM86V is a minimal core mutant, characterized by an intermediate expression 
level compared to L5X and C7E02, high detergent-stability in both the ligand-free as well 
as the agonist-bound state, and a signaling competence similar to C7E02.  
The similar high detergent-stability of TM86V and L5X is achieved by independent 
solutions: While TM86V combines solely the three most stabilizing shift mutations when 
analyzed individually, L5X carries 15 shift mutations, but contains only two of these most 
stabilizing shift mutations. The differences in signaling competences allow us to conclude 
that TM86V and L5X likely prefer different receptor conformations.  
Crystallization of membrane proteins in general requires approaches that are 
especially adapted to the characteristics of membrane proteins. Even though the evolved 
receptor variants allow us to produce high amounts of pure, homogeneous and detergent-
stable receptor preparations that are optimal for crystallization purposes, we could not yet 
successfully crystallize all of these receptor variants. A likely explanation is the high 
flexibility of the helix-connecting loops, which are solvent-accessible and present the main 
available surface for crystal contact formation. Recent progress in crystallization of 
GPCRs was in most cases facilitated by replacement of the intracellular loop 3 (IL3) by 
the rigid protein T4-lysozyme (Rosenbaum et al., 2007), providing a large hydrophilic 
surface for crystal contact formation. Despite its advantages, the excision and 
replacement of functional receptor parts, in this case the interaction surface with 
downstream effector proteins, is a main drawback of this strategy.  
 An optimal solution to this issue would be a binding protein that specifically 
recognizes the receptor surface, constraining the flexibility of the loop regions and adding 
a rigid hydrophilic surface for crystal contact formation. 
The aim here is to employ the DARPins as binding proteins to the evolved receptor 
variants to facilitate crystallization. L5X and TM86V were chosen as targets for the 
selection of DARPin binders, since these variants display highest detergent-stability and 
most likely prefer different receptor conformations.  
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5.1.1 DARPin as binding molecules 
Designed ankyrin repeat proteins (DARPins) are versatile binding proteins. 
DARPins are small, highly expressed and soluble proteins with extremely high stability 
(Binz et al., 2003; Kohl et al., 2003). DARPins are derived from naturally occurring ankyrin 
repeat proteins (Forrer et al., 2003). The scope and diversity of repeat proteins is 
illustrated by the fact that the immune system of jawless vertebrates is based on the 
diverse repertoire of leucine-rich repeat proteins (Alder et al., 2005). The scaffold of 
DARPins is based on a consensus design, and characterized by an -helical fold (Forrer 
et al., 2004). A single ankyrin repeat is composed of a -turn followed by two antiparallel 
helices, connected to the next repeat by a flexible loop. The -helical scaffold results in a 
slight curvature, giving the DARPin a paraglider-like appearance (Binz et al., 2004). The 
flexible loops and the more concave side make up the binding interface with the target 
protein. The DARPin library carries randomized positions in the flexible loops and in one 
of the helices, providing an enormous theoretical diversity for possible binding to a given 
target (Figure 5-1).  
 
 
 Figure 5-1. DARPin design and structure. (A) Consensus sequences of the N-cap, internaland C-cap modules. Randomized positions are highlighted in red letters (x, any aa except
C, G or P; z,  N, H or Y). (B) Schematic assembly of a DARPin from the individual modules.
(C) Structure of off7, an MBP-binding DARPin. Figure taken from Binz et al., 2004. 
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5.1.2 DARPin libraries 
DARPins are composed of randomized repeat modules, with a C-terminal and N-
terminal capping repeat. The conventional DARPin libraries contain two and three internal 
repeats, called the N2C and N3C libraries. These libraries have been successfully used to 
select DARPin binders against a range of soluble proteins, for example MBP (Binz et al., 
2004). Conventional DARPin libraries are well-suitable for the binding of rather flat 
surfaces, but cannot protrude into target protein cavities. Recently, a DARPin library was 
engineered that carries a new internal repeat in which the -turn was extended into a 
flexible loop by the introduction of 13 additional amino acids (J. Schilling, unpublished). 
The randomized positions in this extended loop allow binding of groves in the target 
protein surfaces, thus extending and broadening the application potential of DARPins 
(N3Cloop library). The loop library might be ideal for the binding of a GPCR surface, which 
display flexible loops and cavities within the GPCR helix bundle. Further engineering was 
applied to the capping N-terminal and C-terminal repeats (N-cap and C-cap), which 
display a hydrophilic surface to the solvent. Extensive optimization of the C-cap sequence 
resulted in improvement of protein stability (Interlandi et al., 2008), by better packing of 
the capping repeat to the internal repeats (library N3Cnew). Furthermore, crystal structure 
analysis of DARPin-target complexes revealed that the N- and C-cap could potentially 
make contacts to the target. Selection of DARPin-binders to a given target might thus be 
artificially limited by the consensus design of the N- and C-cap, which excludes binders for 
which the consensus design of the N- and C-cap is not compatible with the target surface. 
In an improved DARPin library, certain positions in the N- and C-cap were randomized, 
adding a further degree of diversity to the DARPin libraries (design and synthesis: J. 
Schilling). The resulting libraries N3Cloopran and N3Cran were also used for selection. All 
individual libraries were used for panning against the target receptors, thus fully exploring 
the available DARPin library space for selection of DARPin binders. Table 5-1 gives an 
overview of the libraries used.  
Table 5-1. DARPin libraries used in selections. 
DARPin library    description 
N2C  two randomized repeat modules, N- and C-cap module 
N3C  three randomized repeat modules, N- and C-cap module 
N3Cloop  as N3C; loop extension in middle repeat module 
N3CloopRan  as N3Cloop; randomized N- and C-cap 
N3Cnew  as N3C; new C-cap 
N3Cran    as N3C; randomized N- and C-cap 
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5.1.3 Ribosome display – an in vitro selection system 
Ribosome display (RD) is an in vitro selection system (Hanes and Plückthun, 
1997) for the screening and selection of large and diverse libraries, and commonly used in 
directed evolution of proteins. The main advantage of RD is the absence of any in vivo 
step: In vivo selection methods such as phage display and E. coli-based selection 
systems require a transformation step, which constitutes the bottleneck of any in vivo 
approach and thus limits the library diversity to approximately 107-108 library members. In 
RD, diversity of the displayed library is instead limited by the number of ribosomes in the 
reaction and PCR amplification of the displayed library. In a typical RD selection, about 
1014 active ribosomes are present (Plückthun, 2012).  
The DARPin libraries are transcribed in vitro from a PCR product carrying a 
ribosome binding site (RBS) and a T7 promotor sequence (Figure 5-2 for illustration). The 
absence of a stop codon leads to the formation of ribosome-nascent-chain complexes 
(RNCs), in which the translated and folded DARPin stays linked to its genetic template in 
the form of mRNA that is stalled within the ribosome decoding center. An unfolded peptide 
sequence originating from the TolA protein acts as a spacer to allow the DARPin to 
extend out of the ribosome exit tunnel and to fold properly. The in vitro translated 
DARPins are then bound to the immobilized target protein, and unspecific binding is 
reduced by several washing steps. At this stage, the washing steps can be extended in 
subsequent selection rounds to increase specificity and affinity. The mRNA of specific 
binders is subsequently eluted by destabilization of the RNCs by high amounts of EDTA 
and excess of unspecific RNA (Saccharomyces cerevisae RNA, short scRNA) and 
reverse-transcribed into cDNA. The resulting DNA is ligated into pRDVLDnew (a 
derivative of pRDV, designed by J. Schilling, plasmid ID 2228). This ligation step is 
necessary to reappend an RBS and a promotor sequence to the ligated cDNA by PCR-
amplification with primers binding outside of the ligated cDNA and within in the 
pRDVLDnew sequence. This step is necessary since the cDNA and the subsequent PCR 
amplification (PCRonRT) are generated with internal primers, in order to exclude biased 
reverse transcription and amplification due to partial terminal degradation of the mRNA. 
Hence, only the more central DARPin coding sequence is reverse transcribed. The PCR 
pool amplified from ligation into pRDVLDNew (PCR on ligation) can be directly used for 
subsequent selection rounds (Dreier and Plückthun, 2011; Hanes and Plückthun, 1997; 
Plückthun, 2012).  
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5.1.4 GPCR target constructs 
TM86V and L5X were chosen as targets for selection of DARPin binders. 
Immobilization of the targets during selection is preferably achieved via biotin-streptavidin 
or biotin-neutravidin, respectively. For this purpose, TM86V and L5X were fused with the 
AviTag (AviTag, (Cull and Schatz, 2000)). The AviTag is a 15 amino acid peptide 
(GLNDIFEAQKIEWHE), in which the central lysine is recognized and biotinylated by the 
E. coli BirA ligase (Chapman-Smith and Cronan, 1999; Schatz, 1993). In vivo biotinylation 
is highly advantageous over chemical in vitro biotinylation, since it is stoichiometric and 
directed.   
Figure 5-2. Scematic overview of the ribosome display process (taken from (Dreier and
Plückthun, 2011)). All selection steps are performed in vitro. A selection round starts from
the PCR product of a library (top) that is in vitro transcribed into mRNA and subsequently
translated into protein. The nascent DARPin-polypeptide chain folds into its tertiary
structure upon exit from the ribosomal exit tunnel, facilitated by an unstructured spacer
that allows the DARPin to fully exit the ribosome. The DARPin remains covalently linked to
its mRNA and translating ribosome due to the absence of any stop codon. The mRNA of
DARPins that have bound to a target molecule is eluted by addition of EDTA and excess of
unspecific scRNA. The eluted mRNA is reverse-transcribed into cDNA, and amplified by
PCR. The enriched PCR pool is ligated into the vector pRDVLDnew. PCR-amplification of
the library with outer primers annealing on pRDVLDnew allows to include again the
ribosome binding site and the spacer sequence necessary for subsequent selection
rounds. 
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The GPCR is expressed as a fusion protein with an N-terminal MBP and a C-
terminal thioredoxin, separated in the standard expression construct by recognition sites 
for the tobacco etch virus protease (TEV) (Figure 5-3A). 
 
  
To allow efficient cleavage under the applied purification conditions, the TEV-
cleavage sites between the fusion tags and the GPCR were replaced by recognition sites 
for the 3C-protease (human rhinovirus 3C protease; LEVLFQGP), and the flexible termini 
of the receptors were shortened to allow efficient crystallization (termini optimized by P. 
Egloff, see Figure 5-3).  
Figure 5-3. Overview of the GPCR constructs used in this study. (A) Standard fusion protein
construct for expression with FACS-based selection. (B) Adapted construct for
crystallization purposes. The flexible N-termini are shortened, and the 3C-cleavage sites
allow optimal cleavage under purification conditions (pRG-TM86V-P51-dW392_3C, obtained
from P. Egloff; termed pRG-xD_TM86V in this study). (C) Fusion protein construct for target
immobilization in RD selections. An AviTag is C-terminally attached to the GPCR via an
(G4S)6-linker. H6/H10, Histidine tag with 6/10 histidines. 
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5.2 Results 
5.2.1 Expression and purification of target proteins 
Biotinylated TM86V (abbreviated b-TM86V, plasmid pRG-RD_TM86V, ID 3370, 
Appendix page 191) and b-L5X (plasmid pRG-RD_L5X, ID 3369, Appendix page 191) 
were expressed in E. coli BL21(DE3) in a 50 L-fermenter (Bioengineering) for 18 h at 
28°C (see Section 5.4, Materials and Methods). 100 g wet cell pellet was used for one 
purification process. Briefly, cells were opened by sonification, receptor molecules were 
detergent-solubilized and captured by binding to the agonist neurotensin immobilized on 
Sepharose resin (“NT-column”) as a fusion with protein D (pD, the bacteriophage head 
protein (Forrer and Jaussi, 1998)). The neurotensin peptide was connected to its fusion 
partner pD by a 3C-protease recognition site, allowing cleavage of the agonist-bound 
receptor from the resin together with the fusion protein tags MBP and thioredoxin (Figure 
5-3). The agonist-bound receptor was separated from MBP by ion exchange 
chromatography (IEX), and subsequently purified via size exclusion chromatography 
(SEC) for separation of the remaining protein tags (Figure 5-4).  
 
The individual purification steps of the receptor preparations were subsequently 
analyzed by SDS-PAGE (Figure 5-5). Both receptor variants were successfully separated 
from their fusion partners and the 3C protease. The two additional bands at low molecular 
weight resulted from cleavage of an intrinsic and unspecific 3C-recognition site in IL3 (P. 
Egloff, personal communication). The monodisperse behavior of the receptor preparation 
in SEC analysis suggests that the helix-helix interactions keep the receptor fragments 
connected and intact within a detergent micelle, while they fall apart under the 
denaturating conditions of an SDS-PAGE (Figure 5-5). For both receptor variants, 1 mg of 
purified receptor was obtained. Unbiotinylated receptor for competition ELISA experiments 
was expressed in the absence of BirA and was purified accordingly (plasmids pRG-
xD_TM86V and pRG-xD_L5X, Appendix page 191). 
Figure 5-4. SEC-profiles of purified b-L5X (A) and b-TM86V (B). For the final purification 
step, the receptor preparation was loaded onto a preparative S200 (20 ml CV). Grey areas
highlight the fractions that are pooled and used for ribosome display selections. 
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For quantitative in vivo biotinylation, b-L5X was co-expressed with the E. coli 
biotin-ligase BirA (plasmid pBirAcm, plasmid ID 212). The expression product of b-L5X 
could be processed without difficulty, yielding purified and biotinylated receptor cleaved 
from its fusion protein tags. Notably, processing of b-TM86V from cells co-expressing b-
TM86V and BirA failed during the 3C-protease cleavage step, because the fusion protein 
tags MBP and thioredoxin were not efficiently cleaved. When expressed in the absence of 
BirA, b-TM86V could be successfully cleaved and purified. The reasons for this 
observation are not clear, since TM86V and L5X differ only in a few shift mutations 
located within the transmembrane helices. Importantly, biotinylation efficiency was similar 
in both expression constructs at approximately 95% (Figure 5-6), showing that with the 
moderate expression level of GPCRs, compared to soluble and highly-expressed proteins 
such as DARPins, the intrinsic E. coli BirA ligase is sufficient for quantitative biotinylation. 
Biotinylation efficiency was quantified according to the approach from Petris and 
coworkers (Petris et al., 2011), exploiting the fact that the biotin-streptavidin binding does 
not fall apart in SDS-PAGE. This method is most suitable for our needs, since it allows 
accurate quantification of low protein amounts, which is not the case for any commercially 
available biotin-quantification kit. 
Figure 5-5. Analysis of the purification process of b-L5X (A) and b-TM86V (B) by SDS-PAGE.
Resin: column material after sample loading; W1, W2: wash fractions; FT: flow-through
fraction; 28-33: SEC fraction number. 20 l (Resin, W1, W2, FT, eluate) or 5 l (SEC fractions)
were loaded on a gradient SDS-PAGE 4-15% (NuPAGE). Red arrows indicate the size of
MBP, the GPCR, 3C protease (3C) and thioredoxin (trx). 
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5.2.2 DARPin selections by ribosome display 
As explained above, the purified receptor variants are embedded in a detergent 
micelle, with only the helix-connecting loops on the top (extracellular) and bottom 
(intracellular side) facing the solvent. The available surface for binding of DARPins is thus 
rather small, compared to soluble proteins. To explore all possibly binders, different 
DARPin libraries were used for selection experiments.  
Conventional RD makes use of the detergent Tween-20 during the washing steps, 
in order to remove unspecifically bound DARPin binders. However, such harsh detergents 
are detrimental to membrane proteins, and the RD protocol thus had to be adapted for the 
work with GPCRs. First of all, we have tested two detergents that are commonly used with 
GPCRs, namely DM and OG, for their compatibility with ribosome display components. 
OG would be advantageous due to its small micellar size, which would present a larger 
solvent-accessible surface compared to DM. However, it is known that short-chain and 
harsh detergents such as OG can disturb in vitro selection systems (Spirin and Swartz, 
2007). These detergents were thus tested with the established test system of MBP as 
target protein and off7 as the binding DARPin (Binz et al., 2004). Under both detergent 
conditions, we could efficiently enrich the off7-specific mRNA in a selection performed in 
solution (Figure 5-7). 
 
 
 
Figure 5-6. Quantification of biotinylation efficiency of b-L5X and b-TM86V. Increasing
amounts of receptor were incubated with 1 g Streptavidin in 1x SDS-loading buffer for 30
min at RT and resolved on a 4-15% NuPAGE (Invitrogen) SDS-PAGE. Free receptor is
quantified with ImageJ software (http://rsbweb.nih.gov/ij/). Receptor is in excess over
streptavidin at the higher titration points. The ratio of free receptor in the presence of
Streptavidin and the total amount of receptor gives the fraction of biotinylated receptor (see
section 5.4, Materials and Methods). 
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Selection in solution was chosen for this test round, since subsequent selections 
were performed using the KingFisher Flex (KFF), an automated platform for the parallel 
in-solution selection of high sample numbers. DM was chosen as the standard detergent 
for our target selections, since the evolved receptor variants show very high stability in this 
detergent over a long time period (see published article, sections 4.1 and 4.2). 
Six different DARPin libraries (Table 5-1) were used for selection of DARPin 
binders against the two target receptors by means of ribosome display. During 
subsequent selection rounds, the stringency of the washing steps was increased stepwise 
to favor selection of specific binders with high affinity. The washing conditions turned out 
to be highly crucial for efficient enrichment and recovery of binders when selecting against 
membrane protein targets, and the washing stringency was lower than for soluble 
proteins. In the fourth and final selection round, a total washing time of 68 minutes was 
used (Table 5-2).  
Table 5-2. Washing stringency during individual RD selection rounds. 
RD selection round  
    1 2 3 4 
wash step (min) 
1 - 1 2 2 
2 - 5 5 5 
3 - 5 8 10 
4 - 5 8 10 
5 - 1 5 15 
Σ wash time 
( i ) *
  20 38 48 62 
* the total wash time is the sum of the actual duration plus the 
transfer times between individual steps.
 
 
The conventional libraries N2C and N3C showed no enrichment after two iterative 
selection rounds and were thus excluded from further experiments. Libraries N3Cloop and 
N3Cloopran were evolved for four rounds, and libraries N3Cnew and N3Cloop for three 
rounds. After the first selection round, the band intensity was similar for the target and no-
target selection (Figure 5-8). During later selection rounds, a continuous enrichment of a 
Figure 5-7. Analysis of detergent compatibility with ribosome display selections. MBP and
its DARPin binder off7 were used to compare the enrichment of off7-mRNA in the presence
of DM or OG. The output after PCR on RT (3 l volume) is analyzed on a 1.5% agarose gel.
RT +/-, reverse transcription in presence/absence of reverse transcriptase 
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specific DARPin band was observed for the target-selections (Figure 5-9). The theoretical 
and expected band sizes are given in Table 5-3 (primer pair T7B and TolAk for PCR on 
ligation; primer pair JSCRDif4 and JSCRDir2 for PCR on RT).   
Table 5-3. PCR product sizes for the different DARPin libraries.  
DARPin library   primer pair
T7B / TolAk JSCDif4 / JSCDir2 
N2C 839 517
N3C 938 616
N3Cloop 980 654
N3CloopRan 980 654
N3Cnew 938 616
N3Cran   938 616
 
 
 
However, in the final selection round, a PCR product corresponding to the size of 
an N2C library was strongly enriched (Figure 5-9C), and this result was confirmed in an 
independent duplicate. The size of the input library is that of an N3C library, showing that 
the observed enrichment is truly the result of the final selection round (Figure 5-10).  
 
Figure 5-8. Analysis of RD selection round 1. Enrichment of DARPin binders analyzed after 
PCR on RT (3 l PCR, 1.5% agarose gel). Specific band sizes are given in Table 5-3. Target 
T, TM86V; target L, L5X. 
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Figure 5-9. Analysis of RD selection rounds 2 (A), 3 (B) and 4 (C). Enrichment of DARPin
binders analyzed after PCR on RT (3 l PCR, 1.5% agarose gel). Specific band sizes are
given in Table 5-3. Target +/-, selection in presence/absence of target; 2, N2C library; 3,
N3C library; L, N3Cloop library; R, N3CloopRan library; N, N3Cnew library; C, N3Cran
library. 
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Additives (5% DMSO or 240 mM urea) to the PCR on RT did not improve 
amplification of the specific library fragment, but substantially decreased the PCR output 
below a detectable limit (Figure 5-11).  
 
Figure 5-11. Influence of additives on the PCRonRT reaction after RD selection round 4. 
Addition of 240 mM urea (3% of 8 M stock solution) was tested in comparison to 5% DMSO 
(standard reaction condition) with respect to specific amplification of the DARPin library. In 
the presence of urea, the PCR reaction did not give specific product. 
 
It thus appears that under the current conditions, no further improvement of the 
selection is possible. The output of the last selection round was nevertheless subcloned 
into the expression vector pDST67 for screening of DARPin binders by ELISA. 
Figure 5-10. Quality analysis of the input DARPin library before RD selection round 4. The
PCR products used for in vitro transcription are about 1000 bp, in agreement with the
correct fragment sizes of 980 bp (N3Cloop libraries; compare the PCR product of off7, an
N3C) and 938 bp (conventional N3C libraries), respectively. Only the selections with
N3CloopRan library (R) shows a shift towards smaller fragments. L, N3Cloop library; R,
N3CloopRan library; N, N3Cnew library; C, N3Cran library. 
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5.2.3 Screening of the final evolved pools for DARPin binders 
The final selected pools were subcloned into the expression plasmid pDST67 
(plasmid ID 827), and individual DARPin clones were expressed in the E. coli XL1blue 
strain fur subsequent screening by crude-extract ELISA (ceELISA). Depending on the 
enrichment of the selected pool, between 50 and 200 individual clones were screened for 
each library selection, with a total of 900 screened clones. MBP and its DARPin binder 
off7 were used as control. 
From the 900 screened DARPin clones, 48 DARPins showed a signal-to-noise 
ratio in crude-extract ELISA above 6, while the signal-to-noise ratio of off7-MBP was 
above 6 (Figure 5-12). The remaining >90% of clones were characterized by high 
unspecific binding in the absence of target. These DARPins likely bind to empty detergent 
micelles, thus explaining the high crude-extract ELISA signal both in the presence and 
absence of receptor.  
The 48 DARPins with the highest signal-to-noise ratio were further characterized 
by SDS-PAGE and sequence analysis, showing that many of these clones are truncated 
DARPins, with an early frameshift or stop codon within the N-cap or first internal repeat 
module. The fact that such truncated DARPin sequences give some of the strongest 
signals observed in this screening is very unusual and indicative of highly unspecific 
binding. Since the His6-tag used for ELISA detection is N-terminal to the DARPin 
sequence, it is correctly translated and an ELISA signal can be detected if these clones 
bind unspecifically to detergent micelles. 
As explained within the next paragraph, the remaining 12 clones represent only 5 
unique sequences, and are furthermore characterized by deletion of one internal repeat. 
These binders, indicated by name in Figure 5-12C, are not the clones giving the highest 
ELISA signal, but are the only intact DARPin sequences that are of correct size in SDS-
PAGE analysis (see Section 5.2.5). 
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Figure 5-12. Overview of the screening of the final evolved DARPin library pools. (A)
Representative raw data of a 96-well crude-extract ELISA screen for binders to b-TM86V. In
total, 900 clones were analyzed, covering both selections against b-TM86V and b-L5X. Black
bars, immobilization of b-TM86V via neutravidin; grey bars, neutravidin-coating only; *, MBP-
off7 control. (B) Signal-to-noise ratio of the screened DARPins, calculated and replotted from
(A). The signal-to-noise ratio is the ratio of the ELISA signal of DARPin binding to
immobilized b-TM86V (black bars in (A)) to the ELISA signal of DARPin binding to
neutravidin (grey bars in (A)). *, MBP-off7 control. (C) Signal-to-noise ratio of the 48
strongest binders among the 900 screened DARPin clones. The five binders that were
further characterized are labeled by their name.  
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5.2.4 Sequence analysis 
The strongest 40 DARPin clones were sequenced and their amino acid sequences 
in the variable library position were studied. From the 40 clones, only 12 showed a correct 
DARPin sequence (Figure 5-13). 
 
 
 
 
 
 
 
 
 All other sequences correspond to truncated DARPin sequences that, as a result 
of frameshifts in the sequence, did not extend beyond the N-terminal His6-tag or the N-
cap. The His6-tag is used for ELISA detection, and can thus explain the signal for the 
truncated clones.  However, it is not entirely clear why these clones have such a high 
signal-to-noise ratio. In case these are false-positive clones, the fraction of false-positives 
would be 75%. Such a high error rate is indicative of a non-robust selection.  
Interestingly, the 12 remaining sequences revealed only 5 unique DARPin binders, 
with a dominant binder T2 that is retrieved seven times and a second binder that appears 
twice (T3, Table 5-4). All five binders are N2C-derived, with either an internal repeat 
module (T2, T3, L1, L2) or the N-cap (T1) deleted (Figure 5-13). The three binders T2, T3 
and L1 have very similar sequences, and differ only in a few positions. Interestingly, all 
binders contain a loop sequence, and either a randomized or a new C-cap. The loop 
sequence is mostly hydrophobic, while basic amino acids are dominant in the randomized 
positions (Figure 5-13). These motifs are unusual, in comparison to selections on most 
soluble targets, where these properties are not selected, and might thus reflect a specific 
Figure 5-13. Sequences of the five DARPin binders. T1, T2 and T3 are identified to bind 
against TM86V, and L1 and L2 against L5X. The sequence of the N3Cloop library is given as
reference. White areas indicate identity to the N3Cloop consensus. Individual mutations are
colored with respect to their amino acid type. Deletions are highlighted in black. 
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property of DARPin binders to membrane proteins, or a technical issue within the 
selection (personal communication, J. Schilling). 
Table 5-4. Characteristic values of the five identified DARPin binders. 
        theoretical values  purified protein 
yield concentration 
DARPin C-cap 
# of 
sequences aa 
MW  
(kDa) pI    mg/L mg/ ml  M 
T1 Cran/Cnew 133 14.7 5.89 23950 11.5 2.84 193 
T2 Cran 12x 153 16.2 5.59 13980 8 1.96 121 
T3 Cran 2x 153 16.1 5.68 13980 9.5 2.28 142 
L1 Cran 153 16.3 5.58 20970 3 0.7 43 
L2 Cold   153 16.7 5.82 17420  1.5 0.37 22 
  
5.2.5 Analysis of DARPin binders by ELISA 
The five DARPin binders T1, T2, T3, L1 and L2 were expressed in a 1  L- scale 
and purified via IMAC (Figure 5-14).  
 
 
 
 
 
The purified protein was used for binding analysis to both targets b-TM86V and b-
L5X by ELISA. Independent of the target that they were selected on, all five selected 
DARPins recognize both TM86V and L5X (Figure 5-15A). Hence, L5X and TM86V must 
display rather similar interaction surfaces. Different concentrations of DARPins were 
analyzed, and showed that for some binders, an equimolar ratio of target and DARPin 
(each 15 nM) is sufficient to obtain the full signal, indicating an affinity in the low 
nanomolar range. Apart from potential differences in DARPin-binding affinity, L2 gives the 
smallest ELISA signal which is close to background binding to neutravidin only (Figure 5-
15A). L2 showed a very low purification yield, and the low ELISA signal might suffer from 
inaccurate determination of protein concentration.  
Figure 5-14. SDS-PAGE analysis of DARPin purification by IMAC. L= lysate, W= wash
fraction, E= elution. L2 expresses at a low level compared to the other DARPins.  
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Furthermore, we observe that the specific ELISA signal for binder T3 is stronger at 
lower DARPin concentrations. This can be an irrelevant observation, or could potentially 
point towards an inhomogeneous DARPin population, for which aggregation behavior is 
concentration-dependent. To further characterize the DARPin binders and narrow down 
the range of binding affinity, a competition ELISA was performed. In this setup, the binding 
of 15 nM DARPin to 15 nM biotinylated and immobilized target receptor was competed 
with 500 nM unbiotinylated and free receptor. However, the specific binding signal could 
not be competed with excess of free receptor, or only partially in the case of T2 (Figure 5-
15B). This result is surprising regarding the specific DARPin binding observed under 
standard ELISA conditions, where the DARPins T1-T3 and L1-L2 do not bind empty 
micelles (Figure 5-15A). A possible explanation for this observation is that the DARPins 
bind to the interface of GPCR and detergent micelle, where the interactions with detergent 
micelles are strongly hydrophobic and dominant, and hence can not be competed. 
 
 
 
 
 
Figure 5-15. Analysis of DARPin-GPCR binding by ELISA. (A) Binding of purified DARPin
(100 nM, black bars; 50 nM, grey bars; 10 nM, white bars) to  15 nM immobilized TM86V or
L5X. Various DARPin-concentrations were tested. (B) Binding of 15 nM DARPin to 15 nM
immobilized target in the presence of 500 nM non-biotinylated free target. Binding is poorly
competed by soluble GPCR. 
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5.2.6 SEC analysis of DARPin binders 
The DARPins were analyzed for their behavior in an analytical size exclusion 
chromatography with a separation of up to 200 kDa (SEC200).  
 
 
 
Figure 5-16. SEC200 analysis of the five selected DARPins T1, T2, T3, L1 and L2 in the
absence of detergent (A) and presence of detergent (B). (A) 10 M DARPin was analyzed on
an analytical SEC200 (CV 2.4 ml) in 10 mM Tris·HCl pH 7.4 and 150 mM NaCl. (B) 20 M
DARPin was analyzed on an analytical SEC200 (CV 2.4 ml) in PBS/ 0.2% DM. (A) and (B)
*, void peak; 1, standard peak -amylase 200 kDa; 2, standard peak albumin 66 kDa; 3,
standard peak cytochrome c, 12.4 kDa 
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Two different experimental conditions were used to assess the influence of 
detergent on protein behavior. In this study, DARPins were generated against membrane 
proteins in the presence of detergent, but the DARPins should be soluble and well-
behaved also in the absence of detergent. In a buffer of 10 mM Tris pH 7.5 and 150 mM 
NaCl, all five DARPins showed multiple peaks up to the void volume (Figure 5-16). The 
actual DARPin would be expected at an elution volume of 1.8 to 2 ml. The small fraction 
of DARPin observed at this elution volume shows that most protein is oligomeric or 
aggregated. A similar result was obtained in the presence of detergent, here 0.2% DM, 
which was used throughout all selections. It thus appears that the protein properties of the 
selected DARPins are too poor for further studies. 
5.3 Summary and discussion 
Selections of DARPin binders against membrane proteins have been successfully 
performed for different proteins, such as the sodium symporter CitS (Huber et al., 2007) or 
the membrane transporter AcrB (Monroe et al., 2011). The latter protein has very large 
extracellular domains and thus behaves more like a soluble protein in selection 
experiments. The actual target proteins are well-behaved in their wild-type state and 
display high detergent stability that allowed crystal formation (Monroe et al., 2011).  
Here, we have performed selections with the receptor variants b-TM86V and b-
L5X, which have been previously evolved for high detergent-stability. Specific DARPin 
binders to these evolved variants could facilitate structure determination of the receptor by 
cocrystallization approaches, and, depending of their mode of binding and action, might 
be of interest for functional studies such as activation or inhibition.  
The specific enrichment of DARPin binders throughout selection was weak for the 
first two rounds and stronger in subsequent rounds. However, these selections were 
highly susceptible to changes in the washing stringency, and too strong washing steps 
abolished any enrichment. Individual selection rounds had to be repeated in order to 
optimize the washing stringency, and relatively short washing steps had to be used for 
selections against TM86V and L5X. Low washing stringencies do not necessarily indicate 
problematic selections, but rather result in binders with low affinity or in reduced 
discrimination between specific and unspecific binders. However, in this study, we could 
not identify specific DARPin binders. About 90% of all screened DARPin clones were 
characterized by high, but unspecific binding – defined as crossreactivity with neutravidin 
in the absence of GPCR – which is likely a result of binding to empty detergent micelles. 
The fact that so many false positives are observed is very unusual. Moreover, the five 
N2C-binders exhibit poor biophysical behavior, and display a non-competable ELISA 
signal. Repetition of selection round 4 produced a very similar result, with no better 
behaved DARPins among 1000 additional clones. Since enrichment of N2C vs. the 
original N3C library only occurred in the fourth round of selection (Figure 5-10), further 
400 clones of the enriched pool after the third selection round were screened, also without 
success. While many positive signals were observed in the crude-extract ELISA, only five 
clones could be confirmed as a full-length N2C DARPins. 
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Taken together, selections against GPCRs might be hampered by presentation of 
the target protein in a detergent micelle, restricting the surface that is accessible for 
DARPin binding, as well as by the low degree of structure in the target protein region that 
is solvent-accessible. GPCRs that are embedded within a detergent micelle display their 
extra- and intracellular surface towards the solvent. These interfaces are mainly formed by 
helix-connecting loops, creating a conformationally flexible surface, which might not be 
suitable for DARPin binding. It is interesting to note that the five DARPin binders that were 
identified are all derived from the loop-DARPin library. The loop-DARPins were especially 
designed for binding of target-specific grooves. Even though the selected DARPins 
display poor biophysical properties, the loop sequence might nevertheless be crucial to 
allow binding to these targets at all. Most loop sequences are not only identical in their 
sequence, but are furthermore very hydrophobic, with high prevalence of tyrosine. Binding 
of the DARPin loop sequence between the interface of receptor and detergent would be a 
potential hypothesis to explain the observed results. Such binding would be mainly 
specific to the binding milieu, and hydrophobic binding to the detergent could explain the 
specific, but non-competitive binding, since such an interface would not be present in an 
empty detergent micelle.  
Selection of DARPin binders to most soluble proteins by RD can be considered a 
very robust technique, and DARPins are versatile enough to generate binders that 
unambiguously distinguish the phosphorylation status of a target protein (Kummer et al., 
2012). Specific binders with high affinity to small soluble proteins such as the Bcl2-family 
have been successfully obtained within in a single selection round (J. Schilling, personal 
communication).  
Hence, the failure to select DARPin binders to TM86V and L5X is likely attributed 
to the poor biophysical properties of the targets. Possible future approaches could be 
selections against GPCR fragments, such as loop fragments. Furthermore, purified 
receptors could be embedded into nanodisc particles (Leitz et al., 2006). Nanodiscs are 
island-like particles composed of lipids, kept in a disc by the -helical MSP protein 
surrounding the disc like a belt (Bayburt and Sligar, 2010). Nanodiscs better mimic the 
natural lipid bilayer than detergent micelles, and especially the protein-lipid interface 
would be more native-like. If binding between the detergent micelle and the protein is 
really the reason for the obtained results, selection against the target receptor embedded 
in nanodiscs could potentially resolve the issue.  
Future selections could further address optimization of selection conditions. 
Possible “access points” would be the optimal ratio of streptavidin-binding sites to 
biotinylated target receptor and the washing stringency during the selection rounds. The 
presence of a detergent micelle largely increases the size of the target protein, and in 
case of target saturation, the detergent-micelles of immobilized target receptors could 
result in a continuous detergent layer that shields the G-protein interacting surface of the 
receptor from the actual selection (the biotinylated AviTag is located on the receptor C-
terminus). To avoid this, the ratio of binding sites to target molecules should be increased, 
in order to separate individual receptor-containing micelles from each other. Along the 
same line, immobilization of the receptor via the N-terminus would preferentially present 
the G-protein interaction surface to the solvent, which might facilitate selection of DARPin 
binders to this interface. The washing stringency was carefully adjusted for each selection 
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round, but by performing selection on the King Fisher Flex (KFF), the duration of each 
washing step is necessarily longer than in manual selections: The King Fisher Flex is a 
platform that provides automated transfer of beads in a 24- or 96-well format and is 
routinely used for high numbers of parallel selections, where identical treatment of all 
samples is essential. However, individual steps such as bead collection via magnetic tips 
and transfer between individual plates are relatively slow, hence defining a minimum 
washing time of ~20 min. It cannot be excluded that this washing stringency was too 
harsh, and eliminated potential binders. To account for that, a manual selection of the 
naïve library would be recommendable, since it allows the washing stringency to be freely 
defined down to the second/minute time scale.   
However, it is not clear from the above results whether such approaches are 
promising, or whether more profound target protein issues are encountered that cannot be 
easily alleviated. The receptor variants TM86V and L5X display the highest detergent 
stability reported for GPCRs so far, and L5X is furthermore preferentially stabilized in the 
agonist-bound state (Schlinkmann et al., 2012), chapter 4 of this work). If these receptors 
variants are not suitable for DARPin selections, it is quite likely that no rNTR1 variant will 
be. 
5.4 Materials and Methods 
5.4.1   Expression of pD-NT1 fusion protein  
The plasmid pAT223-3C-NT1 (obtained from P. Egloff, Appendix page 190), 
encoding the fusion of the neurotensin peptide 8-13 and pD (phage  head protein gpD, 
(Forrer and Jaussi, 1998)) connected by a linker and a 3C recognition site (termed pD-
NT1), was transformed into E. coli BL21(DE3). A single colony was used to inoculate an 
overnight preculture (200 ml 2YT medium, 1% glucose, 100 g/ml ampicillin). Five 1 L – 
expression cultures (2YT, 0.2% glucose, 100 g/ml ampicillin in 5 L Erlenmeyer flask with 
baffles) were inoculated to OD600 = 0.1 and grown at 37°C to OD600 = 0.8 in a shaking 
incubator. Protein expression was induced by addition of 250 M IPTG and continued for 
5 h at 37°C. Cells were harvested by centrifugation, and the cell pellet stored at -80°C. 
5.4.2 Purification of pD-NT1 fusion protein by IMAC 
Cells (40 g wet cell weight) were homogenized in 100 ml buffer RB (50 mM 
HEPES pH 8, 500 mM NaCl, 25 mM imidazole, Complete Protease Inhibitor (Roche)). 
Cells were lysed by sonification (aliquots of 40 ml, 10x 30 s at duty cycle 6, output 50%; 
Branson sonifier 250) in the presence of 5 g/ml DNase I (Roche), 5 mM MgCl2 and 50 
g/ml lysozyme (Sigma-Aldrich). The soluble fraction was separated from cell debris by 
centrifugation at 11,000 g for 30 min, and applied by gravity flow to 12 ml Ni-NTA resin 
(Qiagen) equilibrated in buffer EQ (25 mM HEPES pH 8, 500 mM NaCl, 25 mM imidazole) 
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for immobilization of the His6-tagged pD-NT1. The resin was washed with 10 CV of buffer 
EQ and 10 CV of buffer WB (0.2 M NaHCO3 pH 8.3, 500 mM NaCl, 5 mM imidazole). The 
immobilized protein was subsequently eluted with 12 ml buffer EL (0.2 M NaHCO3 pH 8.3, 
500 mM NaCl, 300 mM imidazole). The eluate was concentrated to 15 mg/ml (if 
necessary) in an Amicon® Ultra 10,000 MWCO (Millipore) and dialyzed 3× against 1 L 
coupling buffer (0.2 M NaHCO3, 500 mM NaCl). The purified and dialyzed protein fraction 
was stored at -80°C until further use. 
5.4.3 Coupling of pD-NT1 to NHS-activated sepharose 
The purified pD-NT1 fusion protein was covalently coupled to NHS-activated 
sepharose 4 Fast Flow (GE Healthcare 17-0906-01) for subsequent capturing of active 
rNTR1-variants by binding to the presented neurotensin peptide. 25 ml NHS resin was 
equally distributed into five empty PD10 columns (GE Healthcare), drained from the 
storage solution and washed by 60 ml ice-cold 1 mM HCl (given volumes apply per 
column). For the coupling reaction, 2.5 ml of 13 mg/ml pD-NT1 was added per column, 
and allowed to react for 2 h at room temperature (RT) under constant mixing. Remaining 
unreacted protein solution was drained, and the reaction was stopped by addition of 10 ml 
0.1 M Tris·HCl pH 8.5 and incubation for 2 h at RT under constant mixing. The resin was 
subsequently washed by 12 ml each of 0.1 M NaOAc pH 4.5, 0.5 M NaCl and 0.1 M 
Tris·HCl pH 8.5. Subsequently, each column wash washed with 24 ml of 8 M GdmCl, H2O 
and 20% ethanol, respectively. The resulting pD-NT1-resin was stored in a 1:1 dilution 
with 20% ethanol at 4°C. 
5.4.4 Cloning of AviTag- receptor variants 
The constructs pRG-RD_L5X and pRG-RD_L5X were generated for in vivo 
biotinylation in E. coli via the AviTag (GLNDIFEAQKIEWHE) in which the lysine is 
recognized by the E. coli biotin ligase (BirA). Starting from pRG-TM86V_P51-dW392_3C 
(obtained from P. Egloff), the 2724-bp fragment including the fusion protein sequence 
from MBP to thioredoxin plus the C-terminal His10-tag and two stop codons was obtained 
by restriction digest with XbaI (see Figure 5-3B for illustration of the fusion protein 
sequence), and subcloned into pRGD03, for which the backbone EcoRI site was 
previously removed. The resulting construct pRG-xD_TM86V was used for expression of 
unbiotinylated receptor (Appendix page 191). Plasmid pRG-xD_L5X was obtained by 
replacing the TM86V-coding fragment of pRG-RD_TM86V with that of L5X via 
BamHI/Cfr9I. pRG-RD_TM86V (plasmid ID 3370) was subsequently obtained by replacing 
the Cfr9I/EcoRI fragment covering the 3C-recognition site (LEVLFQGP) and the N4(G3S)2-
linker with the synthetically assembled (G4S)6-AviTag-3C_site-N4(G3S)2 sequence (see 
Figure 5-3 for illustration of the fusion protein sequence, and Appendix page 191). pRG-
RD_L5X (plasmid ID 3369) is obtained by replacing the TM86V-coding fragment with that 
of L5X via BamHI/Cfr9I. 
SELECTION OF DARPIN BINDERS TO TM86V AND L5X BY RIBOSOME DISPLAY 
- 173 - 
5.4.5 Expression of TM86V and L5X 
rNTR1-receptor variants were expressed in large scale in a 50 L fermenter 
(Bioengineering). For in vivo biotinylation of L5X (b-L5X), pRG-RD_L5X was co-
transformed with the plasmid pBirAcm (plasmid ID 212), encoding the E. coli biotin ligase 
BirA under control of the lac- promotor, into the E. coli strain BL21(DE3). For b-TM86V, 
overexpression of the BirA ligase interfered with 3C-cleavage of the fusion tags, and 
biotinylated TM86V was hence expressed in the absence of pBirAcm in BL21(DE3). 
Unbiotinylated receptor was expressed from the plasmids pRG-xD_L5X and pRG-
xD_TM86V, respectively. A 50 ml pre-preculture (2YT medium, 1% glucose, 100 g/ml 
ampicillin, 10 g/ml chloramphenicol in the presence of pBirAcm) was inoculated with a 
single colony and grown overnight at 37°C in a shaking incubator. In the morning, a 1 L – 
preculture (5 L Erlenmeyer flask with baffles) was inoculated to an optical density 
OD600= 0.1, and grown at 37°C for 8 hours. The actual expression in the fermenter 
(Bioengineering) was performed in 50 L 2YT medium supplemented with 0.6% glucose 
and 100 g/ml ampicillin (no chloramphenicol during expression of BirA). Instrument 
settings were set to 37°C, 400 rpm, pH 6.5 ± 0.5 (adjusted by 5 M NaOH with 5 s on-time 
and 10 s off-time), 1 bar overpressure, and foam control with 1:10 diluted Antifoam Y30 
(Sigma-Aldrich). Expression was inoculated with 1 L preculture. At OD600 = 3.5, the 
temperature was downregulated to 28°C and expression was induced by 250 M IPTG 
(isopropyl--D-thiogalactoside). In case of BirA coexpression, 25 M free biotin was 
added. Expression was continued for 12-15 hours, and the fermenter was then cooled to 
18°C before harvesting by continuous centrifugation. The obtained wet cell pellet (500 – 
600 g) was stored at -80°C until further use. 
5.4.6 Purification of GPCR variants 
100 g wet cell pellet was thawed at room temperature for 1 h, and homogenized in 
200 ml 2× solubilization buffer (100 mM HEPES pH 8, 400 mM NaCl, 20% glycerol, 
complete protease inhibitor (Roche)). All subsequent steps are performed at 4°C. The cell 
suspension was supplemented with 2.5 mM MgCl2, a few crystals of DNase I, 400 mg 
lysozyme, 0.6% CHAPS, 0.12% CHS and 1.7% DM in a total volume of 400 ml and stirred 
for 15 min. Cells were opened by sonification (Branson Sonifier 250) for 30 min (duty 
cycle 30%, output 5) under continuous stirring in an ice/water bath. After addition of 
10 mM EDTA, solubilization was continued for 30 min. Solubilized material was separated 
from cell debris by centrifugation for 30 min at 15,000 g. The supernatant was mixed with 
5 ml pD-NT1-resin previously equilibrated in buffer NTW1 (25 mM HEPES pH 8, 10% 
glycerol, 150 mM NaCl, 2 mM DTT, 0.3% DM) and incubated overnight to allow for 
receptor binding. The resin was collected by centrifugation at 600 g for 10 min, 
supernatant was partially removed and the resin was loaded into 2 empty PD10-columns. 
Each column (~2.5 ml column volume (CV)) was washed with 60 ml buffer NTW1 and 
subsequently with 40 ml buffer NTW2 (25 mM HEPES pH 7, 10% glycerol, 150 mM NaCl, 
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2 mM DTT, 0.3% DM). Resin was resuspended in 1 CV of buffer NTW2 each, and 
cleavage of the 3C-recognition sites performed in the presence of 125 l 3C-protease (5.6 
mg/ml) in buffer NTW2 for 3 h under continuous rotation. Cleaved receptor and fusion 
proteins were collected by elution with 10 ml buffer NTW2 per column. The salt 
concentration of the eluted fraction was adjusted by dilution with 2 volumes of buffer SP-B 
(10 mM HEPES pH 7.7, 10% glycerol, 2 mM DTT, 0.3% DM), loaded on a SP-sepharose 
column (5 ml CV, PD10 column, GE Healthcare) and washed with 10 ml buffer SP-B and 
25 ml buffer SP-W (10 mM HEPES pH 7.7, 10% glycerol, 35 mM NaCl, 2 mM DTT, 0.3% 
DM). The pH was readjusted by washing with 3 ml buffer SP-W, and the bound protein 
was eluted with 12 ml buffer SP-E (10 mM HEPES pH 7, 10% glycerol, 350 mM NaCl, 2 
mM DTT, 0.3% DM, 0.5 M NT1-peptide) directly into a concentrator (Millipore Amicon® 
Ultra, 50,000 MWCO) and concentrated to less than 500 l. The concentrated fraction 
was then applied to size exclusion chromatography on an S200-column (GE Healthcare 
Superdex 200, 24 ml CV) equilibrated in buffer SEC (10 mM HEPES pH 8, 150 mM NaCl, 
2 mM DTT, 0.3% DM, 0.1 M NT1-peptide). Fractions of 0.5 ml were collected at a flow 
rate of 0.4 ml/min.  The relevant fractions were pooled, concentrated to 0.5 mg/ml (~10 
M) in an Amicon® Ultra 50,000 MWCO, supplemented with 30% glycerol, flash-frozen in 
liquid nitrogen and stored in 50 l aliquots at -80°C.  
5.4.7 Quantification of biotinylation efficiency 
The degree of biotinylation for b-L5X and b-TM86V was analyzed according to 
Petris et al., 2011. Here, 11.5, 28.75, 57.5, 92 and 115 (and 138 pmol for b-TM86V) pmol 
receptor were incubated at 50°C for 10 min in SDS loading buffer (35 mM Tris·HCl pH 6.8, 
10% glycerol, 2% SDS, 1% -mercaptoethanol, 0.15% bromphenol blue). Samples were 
allowed to cool to room temperature before addition of 1 g (71 pmol) streptavidin and 
incubation for 30 min at room temperature. Streptavidin-bound receptor was separated 
from free receptor on a 4-15% NuPAGE (Invitrogen) gradient SDS-PAGE. The binding of 
biotin-streptavidin is strong and retained also under denaturating SDS-PAGE conditions, 
provided that complex formation is allowed to proceed at room temperature. ImageJ 
(http://rsbweb.nih.gov/ij/) software was used to quantify the band intensity of free receptor. 
The band intensity of free receptor in the presence of streptavidin and free receptor in the 
absence of streptavidin was used to calculate the ratio of biotinylated receptor.  
5.4.8 Expression of DARPins  
The respective pDST67-derived clone encoding the DARPin was transformed into 
E. coli XL1blue. A single colony was used to start an overnight preculture (50 ml 2YT 
medium, 1% glucose, 100 g/ml ampicillin). A 1 L – expression culture (5 L Erlenmeyer 
flask) was inoculated to OD600 = 0.1, and grown at 37°C to OD600 = 0.7. Protein expression 
was induced by addition of 1 mM IPTG and continued for 5 h at 37°C. 
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5.4.9 DARPin purification 
Cells were solubilized in 10 ml buffer TBS400 (50 mM Tris·HCl pH 7.4, 400 mM 
NaCl) and lysed by sonification (3x 30 s, duty cycle 50%, output 6). Soluble material was 
separated from cell debris by centrifugation at 13,000 g for 20 min at 4°C and 
subsequently applied to 3 ml Ni-NTA resin (Qiagen) equilibrated with 10 CV buffer TBS-W 
(50 mM Tris·HCl pH 7.4, 400 mM NaCl, 20 mM imidazole, 10% glycerol). The resin was 
allowed to clear by gravity flow and washed with 20 CV buffer TBS-W. The bound DARPin 
was eluted stepwise (fraction e0: 1 ml, e1: 1.5 ml, e2: 1.5 ml, e3: 1.5 ml) with buffer TBS-
E (50 mM Tris·HCl pH 7.4, 400 mM NaCl, 250 mM imidazole, 10% glycerol). Fractions 
were analyzed for their protein content by SDS-PAGE, and relevant fractions were pooled. 
Absorption at 280 nm (NanoDrop 1000, Thermo Scientific) was measured to determine 
the final protein concentration using the specific extinction coefficients (Table 5-4). 
5.4.10   Analytical size exclusion chromatography  
The behavior of the selected DARPins was analyzed on an analytical size 
exclusion chromatography (Superdex 200, 2.4 ml CV, GE Healthcare). DARPins were 
diluted to 10 M/ 20 M in the buffer of interest (PBS/0.2% DM to analyze protein 
behavior in the presence of detergent, as during selection; 10 mM Tris·HCl/ 150 mM NaCl 
to analyze protein behavior in the absence of detergent). The column was equilibrated in 
the assay buffer, and 100 l DARPin sample was injected via the autoloader of the 
AEKTAMicro (GE Healthcare).  
5.4.11   Ribosome display selections 
All ribosome display (RD) selections were performed according to the detailed 
ribosome display manual version 01.2 (March 17th, 2011), and the manual “ribosome 
display in 96 well format” (see protocol database) and employing the King Fisher Flex 
(KFF) for automated selections in solution. Selections were performed in the presence of 
250 nM target receptor on 50 l MyOne Streptividin beads T1 (Invitrogen) per reaction, 
with a target to binding site ratio of 1 to 4.4. The low ratio was chosen to account for the 
large radius of the detergent micelle, which might shield neighboring streptavidin 
molecules. The standard detergent Tween 20 was consequently replaced by 0.2% DM 
throughout all selection with the target proteins b-TM86V and b-L5X. The S30-extract 
without DTT was used to retain the target disulfide bridge. Throughout all PCR reactions, 
the primer WTC4 was replaced by JSDRDir4 (designed by J.Schilling, ATCTGCTTCG 
GCCTTCGCTT TAGCATCTGC CGCCGCTTTCG) and the primer EWT5short by 
JSCRDif2 (designed by J. Schilling, AGAGGATCGC ATCACCATCA CCATCACGGA 
TCCGACCTGGG). VentR® Polymerase (NEB) was replaced by Herculase® II 
(Stratagene). The outline of a typical selection round on KFF, here round 3, is given in 
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Table 5-5 and Table 5-6. All other rounds were performed accordingly with adjustment of 
the washing times (Table 5-7). 
Table 5-5. Protocol of RD selection round 3 performed on King Fisher Flex. 
      release 
(min)
 mix (min)   collect (min) 
step substep plate  slow medium cycle (#)   count  time  
start pick up tip pp-p-pd 
collect beads wash 1 02:00 00:05 00:10 
prepanning prepanning pp-p-pd 02:00 04:00 01:00 6 00:05 00:10 
removal of prepanning beads trash 01:00 
pause add target pp-p-pd 
panning mix pp-p-pd 04:00 01:00 12 
pause add beads to wash 1 wash 1 
pulldown collect new beads wash 1 00:05 00:10 
pulldown pp-p-pd 00:30 04:00 01:00 6 00:05 00:10 
wash 1 wash 1 00:30 01:00 01:00 1 00:05 00:10 
wash 2 wash 2 00:30 04:00 01:00 1 00:05 00:10 
wash 3 wash 3 00:30 03:00 01:00 2 00:05 00:10 
wash 4 wash 4 00:30 03:00 01:00 2 00:05 00:10 
wash 5 wash 5 00:30 04:00 01:00 1 00:05 00:10 
elution elution 03:00 04:00 01:00 2 00:05 00:10 
release beads trash 01:00 
end leave plate pp-p-pd                
 
Table 5-6. Plate setup on RD selections using King Fisher Flex. 
 
 
 
 
 
 
 
Table 5-7. Washing conditions used in RD selections. 
RD selection round  
    1 2 3 4 
wash step (min) 
1 - 1 2 2 
2 - 5 5 5 
3 - 5 8 10 
4 - 5 8 10 
5 - 1 5 15 
Σ wash time*   20 38 48 62 
* the total wash time is the sum of the actual duration plus the 
transfer times between individual steps. 
plate reagent volume (l) 
pp-p-pd stop buffer  250 
translation mix 250 
target 12.5 
wash 1 buffer WB-DM 800 
beads 100 
wash 2 buffer WB-DM 1000 
wash 3 buffer WB-DM 1000 
wash 4 buffer WB-DM 1000 
wash 5 buffer WB-DM 1000 
elution buffer EB 200 
trash buffer WB-DM 500 
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5.4.12   ELISA methods 
High throughput crude-extract ELISA  
The screening of DARPin binders by crude-extract ELISA was performed 
according to the HT_ELISA manual (ht_elisa_protocol_09.11.11.pdf; T. Looser) with the 
following modifications: The detergent Tween-20 was replaced by 0.2% DM to ensure 
target protein activity. For the same reason, cell lysis was not performed with the 
detergent mix B-PER II (Pierce), but instead achieved by incubation with DNase I and 
lysozyme. The cell pellet was resuspended in 250 l buffer DESOL (1× PBS, 1 mM EDTA, 
50 g/ml DNase I (Roche), 0.5 mg/ml lysozyme, 10 mM MgCl2) and incubated on a 
horizontal plate shaker (Titramax 1000) for 1 h at RT. The crude extracts were diluted with 
PBS to a final volume of 1 ml, and frozen at -80°C until further use. 
 
ELISA 
A 96-well MaxiSorp ImmunoPlate (Nunc) was washed twice with 250 l PBS and 
subsequently coated with 100 l of 66 nM neutravidin solution per well overnight at 4°C. 
All incubation steps were performed on a horizontal plate shaker (Titramax 1000). 
Remaining binding sites were blocked with 250 l PBS-DB (PBS, 0.2% DM, 0.5% BSA) 
for 1 h at RT. Each well was washed 3x with 250 l PBS-D (PBS, 0.2% DM) before 
immobilization of 100 l 15 nM TM86V or L5X, respectively, for 1 h at 4°C. Each well was 
again washed three times, followed by incubation with 100 l DARPin solution of a defined 
concentration for 1 h at 4°C. Each reaction was performed in duplicates. After the next 
wash step, bound DARPin was detected by 100 l RGSHis6-antibody in PBS-DB (diluted 
1:5000; internal ID 24) for 1 h at 4°C and the secondary mouse IgG - antibody 
conjugated with alkaline phosphatase (1:10,000 in PBS-DB, internal ID 38). Subsequently, 
100 l of 3 mM 4-pNPP substrate (4-nitrophenyl phosphate disodium salt) in buffer pNPP 
(50 mM NaHCO3, 50 mM MgCl2) was added to each washed well for reaction with alkaline 
phosphatase and the signal was allowed to develop for 30 min to several hours. OD405 
was measured for readout (Tecan Infinite M1000 plate reader).  
 
 
 
Competition ELISA 
The competition ELISA was essentially performed according to the above protocol. 
To assess if the DARPin binding to immobilized target receptor is competitive, the 
following reaction setup was chosen: In one reaction, 50 nM DARPin were allowed to bind 
to immobilized target, and in a second reaction, 50 nM DARPin were mixed with 500 nM 
unbiotinylated target receptor before addition to the immobilized biotinylated receptor.  
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Saturating Mutagenesis 
Despite enormous effort, the pace and progress of GPCR research has not caught 
up with that of soluble proteins. While brute-force approaches have been successful in 
some cases, it was clear that the crucial limitations that are intrinsic to GPCRs had not 
been addressed yet, and that innovative approaches were necessary to break new 
ground. Many mutagenic studies have been performed on GPCRs, but they were never 
exhaustive in their coverage, leaving open questions regarding the potential still hidden 
within GPCR sequences. 
 
Instead of searching manually for the needle in the haystick, we have 
systematically dissected the contribution of every side chain to expression and function of 
the rNTR1-D03 by saturating mutagenesis of every receptor position. Alanine-scanning 
mutagenesis has been applied to several targets and also to some GPCRs (Magnani et 
al., 2008; Serrano-Vega et al., 2008; Shibata et al., 2009), but saturating mutagenesis 
was previously only selectively applied to relevant positions of a target protein (Tan et al., 
2008), or to ensembles of several positions (Delagrave and Youvan, 1993; Huang et al., 
1996). Such a comprehensive saturating scanning approach as performed here was the 
first of its kind, and will likely remain so. The main argument for this assumption is that 
generation of hundreds of individually randomized libraries is laborious and cost-intensive, 
and requires stringent quality control measures to ensure library diversity, the most critical 
factor of this study. About a third of all position-specific libraries had to be re-synthesized 
due to early quality control issues. With the final ultra-deep sequencing analysis of the 
evolved library pools, we could confirm that, except at about 10 positions, those issues 
had been resolved. Selection and sequencing analysis of about 400 libraries with the 
handling of more than 25,000 individual clones was certainly worth the effort, but is too 
time-consuming to be performed for every receptor of interest. 
 
Among many possible implications, we expected that the analysis of the position-
specific libraries would reveal something about the tolerance of each receptor position 
towards mutagenesis and identify the positions with obvious constraints. More than that, 
thirty shift positions were found that increased expression levels, and some also affected 
detergent stability. With the subsequent generation of combinatorial libraries, the full 
potential of the identified shifts was revealed, highlighting that pivotal positions had been 
identified, and that the shift mutations alleviated previous constraints. Notably, these shift 
mutations target receptor-specific constraints, as shown by high expression of the evolved 
variants in Sf9 cells, and are by no means a result of host adaptation. The creation of 
evolved receptor variants with unprecedented expression and detergent stability 
represents the key finding of this study.  
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Coevolution of expression levels and detergent stability 
The strong coevolution of expression and detergent stability observed for the 
combinatorial variants was surprising, as the latter was never under direct selection 
pressure. This observation is in agreement with the results of previous studies applying 
random mutagenesis and selection to evolve GPCRs in vitro (Dodevski and Plückthun, 
2011; Sarkar et al., 2008). Obviously, selection for functionally expressed GPCR indirectly 
selects for stability. Such a correlation could arise from effects on protein folding and 
packing, thus improving the efficiency of correct insertion into the membrane. Preliminary 
data suggest that for the evolved receptor variants, the total fraction of active receptor in 
the membrane is increased, but the total amount of protein is still similar to wild type. This 
observation supports the above hypothesis that protein folding and insertion of the 
evolved variants is improved. In this respect, it is interesting to note that highest functional 
expression of the evolved receptor variants is observed at 30°C, which is not the case for 
the less-evolved D03 or for wild-type rNTR1. This shows that the E. coli protein synthesis 
machinery can actually accommodate higher expression levels, and that the toxicity of 
GPCR overexpression is a result of its primary amino acid sequence and poor biophysical 
properties. Usually, GPCRs such as the wild-type rNTR1 are expressed in E. coli at low 
temperatures to decrease the rate of protein synthesis, providing sufficient time for protein 
folding and insertion. 
An interesting hypothesis is that expression and selection in E. coli exerts a strong 
selective pressure for fast synthesis and folding of membrane proteins (Tate, 2010). 
Mammalian cells divide approximately every 24 h, providing ample time for a GPCR to 
reach the surface, while in E. coli, the short generation time of approximately 20 min 
provides a much smaller time window to do so, hence exerting selective pressure. In 
mammalian cells, it is less relevant how long the process of folding and membrane 
insertion takes, as long as enough functional molecules are presented at the cell surface. 
Hence, the enforced selection pressure could explain the coevolution of expression and 
detergent stability as observed here. 
  
In a perfect world, the evolved variants would be functionally identical to the wild 
type, while displaying increased expression and stability. With respect to ligand binding, 
the evolved variants behave as wild type, with the only exception of reduced antagonist 
affinity for L5X. The evolved variants also display signaling activity after restoration of the 
functionally important DRY motif, but similar to D03, are characterized by increased basal 
activity of the receptor. Other than C7E02 and TM86V, the L5X variant does not respond 
to agonist stimulation, and is assumed to be preferentially stabilized in the active 
conformation R*. The slight decrease in signaling ability is not desired, but tolerable, since 
especially for L5X, it indicates conformational stabilization of the active receptor, which in 
turn is advantageous for structural studies. Furthermore, all variants do still bind the 
heterotrimeric G protein, and cocrystallization of evolved GPCR variant with its cognate G 
protein is surely a relevant approach, restraining the flexible intracellular loops of the 
GPCR and providing a large hydrophilic surface for crystal contact formation.  
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Implications for the directed evolution of further GPCRs 
The high potential of D03 for directed evolution without compromising the receptor 
phenotype is striking. Together with results with other receptors, it can be assumed that 
this feature is common to all GPCRs. Future studies should therefore address if and how 
the identified shifts are transferrable to other GPCRs. As discussed above, it is not 
feasible to apply saturating mutagenesis as a standard tool for directed evolution to every 
GPCR. Rather, a combination of targeted mutagenesis, full randomization of some “hot 
spots” together with random mutagenesis of the receptor sequence could prove 
successful. Some effects identified here are likely hot spots of general relevance, allowing 
specific targeting of these positions in other GPCRs: First and foremost, avoidance of any 
free cysteine in the extracellular space is relevant for high expression of D03 (mutants 
L5X and MT1), and is likely of general interest, since it facilitates correct disulfide 
formation. Notably, mutation of C3326.59 on rNTR1 wild type does not increase functional 
expression of the wild-type receptor (Grisshammer et al., 1993). The fact that proper 
formation of the one disulfide bridge becomes relevant only at very high expression levels 
suggests that this is a limitation imposed by the E. coli host rather than by the GPCR. 
High GPCR expression levels could lead to oversaturation of the periplasmatic E. coli 
Dsb-protein family responsible for disulfide formation, or the respective cysteines may be 
inaccessible, thus causing other, unspecific intramolecular or intermolecular reactions, 
which is in both cases alleviated by mutation of C3326.59. A further striking observation is 
that many shifts hit highly conserved helical positions, denoted as x.50 by the Ballesteros-
Weinstein numbering. These positions are highly conserved throughout GPCR evolution, 
and are characteristic for each transmembrane helix. Apparently, these positions are 
highly relevant for regulation of receptor expression levels. Since these residues are also 
often involved in receptor functionality, such as R1673.50 in D03, targeted mutagenesis at 
these positions should include full randomization to include also the wild type, and 
demands further analysis to assess the effect on receptor functionality.  
Implications and questions for additional studies 
An interesting continuation of this study would be to analyze how the evolved 
variants achieve high expression and stability. Mutagenic studies on TM86V and L5X 
have already highlighted crucial residues for high detergent stability and functional 
expression levels. However, the molecular basis for these effects is not yet elucidated. 
Structure determination of individual variants could highlight differences in helix packing, 
side chain interactions and conformational state of the receptor, to decipher the molecular 
details of how expression and detergent-stability is achieved. However, despite ongoing 
efforts, crystallization of GPCRs is still a cumbersome undertaking, with no guarantee of 
success. L5X could be a first promising candidate, since it is stabilized in the active state, 
thus reducing the conformational heterogeneity of the receptor population, which is 
advantageous for crystallization. TM86V is another interesting candidate, since it is a 
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minimal mutant with respect to detergent stability. Surely, structure determination of these 
variants would mark a new milestone in our understanding of the mutants’ phenotype, and 
will simultaneously give rise to new questions and hypotheses. 
Equally interesting is the question of how the evolved variants differ from the wild 
type receptor, or other GPCRs, in terms of membrane insertion and folding to give an 
active receptor. Functional studies assaying the process of membrane targeting and 
integration via the SecYEG translocon pore in E. coli (or Sec61 in eukaryotes) could 
unravel whether the evolved variants have been adapted for efficient insertion into the 
membrane. The process of membrane insertion might represent a crucial bottleneck, 
eventually imposing an upper limit to GPCR expression by saturation of the translocon 
machinery. In light of the hypothesis that expression and selection in E. coli could have 
fostered selection for efficient protein folding, it would be interesting to analyze protein 
folding in vitro, and to compare these results to the in vivo efficiency of GPCR folding and 
integration into the lipid bilayer, both in E. coli and in mammalian cells.  
Summary 
Taken together, this work has successfully addressed the main bottlenecks in in 
vitro GPCR research, namely low expression and detergent-stability. The evolved variants 
overcome these restraints without affecting function, and hence hold great promise as 
targets for structural, functional and drug screening studies. The knowledge gained from 
the saturating mutagenesis will eventually help to more rationally engineer further GPCR 
targets, and so to expand the spectrum of GPCRs that are available for drug screening 
approaches.   
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1. Relevant plasmids  
1.1  pRGD03 and pRGD03_Avi 
The plasmid pRGD03 (Plasmid ID 2438) was used as the basis for expression and 
selection of all position-specific libraries (chapter 3), as well as for expression and 
selection of the single StEP-libraries (chapter 4). Sloning library L1 was also expressed 
from this plasmid, and Sloning libraries L2-L4 (Chapter 4) were expressed from pRGD03 
in a modified form (see Figure A-3B-D). Any library is subcloned into pRGD03 via BamHI 
and Cfr9I restriction sites. 
The plasmid pRGD03_Avi (Plasmid ID 2433) is identical to pRGD03 except for the 
C-terminal His10-tag, which is replaced by the AviTag sequence GLNDIFEAQKIEWHE. 
Expression from pRGD03-Avi leads to in vivo biotinylation of the fusion protein at the C-
terminus, and is used for all detergent-stability assays requiring immobilization of the 
fusion protein. 
 
 
 
Figure A-1. Circular presentation of plasmid pRGD03. The GPCR coding fragment, here
D03, can be replaced using BamHI and Cfr9I restriction sites. The linker between MBP and
before the TEV-site and D03 is a GS(N)10-sequence, and the linker between TEV site and
thioredoxin (TrxA) is a N5(G3S)2-EF sequence. 
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1.2   eLIC47D03 and eLIC47patD03 
eLIC47D03 and eLIC47patD03 were cloned to express D03 or any GPCR variant 
as fusion with N-terminal MBP and C-terminal thioredoxin (as in pRGD03, plasmid ID 
2438) from plasmids with higher copy number (Chapter 4). eLIC47D03 (plasmid ID 3254) 
was obtained from eLIC_047 (plasmid ID 3041, alternative name HT_369) harboring a 
ColE1-origin by replacing the SacB cassette of eLIC_047 with the MBP-GPCR-trx-H10-
2×stop fragment from pRGD03 using ligase-independent cloning. eLIC47patD03 (plasmid 
ID 3361) was subsequently obtained from eLIC47D03 by replacing the ColE1- origin of 
replication with a mutagenized ColE1-sequence ((Bayer et al., 2007)) 
 
1.3  Sloning library constructs 
Sloning library L1 (ID 3493), L5 (ID 3501) and L6 (ID 3503) were expressed as 
conventional fusion protein constructs as in pRGD03 (Figure A-3A) from vectors with 
different plasmid copy numbers. Library L1 (Figure A-4A) was cloned into vector pRGD03 
(plasmid ID 2438), whereas Library L5 was cloned into eLIC47D03 (plasmid ID 3254) and 
library L6 (Figure A-4B) into eLIC47patD03 (plasmid ID 3361). L5 and L6 are identical 
except for point mutations in the vector origin of replication. Libraries L2 (ID 3495), L3 
Figure A-2. Circular presentation of eLIC47D03 (ID 3254). eLIC47patD03 (ID 3361) is identical 
to eLIC47D03 except for ColE1, which carries additional base changes that increase plasmid
copy number further.  
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(3497) and L4 (ID 3499) are characterized by truncation of the receptor C-terminus and 
absence of the thioredoxin fusion protein (L3-L4, Figure A-3B-D). 
 
 
 Figure A-3. Sloning library constructs used in selection. (A) Conventional fusion proteinsequence of library L1. (B) Library L2 is truncated after helix 8 of the GPCR (incl. C389) in
contrast to L1, L5 and L6 (A). (C) Library L3 is truncated after helix 8 (incl. C389) and
expressed without any C-terminal tag. (D) Library L4 carries a TEV site and His10-tag after
helix 8 (incl. C389).  
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Figure A-4. Comparison of vector constructs used for Sloning library selections. Vector L1 is
derived from pRGD03, and vector L6 from eLIC47patD03. The fusion protein sequence is
identical, but the vector and importantly, origin of replication are different. L5 differs from L6
only by point mutations in the vector origin of replication. 
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1.4 Constructs for ribosome display selections 
Plasmid pAT223-pD-NT1 for expression of pD-NT1 was obtained from P. Egloff. 
The NT(8-13) peptide sequence is C-terminally fused to pD via a linker sequence. 
 
 
 
The cloning of pRG-RD_TM86V and pRG-RD_L5X is described in chapter 5, 
paragraph 5.5.4. The plasmid pRG-TM86V_P51-dWC392_3C, used for crystallization 
trials, was previously generated by P. Egloff, starting from pRGD03_TM86V. The 
unstructured N- and C-termini of the receptor were truncated and the recognition sites for 
TEV protease cleavage were replaced by 3C-recognition sites. pRG-xD_TM86V (and 
pRG-xD_L5X) is identical except for an EcoRI restriction enzyme site in the vector (Figure 
A-6). pRG-RD_TM86V (plasmid ID 3370) and pRG-RD_L5X (plasmid ID 3369) are 
derived from this construct, fusing a (G4S)6-AviTag linker to the C-terminus of the receptor 
(Figure A-7).  
 
Figure A-5. Plasmid pAT223_3C-NT1 for expression of pD-NT1. (A) Sequence of the pD-NT1
fusion protein. (B) Circular presentation of plasmid pAT223_3C-NT1.  
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The previously constructed plasmid pRDVLDnew (plasmid ID 2228; adapted from 
pRDV by J. Schilling) was used throughout ribosome display selection rounds. Plasmid 
pDST67 (plasmid ID 827; by D. Steiner) was used for expression of selected DARPins.  
Figure A-6. Circular presentation of plasmid pRG-xD_TM86V as used for expression of 
unbiotinylated receptor for ELISA experiments (and crystallization trials). Plasmid pRG-
xD_L5X is identical except for the receptor-coding sequence. 
Figure A-7. Circular presentation of pRG-RD_TM86V (plasmid ID 3370). TM86V is extended
by a flexible (G4S)6-linker and the AviTag-sequence (GLNDIFEAQKIEWHE). pRG-RD_L5X
(plasmid ID 3369) is identical except for the receptor-coding sequence. 
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2. Cell strains 
2.1  E. coli DH5 
The E. coli strain DH5 was used throughout all cloning procedures, and for 
expression of rNTR1-variants for selection and detergent-stability measurements. 
Chemocompetent cells were prepared according to a modified Inoue protocol  (Inoue et 
al., 1990). Electrocompetent cells were prepared according to (Dower et al., 1988).  
Genotype: F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZ∆M15 
∆(lacZYA-argF)U169, hsdR17(rK- mK+), λ- 
2.2 E. coli XL1blue 
The E. coli strain XL1blue was used for expression of DARPins. XL1blue provides 
lacIq in trans, and is thus suitable to express DARPins from pDST67 that does not have 
lacIq in cis. Chemocompetent cells were prepared according to a modified Inoue protocol 
(Inoue et al., 1990). 
Genotype: endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq 
∆(lacZ)M15] hsdR17(rK- mK+) 
2.3 E. coli BL21(DE3) 
The E. coli BL21(DE3) strain was used for large-scale fermenter-expression of 
rNTR1-variants. Chemocompetent cells were prepared according to a modified Inoue 
protocol (Inoue et al., 1990). 
Genotype: F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 
sam7 nin5]) 
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3. Detergents 
 
The detergents CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propane- 
sulfonate) and CHS (cholesterol hemisuccinate) in combination with DM (n-decyl--D-
maltopyranoside) were used for solubilization of the receptor variants from the E. coli 
membrane. DDM (n-dodecyl--D-maltopyranoside), DM, NM (n-nonyl--D-
maltopyranoside), OG (n-octyl--D-glucopyranoside) and HTG (n-heptyl--D-
thioglucopyranoside) were used during detergent stability assays, to assess the influence 
of the detergent on receptor stability. The size of the detergent micelle depends on the 
detergent, with decreasing radius in the following order: DDM > DM > NM > OG > HTG.  
   
Figure A-6. Chemical structure of the detergents used in this study. 
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4. Abbreviations 
2YT 2x concentrated yeast tryptone medium 
3C recombinant protease from human rhinovirus 
aa amino acid 
AviTag avidin-tag, a polypeptide sequence for in vivo biotinylation (sequence: GLNDIFEAQKIEWHE) 
b-L5X, b-TM86V biotinylated L5X or TM86V 
BirA E. coli Biotin Ligase BirA 
BODIPY boron-dipyrromethene 
bp  base pairs 
BP-NT BODIPY-neurotensin  
BSA  bovine serum albumin 
C7E02 evolved variant of rNTR1 
cDNA  complementary DNA/ mRNA-copy 
ceELISA  crude-extract ELISA 
CHAPS 3-[(3-cholamidopropyl)-dimethylammonio]-1-propane sulfonate 
CHS cholesteryl hemisuccinate 
CV column volumne 
DARPin designed ankyrin repeat protein 
DDM n-dodecyl--D-maltopyranoside 
DM n-decyl--D-maltopyranoside 
DMSO dimethylsulfoxide 
DTT dithiothreitol 
E. coli Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
EL1/ECL1 extracellular loop 1 
ELISA enzyme-linked immunosorbent assay 
FACS fluorescence activated cell sorting 
GDP guanosine diphosphate 
GPCR G protein-coupled receptor 
GTP guanosine triphosphate 
GTPS non-hydrolyzable GTP analog; thioester bond 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HTG n-heptyl--D-thioglucopyranoside 
ID/plasmid ID plasmid collection identification number for the described plasmid 
IEX ion exchange chromatography 
IL1/ ICL1 intracellular loop 1 
IMAC immobilized metal ion affinity chromatography 
IMP integral membrane protein 
IPTG isopropyl--D-thiogalactoside 
kDa kiloDalton 
KFF King Fisher Flex 
L5X evolved variant of rNTR1 
LB Luria Broth  
LCP lipidic cubic phase 
APPENDIX 
- 195 - 
MBP maltose binding protein 
MFI mean fluorescence intensity 
mRNA messenger RNA 
MW  molecular weight   
MWCO molecular weight cutoff 
N2C  DARPin library with N-cap, C-cap and 2 internal repeats 
NHS N-hydroxysuccinimide 
Ni-NTA nickel-nitrilotriacetic acid 
NM n-nonyl--D-maltopyranoside 
NT neurotensin 
OD600 optical density at 600 nm 
off7  DARPin binder to MBP 
OG n-octyl--D-glucopyranoside 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
pD/ gpD capsid-stabilizing protein from bacteriophage  
PDB Protein Data Bank 
PDB ID Protein Data Bank identification number 
pI isoelectrical point 
Plasmid ID/ ID plasmid collection identification number for the described plasmid 
pNPP 4-nitrophenyl phosphate disodium salt 
R Inactive conformational state of a GPCR 
R* active conformational state of a GPCR 
RBS ribosomal binding site 
RD ribosome display 
RLBA radioligand binding assay 
RNC ribosome-nascent-chain complex 
rNTR1 
RT 
rat neurotensin receptor 1 
room temperature 
scRNA Sacharomyces cerevisiae RNA 
SDS sodium dodecylsulfate 
SEC size exclusion chromatography 
Sf9 Spodoptera frugiperda 
SPR surface plasmon resonance 
StEP staggered extension process 
T4L T4 lysozyme 
TEV tobacco etch virus 
TM transmembrane helix 
TM86V evolved variant of rNTR1 
trx/ TrxA thioredoxin 
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